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ABSTRACT 
The pharmaceutical industry is undergoing a paradigm change with the advancement 
towards the Fourth Industrial Revolution. The manufacturing framework is moving 
from batch to continuous, which has been accompanied by the necessity of the 
implementation of process analytical technologies (PAT) for continuous process 
monitoring and control. There has also been a need to develop advanced quality 
approaches such as Quality by Design (QbD) and Quality by Control (QbC). Within 
these quality approaches, modelling has been used to expand knowledge related to 
raw material attributes and transformations that happen during the process, and to 
monitor and control process parameters. Besides the development of models for 
process and product transformations understanding and monitoring, predictive 
models have been an important advancement to reduce experimental cost during 
formulation development and process design. There are challenges that need to be 
addressed in order to complete the implementation of continuous process and 
advanced quality approaches in that pharmaceutical sector. It is necessary to extend 
the full mechanistic knowledge of processes, to develop data analysis and computer 
simulation, to expand the number of equipment and models to scale up solutions, 
and to upskill personnel to work with the technologies required.   
The general aim of this thesis was to increase understanding of pharmaceutical 
materials and processes by the development of PAT and models for quantitative 
characterization and prediction of drug substance and drug product critical 
properties. To achieve this aim, several specific objectives were established focused 
on different aspects of oral dosage form manufacture. 
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Initially, a PAT was developed to rapidly characterize microcrystalline cellulose (MCC) 
percentage crystallinity index. MCC crystallinity was determined from Raman 
spectral data. Then, MCC moisture sorption and moisture monolayer were 
determined from isotherms obtained using dynamic vapor sorption (DVS). A 
correlation between both attributes was investigated. However, it was not possible 
to confirm the relationship between the monolayer moisture sorption and the 
percentage crystallinity. A total of 30 commercial batches of MCC were used to 
design and validate the MCC crystallinity model. Furthermore, a web application, 
McCrystal, was designed to disseminate the model. Available at 
https://sspc.ie/mccrystal/. 
Secondly, a PAT was developed to determine the endpoint and monitor form changes 
during slurry co-crystallization. This PAT tool involved the application of in situ Raman 
spectroscopy combined with principal component analysis (PCA). An additional PAT 
tool was developed using Mid Infrared spectroscopy (MIRS) combined with 
multivariate curve resolution (MCR) in order to quantitatively evaluate phase purity 
of co-crystals produced by slow evaporation and slurry co-crystallization. The models 
developed were applied to different combinations of active pharmaceutical 
ingredients (APIs) and coformers, and were able to determine the co-crystallization 
endpoint for all systems where the solvents exhibited a weak Raman signal. 
Moreover, the phase purity for all co-crystals systems investigated was determined. 
The third challenge addressed by this study relates to particle-particle interactions in 
powder blends to predict the general behaviour of the blend when it is directly 
compressed into pharmaceutical tablets. Percolation threshold model was used to 
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determine a critical drug load, above which the powder blend behaves similarly to 
the drug substance. As a result, the formulation may show undesirable properties 
above the threshold, which can lead to non-compliance or process difficulties. The 
application of PCA to determine the critical drug loading was investigated. The 
predicted values of critical drug loading were confirmed by changes in powder 
flowability, tablet weight variation, and Raman spectroscopic analysis of drug 
distribution. PCA was not able to precisely predict the threshold, however, it aided in 
clarifying differences between the blends containing different ibuprofen loadings 
and different MCC grades. 
Expanding on the impact of critical drug loading on tablet critical quality attributes, 
the final objective was to investigate the impact of critical drug loads, determined 
from compaction data, on disintegration and dissolution performance. The 
application of novel process analytical technologies, in-process video microscopy 
(PVM) and focused-beam reflectance measurement (FBRM), to study tablet 
disintegration was also proposed and investigated in-depth. FBRM and PVM provided 
important information of tablet disintegration behaviour that cannot be captured by 
the traditional disintegration testing. The critical drug load predicted from 
compaction data was also relevant for disintegration and dissolution behaviour. 
Above the threshold drug loading, disintegration and drug release rates were 
decreased. A PCA model developed from Raman spectra acquired from tablet 
surfaces further supported the finding that blends manufactured with different 
grades of MCC differed more significantly above the critical drug load.  
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The work presented in this thesis is a contribution to solid dosage formulation design, 
co-crystallization understanding, tableting process scale up and scale down, and data 
handling. The models and PAT developed can be used to predict formulation 
performance, determine process parameters based on raw material critical 
attributes, determine process endpoint, and thoroughly assess final product critical 
quality attributes. 
 
Keywords: Pharmaceutical Technology, Quality by Design (QbD), Process Analytical 
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ABBREVIATIONS 
a  Eigenvectors 
Ace  Acetone 
ACN  Acetonitrile 
ALS  Alternating Least Squares 
API  Active Pharmaceutical Ingredient 
BET  Brunauer, Emmett and Teller 
CE  Circle equivalent  
CF  Chloroform  
CFD  Computational fluid dynamics 
CMA  Critical material attribute 
CPP  Critical process parameter 
CPS  Cyber-Physical Systems 
CQA  Critical quality attribute 
D  Tablet diameter 
D10 Diameter at which 10% of a sample's mass is comprised of smaller 
particles  
D50 Diameter at which 50% of a sample's mass is comprised of smaller 
particles (median particle size) 
D90  Diameter at which 90% of a sample's mass is comprised of smaller 
particles 
DCM  Dichloromethane 
DEM  Discrete element methods 
DoE  Design of Experiments 
DSC  Differential scanning calorimeter 
DVS  Dynamic vapour sorption  
EMA  European Medicines Agency 
EtOAc  Ethyl acetate 
EtOH  Ethanol 
FDA  Food and drug administration 
FTIR  Fourier transform infrared spectroscopy 
GAB  Guggenheim, Anderson, de Boer 
Gmix  Gibbs free energy of mixing 
H  Tablet hardness 
 
Ana Luiza Pinto Queiroz Page 25 
HB  Hydrogen bonding to intermolecular interaction of API and coformer 
Hex  Excess enthalpy 
HR  Hauser ratio 
HTZ  Hydrochlorothiazide  
I  Spectral intensity 
I  Generic identity matrix 
ICH  International Conference for Harmonisation 
loT  Internet of Things 
m  Mass 
MCC  Microcrystalline Cellulose 
MCR  Multivariate curve resolution 
MeOH  Methanol 
MIR  Mid-infrared spectroscopy 
MVA   Multivariate analysis 
n  Number of rows in a generic matrix 
NCT  Nicotinamide 
NIR  Near-infrared spectroscopy 
P  Generic matrix of loadings 
p  Number of columns in a generic matrix 
PAT  Process Analytical Technology  
PC  Principal Component 
PCA  Principal Component Analysis 
Ph  European Pharmacopeia  
PLS  Partial least squares 
PXRD  Powder X-ray diffraction 
q  Percolation threshold generic exponent 
QbC  Quality by control 
QbD  Quality by design 
QbT  Quality by testing 
QTPP  Quality target product profile 
r  Pearson correlation coefficient 
RH  Relative humidity 
RMSEC  Root Mean Squared Error of Calibration 
RMSEP  Root Mean Square Error of Prediction 
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S  Covariance matrix 
SEM  Scanning electron microscopy 
SNV  Standard Normal Variate 
T  Generic matrix of scores, tablet thickness  
Tf  Percolation threshold coefficient for tablets tensile strength 
TGA  Thermogravimetric analysis 
W Weight of moisture absorbed onto the surface of a solid per weight of 
the dry solid  
% CI  Percentage crystallinity index 
% w/w  Mass fraction 
?̅?  Arithmetic mean 
µm  Micron/micrometer 
X  Generic matrix of independent variables 
Xc Mass fraction, critical drug loading in the percolation threshold theory 
Y  Generic matrix of dependent variables 
ε  Porosity 
λ  Eigenvalues 
ρ  Relative density/occupation probability 
ρbulk  Powder bulk density 
ρc  Percolation threshold 
ρtablet  Tablet density 
ρtapped  Powder tapped density 
ρtrue  Powder true density 
Ρyield  Yield pressure 
σ   Standard deviation, compaction pressure 
σT  Tablet tensile strength 
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1.1 Background 
The Fourth Industrial Revolution, Industry 4.0, has been changing the dynamic of 
industrial production. According to Lasi et al (Lasi et al., 2014), the future of 
manufacturing systems will be technology-pushed and application-pulled. The 
physical world would be integrated with the virtual space by technologies such as 
Internet of Things (IoT) (Gubbi et al., 2013), Cyber-Physical Systems (CPS) (Lee et al., 
2015), and semantic machine-to-machine communication (Da Xu et al., 2018). Smart 
factories will be progressively more equipped with sensors and autonomous systems 
so that physical parameters will be digitally recorded and processed. In relation to 
automation and control, this means that computational models that contain 
statistical analysis can be used to interpret if processes are trending to achieve 
quality targets. If the production is not within designed spaces, signals can be 
automatically sent back to the process so that the necessary adjustments are 
implemented in every unit operation required. Thus, smart factories are 
characterized by increased efficiency, science-based approaches and continuous 
process verification and optimization. Thorough process understanding and big data 
analysis are seen as key to the transition towards smart factories (Da Xu et al., 2018; 
Spes and Levin, 2018).  
Pharmaceutical and biopharmaceutical manufacturers have been traditionally 
operating in batch processes that were controlled by rigid frameworks. In this 
approach, quality is ensured by testing the raw materials, the process parameters 
and the final product characteristics (Rantanen and Khinast, 2015). When defective 
products are detected, batches can be easily separated for disposal or reprocessing 
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(Crowley and Crean, 2015). This enabled batch production and a quality by testing 
(QbT) system to remain in place for many decades. Even though, this combination is 
known to be limited (Rantanen and Khinast, 2015; Rathore and Winkle, 2009). 
Product wastage is the main problem encountered in this approach, being reported 
to be as much as 50% of the product manufactured in some cases (Rathore and 
Winkle, 2009). Process understanding is not a priority under batch manufacturing 
and QbT. As a result, most of the data generated during the process is only used for 
compliance (Manzano and Langer, 2018). Delays in technological advances in the 
pharmaceutical and biopharmaceutical industries, has been attributed to this 
traditional approach and the regulatory agencies rigorous oversight of the sector. 
Both factors have contributed to the delay and cost of developing, implementing and 
validating new technologies within the sector (Rathore and Winkle, 2009).  
In recent years regulatory agencies acknowledged the advantages of encouraging 
innovative technological solutions and fundamental scientific work to guide 
pharmaceutical development (Rantanen and Khinast, 2015). Regulatory agencies 
have adopted guidelines for the implementation of well-established chemical 
engineering knowledge to pharmaceutical and biopharmaceutical manufacturing 
(International Council for Harmonisation, 2014, 2008, 2005a, 2005b). The published 
guidelines aim to increase safety and quality of medications, reduce manufacturing 
costs and implement more structured pharmaceutical development and 
manufacturing approaches (Rantanen and Khinast, 2015).  
Highlights of those guidelines include (i) migration from batch to continuous 
manufacturing, (ii) implementation of process analytical technologies (PAT) 
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combined with predictive models, and (iii) implementation of advanced quality 
approaches, namely quality by design (QbD) (Yu et al., 2014) and quality by control 
(QbC) (Su et al., 2019). Those three subjects are linked to each other. QbD principles 
are encouraged for both batch and continuous manufacturing processes (Potter, 
2009). However, continuous manufacturing has many advantages (see section 1.3) 
and is being supported by regulatory agencies. To enable the transition from batch 
to continuous processes, the application of QbD concepts and PAT is essential. 
Moreover, a new quality approach, QbC has been developed to address specific 
quality challenges of continuous manufacturing.  
Continuous manufacturing, advanced quality approaches and predictive modelling 
appear to be the basis of the advances towards Pharma 4.0 (De Matas et al., 2016; 
Steinwandter et al., 2019; Su et al., 2019). Thus, the focus of this thesis was the 
underlying science and the main techniques involved in QbD and QbC approaches 
with emphasis on control tools that could be applied to continuous manufacturing. 
PAT tools as well as formulation and process knowledge developed in this thesis 
addressed some of these challenges.  
1.2 Advanced quality approaches  
1.2.1 Overview 
A high-quality drug product was defined as being reliably available, not contaminated 
and to consistently deliver all characteristics stated in the label and clinical 
performance (Woodcock, 2004). A drug product is the final result of an extensive 
work that includes development, manufacture, and registration stages 
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(Steinwandter et al., 2019). Hence, in an optimal scenario, quality should be built in 
the entire drug product life cycle rather than in the final product only.  
In a control strategy point of view, the traditional quality by testing approach (Level 
3, Figure 1.1) is now considered obsolete and has been replaced by QbD. QbD has 
been encouraged by regulatory agencies for both batch and continuous processes 
(Yu et al., 2014). This means that control strategy is moving from Level 3 to Levels 2 
and 1, towards real-time control strategies upon flexible processes. Besides QbD, a 
new approach, known as QbC, has being developed (Nunes de Barros et al., 2017; 
Sommeregger et al., 2017; Su et al., 2019; Szilágyi et al., 2019). The concept of QbC 
emerged from the developments around the Level 1 control strategy proposed by Yu 
et al. (Su et al., 2019). Thus, QbC as a framework is intended for application to 
continuous manufacturing and aims to optimize the Level 1 of control strategy. 
 
Figure 1.1. Control strategy options (Yu et al., 2014). 
QbD and QbC entail widespread scientific understanding, especially extensive 
product and process knowledge (De Matas et al., 2016; Su et al., 2019). This is one 
important milestone to enable the features of Pharma 4.0 (Steinwandter et al., 
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2019). Product and process understanding has been defined as key factors to enable 
high-quality drug products manufacturing and excellence in clinical performance. Sun 
et al. indicated that the pathway to achieve pharma smart manufacturing is to invest 
in continuous processes ruled by quality approaches that emphasize predictive 
understanding and integrated active process control (Figure 1.2) (Su et al., 2019). 
QbD, QbC, and continuous manufacturing will be discussed in detail in the following 
sections. 
 
Figure 1.2. Progression of pharmaceutical quality approaches (Su et al., 2019). 
1.2.2 QbD approach to pharmaceutical development 
Quality by design was developed in 1992 (Juran, 1992). The main concept proposed 
was that most quality problems of a product were due to the way that the product 
was designed. The objectives of QbD include the achievement of meaningful product 
quality specifications, improvement of process capability, reduction of product 
variability and defects, and increase in product development and manufacturing 
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efficiency (Yu et al., 2014). QbD was developed further by the pharmaceutical 
industry and published by the International Council for Harmonization of Technical 
Requirements for Pharmaceuticals for Human Use as a series of guidelines: Q8 (R2) 
Pharmaceutical Development, Q9 Quality Risk Management, Q10 Pharmaceutical 
Quality System, Q11 Development and Manufacture of Drug Substance, and Q12 
Lifecycle Management (International Council for Harmonisation, 2014, 2008, 2005a, 
2005b). 
Pharmaceutical QbD is defined as “a systematic approach to development that 
begins with predefined objectives and emphasizes product and process 
understanding and process control, based on sound science and quality risk 
management” (International Council for Harmonisation, 2005a). Hence, quality is 
ensured when QbD elements are applied to guide the systematic understanding and 
control of the formulation and the manufacturing variables (Yu, 2008). The main 
elements of QbD are: 
 Quality Target Product Profile (QTPP): detailed information about the final 
product characteristics.  
 Critical Quality Attributes (CQA): physical, chemical, biological, or 
microbiological property or characteristic of the excipients, the drug 
substance, intermediates and drug product that should be within an 
appropriate limit, range, or distribution to ensure the desired product quality 
(CQAs for other delivery systems are out of the scope of this thesis).  
 Risk Assessment: used to identify which process parameters and material 
attributes influence product CQAs. 
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 Design Space: multidimensional relationship between the process inputs 
(material attributes and process parameters) and the critical quality 
attributes.  
 Control Strategy: a set of controls that ensure process performance and 
product quality. Controls can include parameters and attributes related to 
drug substance and drug product materials and components, facility and 
equipment operating conditions, in-process controls, finished product 
specifications, the associated methods, and frequency of monitoring and 
control. The development of these controls requires rich formulation, 
product and process understanding (International Council for Harmonisation, 
2008). 
1.2.3 QbC approach to pharmaceutical development 
The main concept of QbC is that high-quality products are obtained when the process 
is effectively controlled, especially when it is applied to continuous manufacturing 
(Nunes de Barros et al., 2017; Sommeregger et al., 2017; Su et al., 2019; Szilágyi et 
al., 2019). QbC is defined as “the design and operation of a robust manufacturing 
system that is achieved through an active process control system designed in 
accordance with hierarchical process automation principles, based on a high degree 
of quantitative and predictive product and process understanding” (Su et al., 2019). 
This approach includes many QbD elements, such as CQAs and critical process 
parameters (CPPs). However, QbD does not provide guidance on systematic 
quantitative procedures for the design of the suitable control architecture and 
methodology. Hence, QbC was developed to address this issue by providing a 
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framework to the implementation of efficient real-time process control, especially in 
continuous manufacturing (Su et al., 2019) 
The proposed framework (Figure 1.3) aims to facilitate the integration of hardware 
and software for control strategy implementation, especially to continuous 
manufacturing. D1 and D2 refer to an extensive raw material characterization and 
product design, respectively. D3 requires specific knowledge of the manufacturing 
process to produce the designed product. Subsequently the manufacturing process 
or pilot plant (P2) is configured with the corresponding control platform and PAT 
sensors (P1). A model library (S1) will be recorded and accessed by flowsheet 
simulation software (S2). This is an important advantage of QbC regarding storage 
and processing of the model of control strategy, as QbD does not provide guidelines 
for that. Simulations performed on S2 will allow continuous verification of the models 
by means of sensitivity analysis and system identification (C1). Subsequently, a 
control design and analysis (C2) will be performed. When the steady state operation 
is identified on C1, the control design and analytics constructs a state-space model, 
which is a set of differential and algebraic equations that represents the system. The 
models designed are then verified by C3, C4, and C5. This three-step verification will 
be performed in loop until the designed models meet real time release requirements 
(Su et al., 2017).  
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Figure 1.3. Quality by control framework (Su et al., 2017). 
Advancements in PAT tools and mechanistic understanding of processes are part of 
QbC framework. Thus, the objectives of this thesis aim to contribute to the 
development of QbC in the design of model-based process quality assurance in 
pharmaceutical process operations. 
1.3 Continuous manufacturing 
A proposed definition of a continuous manufacturing is “an industry with processes 
that are integrated, based on a systems approach, having model-based control, and 
making use of flow” (Badman and Trout, 2014). Continuous manufacturing has been 
indirectly discussed in previously published quality guidelines (International Council 
for Harmonisation, 2014, 2008, 2005a, 2005b). However, the International 
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Conference on Harmonization (ICH) has endorsed a new guideline (ICH Q13) to 
provide a basis for the implementation of continuous manufacturing, which is 
expected to be finalised in 2021 (International Council for Harmonisation, 2018). ICH 
Q13 aims to address technical and scientific requirements necessary to fulfill 
regulatory expectations regarding continuous manufacturing. 
Companies have been investing in continuous manufacturing and, as a result, a 
number of drug substances have been approved by FDA to be produced by 
continuous manufacturing, such as Orkambi (lumacaftor/ivacaftor) from Vertex in 
2015, Prezista (darunavir) from Janssen in 2016, Verzenio (abemaciclib) from Lilly and 
Symdeko (glasdegib) from Pfizer in 2018 (Su et al., 2019). The benefits of operating 
in a continuous manufacturing have been widely discussed and include the following 
(Badman and Trout, 2014; Crowley and Crean, 2015; S. L. Lee et al., 2015; Mascia et 
al., 2013; Nasr et al., 2017; Rogers and Jensen, 2019): 
 Reduction in manufacturing costs. Continuous manufacturing requires 
smaller equipment and infrastructure and allows reduction of unit 
operations. Continuous manufacturing can also enable end-to-end 
production. In other words, drug substance and drug product, that are 
currently often separately located, can be produced in the same facilities.  
 Increase in reliability and safety. For example, hazardous intermediates can 
be converted during production, in isolated systems. 
 Improved flexibility. For example, the amount of product manufactured can 
be changed by running the process for shorter or longer periods of time. 
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 Novel pathways that enable the production of Active Pharmaceutical 
Ingredients (APIs) or final drug products that are not otherwise accessible.  
 Built in quality throughout the process and reduced product time to market.  
The challenges to implement continuous manufacturing have also been discussed. It 
is important to note that continuous manufacturing is already common in other 
industry segments e.g., petrochemical and bulk chemical industries (Darby and 
Nikolaou, 2012; Lee et al., 2015). However, to enable continuous manufacturing in 
the pharma industry it is necessary to expand the full mechanistic knowledge of 
processes, develop modeling and computer simulations, expand the number of 
equipment to scale up solutions from bench to pilot and industrial scales. It is also 
necessary to develop advanced control strategies, such as QbD, and implement PAT 
for real-time control. Furthermore, addressing difficulties such as processing dry 
solids and solid-laden fluids, and multi-unit-operation connectivity would also be 
required (Baxendale et al., 2015; Mascia et al., 2013). Another challenge to 
implement continuous manufacturing is to ensure that there are personnel skilled to 
work with the technologies required (Badman and Trout, 2014; De Matas et al., 
2016). The skill set essential for continuous manufacturing includes chemical 
engineering, physical chemistry, flow chemistry, chemistry–process interface, and 
process-data science interface skills (Baxendale et al., 2015; Steinwandter et al., 
2019).  
The focus of this thesis was drug product manufacture. Solid oral dosage forms are is 
the most common dosage form for drug administration due to their its high degree 
of drug stability and dosage accuracy. Among solid dosage forms, tablets are the 
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most prevalent. Tablets can be manufactured by different processes, including wet 
granulation, dry granulation and direct compression. However, direct compression is 
the most direct route of manufacturing (Figure 1.4). Pharmaceutical companies have 
announced investments in research and development around small molecules to 
adjust APIs for continuous manufacturing of tablets using direct compression 
processes (Hausner, 2018; Nunes de Barros et al., 2017; Su et al., 2019). The smaller 
number of unit operations involved in this process facilitates the migration from 
batch to continuous manufacturing, the application of advanced quality control 
strategies, and usage of robust PAT and models for manufacturing control (Gohel and 
Jogani, 2005). In this thesis, models for prediction and process understanding that 
can be applied to continuous manufacturing related to tablet direct compression 
were investigated. 
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Figure 1.4. Direct compression, dry granulation and wet granulation tableting 
process (Gohel and Jogani, 2005). 
1.4 Process analytical technology  
A Process Analytical Technology is “a system for designing, analyzing, and controlling 
manufacturing through timely measurements i.e., during processing, of critical 
quality and performance attributes of raw and in-process materials and processes, 
with the goal of ensuring final product quality” (European Medicines Agency, n.d.; US 
FDA, 2004). PAT is used to improve understanding and control manufacturing 
processes and it is a broad field that includes process analysis, chemical engineering, 
chemometrics, knowledge and risk management, and process automation and 
control (Bakeev, 2010). Thus, PAT is a tool to enable continuous manufacturing and 
represent an important aspect of QbD and QbC (Page et al., 2015).  
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As per the definition published from the joint report of US FDA and EMA, PAT is not 
only used in process control strategy. The implementation of PAT results in a high 
degree of process understanding. PAT is used at different stages of manufacturing 
process which includes process development studies, before process, in process, 
after process and QbD (Pomerantsev and Rodionova, 2012). PAT used before a 
process to control raw material properties is an important part of PAT since 
properties of input material may tune process parameters. After process PAT refers 
to real-time release testing to confirm if the product has satisfactory quality. In QbD, 
PAT works to help build quality into the product throughout the entire lifecycle. In 
this case, QbD tools are used to define the design space and to reveal the sources of 
process variability. PAT is then placed to control the process within the defined 
design space (Pomerantsev and Rodionova, 2012).  
PAT technologies are reliant on mathematical and statistical models that are 
designed to interpret the signals generated by PAT instruments. Near infrared (NIR) 
(Reich, 2005), Raman spectroscopy (De Beer et al., 2011), and middle infrared (MIR) 
(Van Eerdenbrugh and Taylor, 2011) are the most commonly used PAT instruments 
(Figure 1.5) (Bakeev, 2010). Among numerous chemometric techniques used in PAT, 
multivariate data analysis represents the most applied model in PAT (Figure 1.6) 
(Esbensen and Swarbrick, 2019; Pomerantsev and Rodionova, 2012). The PAT models 
used in this thesis will be discussed in detail in the next sections.  
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Figure 1.5. Spectroscopic techniques used in PAT applications (Pomerantsev and 
Rodionova, 2012). 
 
Figure.1.6. Chemometric models used for PAT applications. Multivariate image 
analysis (MIA), multivariate statistical process control (MSPC), multiway (N-way), 
multivariate curve resolution (MCR), theory of sampling (TOS), design of 
experiments (DoE), partial least squares (PLS), and principal component 
analysis/soft independent modelling of class analogy (PCA/SIMCA) (Pomerantsev 
and Rodionova, 2012). 
1.5 Data analysis and models of control 
Mathematical models are ways to describe a system using mathematical language 
(Kourti et al., 2014). Modelling and big data analysis are key for pharmaceutical 
technological advancements. They appear in all quality approaches, represent a 
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fundamental part of PAT, and are the basis for the 4th industrial revolution (Sin et al., 
2009; Steinwandter et al., 2019; Yu et al., 2014). However, mathematical modelling 
is still in development in the pharmaceutical industry. There is an enormous amount 
of data being generated by sensors placed on processes. However, most of the data 
generated is still only used for compliance (Manzano and Langer, 2018). This gap is 
explained by the complexity of designing practical applications integrating big data 
from heterogeneous sources and the lack of skilled personnel to perform this work 
(Da Xu et al., 2018).  
Quantitative models are generally classified as mechanistic, empirical or hybrid. The 
information required and the overall understanding to derive the models decreases 
from the mechanistic to empirical approaches (Figure 1.7) (Chatterjee et al., 2017). 
 
Figure 1.7. Knowledge of process required in different model classes (Chatterjee et 
al., 2017). 
Empirical models are built based on data acquired from a process and not as much 
from an understanding of that process. Most of these models have a retrospective 
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character because they are based on historical data, and they are usually used to 
identify relationships between input and output variables (Djuris and Djuric, 2017). 
Multivariate empirical analysis such as Design of Experiments (DoE), and 
chemometric models such as Multivariate Curve Resolution (MCR), Partial least 
squares (PLS) and Principal Component Analysis (PCA) are examples of empirical 
models. The application of this class of model is extremely valuable for complex 
process understanding and control when representative data is available for design 
and validation. However, it has a limited application to new experimental or 
operational setups. In other words, an empirical driven model is only valid in the 
design space used to build the model. This problem can be solved by the addition of 
data collected in the new operational setup to the original model (Esbensen and 
Swarbrick, 2019). This class of models is typically used within PAT.  
Mechanistic models are based on physical/chemical laws e.g., conservation of 
energy, fluid flow, and mass balance. Thus, discrete element methods (DEM) 
(Ketterhagen et al., 2009), finite element methods (FEM) (Reddy, 1989), and 
computational fluid dynamics (CFD) (Anderson et al., 1995) simulations are examples 
of this class of models (Djuris and Djuric, 2017). Empirical models are derived from a 
high-level process understanding, and thus provide a very transparent 
representation of the underlying phenomenon (Chatterjee et al., 2017). Developing 
mechanistic models can be very complicated and encounter many difficulties. 
Besides the development of equations, it is necessary to associate parameters that 
represent the system accurately. Pharmaceutical in-line analytical measurement and 
data recording systems have yet to be greatly improved (Djuris and Djuric, 2017).  
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Hybrid models are the result of a combination between mechanistic and empirical 
models. They are usually applied to scale-up and to estimate properties such as 
compression and compaction parameters (Djuris and Djuric, 2017). Heckel, Kawakita, 
and Shapiro equations, and the Percolation Threshold model are examples of hybrid 
models.  
1.6 Mathematical models investigated in this thesis 
1.6.1 Principal component Analysis   
Principal component Analysis (PCA) (Pearson, 1901) is a statistical model used to 
reduce the number of variables, independent or correlated in a data matrix. The vast 
number of variables of the original data matrix is transformed into a new set of 
variables named principal components (PCs) that are ranked so that the first few PCs 
explains the most of the variability in the data (Joliffe and Morgan, 1992; Jolliffe, 
1982; Pearson, 1901). In other words, a small number of PCs is used to explain a large 
variability in the data. The optimal number of PCs depends on the objectives of the 
work. It is important to observe that even PCs that show low amounts of variability 
information may offer predictive value (Jolliffe, 1982). PCs are linear combinations of 
the original variables geometrically defined as orthogonal directions that maximize 
the variance of the data. Therefore, PCs do not hold a physical meaning. 
Besides the principal components, a PCA model also returns scores (T) and loadings 
(P) of a data matrix 𝑋 (Equation 1.1). The variability not explained by the PCs is given 
as the error E.  The data matrix is organized so that the observations e.g., time points 
or batches, are distributed in the 𝑛 rows and the variables in the 𝑝 columns. 
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X , =
x x … x
x x … x
⋮ ⋮ ⋱ ⋮
x x … x
  
𝑋 = 𝑇𝑃  + 𝐸 (Equation 1.1) 
The scores are new values assumed by the observations (samples or time points) in 
the new geometric space determined by the principal components i.e., by the new 
set of variables with reduced dimensionality (𝑘 < 𝑝). The scores are used to identify 
similarities among the observations. Loadings explain which variables are responsible 
for the similarity or dissimilarity among the observations identified in the scores plot. 
Scores and loadings should be analyzed together because they provide 
complementary information. 
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Figure 1.8. Matrix interpretation of principal component analysis. 
PCA can be performed by eigenvalue decomposition as described in the following 
steps (Rencher, 2003): 
Step 1: Determine the mean (?̅?) and the standard deviation (𝜎) of each variable. 
Equation 1.2 shows calculation of the mean and Equation 1.3 shows the calculation 




x  (Equation 1.2) 
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x − x  (Equation 1.3) 
Step 2: Standardize the variables when the variables are not in the same scale. 
Equation 1.4 manipulates the variables, so they have a mean of zero and standard 
deviation of one-unit variance. The following steps considered 𝑥 ,  equal 






Step 3: Mean-centre the data. Shift of the data so the centre point is the centre of 
the swarm of point by making 𝑥 , = 𝑥 − ?̅?   
Step 4: Calculate the covariance matrix (S) (Equation 1.5). The covariance matrix 
explains how the variables are related to each other. This results in a symmetric and 











s c … c
c s … c
⋮ ⋮ ⋱ ⋮





 (Equation 1.5) 
Where the diagonal (𝑠 ) elements are the sample variances for each variable 
(Equation 1.6) and the off-diogonal elements (𝑐 ) are the sample covariances 
between pairs of variacles i and k (Equation 1.7). 
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x − x x − x   (Equation 1.7) 
Step 5: Determine the eigenvalues (λ ) (Equation 1.8) and eigenvectors (a  , i = 1, 2, 
…, p) (Equation 1.9). There exists one eigenvalue for each eigenvector. Thus, each 
eigenvalue is the variance explained by the corresponding eigenvector. 
Geometrically, the eigenvectors are the directions of the axes of the most variance, 
therefore, they are the principal components. All the eigenvectors of a matrix are 
orthogonal to each other, which agrees with the definition of principal components. 
In Equation 1.8, I is an identity matrix i.e., the diagonal elements are equal to one 
and the off-diagonal elements are equal to zero. In Equation 1.9 a  represent the 
principal components (a  , i = 1, 2, …, p). 
det(S − λ I) = 0 (Equation 1.8) 
(S − λ )a = 0 (Equation 1.9) 
Eigenvectors can only be calculated for square matrices. Given a nxn matrix there are 
n eigenvectors. If the eigenvector is multiplied by a scalar, the eigenvector will have 
the length changed but the direction will remain the same. All the eigenvectors of a 
matrix are orthogonal to each other. 
Step 6: Convert the eigenvectors (a ) to unit vectors (𝑎 ) i.e., all the eigenvectors will 
have magnitude of 1. This is done using Equation 1.10 where ‖a ‖ is the magnitude 
of the eigenvector a . This conversion does not change eigenvector direction, it only 
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gives the simpler form of the eigenvector in order to avoid multiple solutions. In 




 (Equation 1.10) 
Step 7: Rank the eigenvalues (λi) from highest to lowest in order to rank the principal 
components in order of significance. 
Step 8: Choose the number of PCs and create the feature vector A i.e., a matrix 
containing the principal components (eigenvectors). 
Step 9: Compute the scores matrix (T) i.e., recast the data along the principal 
components axes using dot product (Equation 1.11), where X is the standardized, and 
mean centred data matrix, and A is a matrix containing all the principal components 
chosen in the previous step in column mode. This is the actual dimensionality 
reduction step. The score matrix defines the location of the orthogonal projection of 
the original observations in the latent subspace (Tauler et al., 2009). 
T = X ∙ A (Equation 1.11) 
Step 10: The loading matrix is composed by eigenvectors corresponding to the largest 
eigenvalues of the covariance matrix of the data set. The loading vectors define the 
directions of highest variability of the new latent subspace (Tauler et al., 2009) and 
the loadings can be described as the directional coefficients that compose each PC 
i.e., loadings are the elements of an eigenvector (Esbensen and Swarbrick, 2019). 
Practical issues of PCA are as follows: 
 Principal components do not hold physical meaning. 
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 PCA is too expensive for applications with extremely big data (e. g. extensive 
web data). 
 PCA is based on linearity, thus it does not work well for a data set that has a 
manifold structure. 
 PCA projects the data to a lower dimension data set. Therefore, if the dataset 
has outliers or special cases of interest, this information would be lost.  
 PCA does not recognize class labels, therefore when the classes are known, 
an additional step is necessary in order to highlight the different classes e.g., 
name the scores by the class to which they belong. Alternatively, if the classes 
are not previously known, clustering algorithms can be applied to the PCA 
scores in order to determine groups that are statistically significantly different 
from each other.  
 PCA is an unsupervised algorithm, thus, the direction of maximal variance is 
not necessarily the one that makes the best separation of classes. The analyst 
has to choose carefully the PCs that best describe the phenomenon studied.  
 Loadings plot helps the analyst to verify the reasons for the separation 
obtained from the model (i.e. observed in the PCA scores plot), however the 
results must be also supported by physicochemical knowledge. 
1.6.2 Partial least squares regression 
Partial least squares regression (PLS) is a multivariate regression model used to 
correlate information in one data matrix of independent variables (X) to the 
information in a matrix of dependent variables (Y) (de Jong, 1993). Similarly to PCA, 
PLS regression captures the maximum variance within X. However, PLS also captures 
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the maximum variance in Y, and calculates the maximum correlation between X and 
Y. As a result, in the future, if only X is known, Y can be predicted. 
Considering X a mean-centered n x m matrix and Y a mean-centered n x p matrix, PLS 
is derived from a covariance matrix of X and Y, S(X,Y), determined by Equation 1.12. 
The correlation between X and Y is determined by equation 1.13 (Ng, 2013). 
S (X, Y) =
1
n − 1
X Y (Equation 1.12) 
𝑐𝑜𝑟𝑟(𝑋, 𝑌) = 𝑣𝑎𝑟(𝑋) ∙ 𝑐𝑜𝑣(𝑋, 𝑌) ∙ 𝑣𝑎𝑟(𝑌) (Equation 1.13) 
There are different algorithms from which PLS can be determined. In this study, an 
orthogonalized PLSR algorithm for one Y-variable from the software the Unscrambler 
(CAMO Analytics, 2011) was used.  
1.6.3 Multivariate Curve Resolution 
Multivariate Curve Resolution (MCR) (Lawton and Sylvestre, 1971; Martens, 1979) is 
a group of algorithms developed to implement constraints on loadings and scores so 
that they have an exact physical interpretation and explain the variance in the data 
(De Juan and Tauler, 2006; Mendieta et al., 1998). MCR decomposes the data matrix 
(X) into a matrix of the variation among the observations, named concentration 
profiles (C), a transpose variance matrix associated with the variation among the 
variables, named spectra profiles (ST), and a matrix of residuals not explained by the 
model (E) (Equation 1.14). As a result, the spectra fingerprint of the single 
components of a mixture are extracted. The model fit is given by the percentage lack 
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of fit (%LOF) (Equation 1.15), where 𝑥  is an element of X and 𝑒  is the respective 
residual. Ideally, %LOF should be close to zero. 
X=CST+E (Equation 1.14) 
% 𝐿𝑂𝐹 = 100 ∙
∑ 𝑒
∑ 𝑥
 (Equation 1.15) 
Juan, Jaumot and Tauler, 2014 listed and compared the main MCR algorithms 
available and discussed the benefits of the algorithm Multivariate Curve Resolution-
Alternating Least Squares (MCR-ALS) (De Juan et al., 2014). MCR-ALS is an iterative 
algorithm that performs alternating optimization in each iterative cycle. The 
algorithm is based as follows (Esbensen and Swarbrick, 2019; Tauler, 1995): 
Step 1: Determine the number of compounds in the data matrix e.g., using PCA or 
previous knowledge about the system. 
Step 2: Determine the initial estimate. The initial estimate can be a pure spectra of 
some of the compounds that is known, any other information that is available, 
or the initial estimate can be mathematically determined by local rank map 
methodologies (Booth, 2005; De Juan et al., 2014). The local rank algorithms 
screen the profiles in order to identify “windows” i.e., regions from which 
chemical information can be obtained such as selective information regions, 
zero-concentration regions, and regions of (A-1) components. The algorithm 
will correctly determine the initial guess if the following theorems are true 
(Manne, 1995): 
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I. The concentration profile of a compound can be determined if all the 
interfering compounds that are identified inside of the concentration window 
the given compound can be also identified outside that window. 
II. The spectrum profile of a compound can be determined if there is a sub 
window where no other component information is present. 
Step 3: Use the initial estimate ST to calculate C (or C to calculate ST) under the 
applicable constraints. 
Step 4: Recalculate ST using C determined in step 3 (using Equation 1.12, with data 
matrix=X). 
Step 5: Apply Equation 1.12 i.e., multiply C and ST from steps 3 and 4 in order to 
calculate the estimated data matrix X. 
Step 6: Repeat steps 3, 4, and 5 until convergence i.e., until the fit between two 
consecutive iterations fall below a previously determined threshold or until 
a previously determined number of iterations are reached.  
The ALS optimization is performed in each cycle for spectra and for concentration 
profiles estimations, therefore, a sensible initial guess is required in order to shorten 
the iteration process and guide the convergence to an accurate solution (Mendieta 
et al., 1998). The set of constraints is what avoids ambiguities inherent to curve 
resolution due to the fact that different C and ST type matrixes can represent the data 
set with the same quality of fit. However, they show different profiles with different 
shape (rotational ambiguity, mathematically given by Equation 1.16, where T is the T 
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PCA matrix of scores) or different magnitude (intensity ambiguity) (Esbensen and 
Swarbrick, 2019). 
𝑋 = 𝐶𝑆 = 𝑋(𝑇𝑇 )𝑆 = (𝐶𝑇)(𝑇 𝑆 ) = 𝐶 𝑆  (Equation 1.16) 
The constraints applied to MCR model for optimization can be divided into (1) 
mathematical conditions, (2) natural constraints, and (3) process constraints (Figure 
1.9).
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Figure 1.9. Multivariate Curve Resolution workflow.
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Mathematical conditions 
1- Correspondence of species: useful when data matrices from several different 
samples are modelled together. Correspondence of species is used to 
determine the presence or absence of components in the analysed samples 
and it is also used to reduce ambiguity. 
2- Local rank: it is usually applied to concentration profiles in order to avoid 
ambiguity. This constraint identifies zones of the profile (windows) where 
there is absence of components. The windows can be determined by local 
rank analysis methods e.g., EFA. When only one component is observed in a 
certain window of the profile the selectivity constraint can be applied i.e., 
there is only one component and therefore it is possible to select the spectra 
of that region as the initial guess of a pure component. When some 
components are observed in a zone of the profile, an internal local rank can 
be applied.  
3- Model constraints: proper for multiset data matrices. It can be understood as 
the applications of conditions of trilinearity, multilinearity, or factor 
interaction. 
Natural constraints 
1- Non-negativity: suitable for all concentration profiles and can be used for 
spectra that do not show values in the negative region. Thus, it cannot be 
applied to derivative spectra. It forces the profiles to be formed by null or 
positive values. Non-negative least-squares or fast non-negative least-
squares. 
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2- Closure: it is appropriate when the mass balance conditions are true.  
3- Known pure spectral concentration profiles: it forces the spectrum of a 
component to be equal to a certain known predefined shape.  
4- Unimodality: employed when there is the presence of a single peak or a 
consistent increasing or consistent decreasing profile. It is not applicable 
when different batches are being compared as screening studies. 
Process constraints 
1- Hard modelling: constrain concentration profiles by setting physicochemical 
parameters. 
2- Correlation constraint: it is used to predict concentrations in unknown 
samples when internal univariate calibration models are available. 
1.6.4 Heckel model 
Heckel model is commonly used for interpretation of the relationship between 
relative density and applied pressure (Ilkka and Paronen, 1993). It describes the 
densification of the powder density under pressure as a first-order kinetics process 
(Patel et al., 2006). According to its differential form (Equation 1.17), the higher the 
porosity (𝜀), which is directly related to the density, the more the porosity decreases 




= 𝑘 ⋅ 𝜀 (Equation 1.17) 
The relation between relative density and porosity is known as 𝜌 = 1 − 𝜀 
(Leuenberger and Leu, 1992). Rewriting Equation 1.17 for relative density and 
integrating, the following linear correlation is obtained: 
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= K ⋅ σ + A (Equation 1.18) 
where ρ is the tablet relative density, σ is the compaction pressure, A is a constant 
that represents the degree of packing that can be achieved by rearrangement of 
particles i.e., before considerable inter-particle bonding take place, and K is a 
constant related to the ability of the powder to undergo plastic deformation. 
1.6.5 Percolation threshold  
Percolation threshold theory can be used in pharmaceutical formulation design to 
determine a concentration range where the property analysed undergoes a sudden 
change, which can be observed as an edge of failure of formulation processability or 
CQAs. From this theory it is possible to predict the blends that would present 
suboptimal properties and thereby determine an optimum drug concentration range 
to achieve blends designs that are robust with respect to those properties. 
Percolation threshold theory is mathematically described by the power law of 
Equation 1.19. 
𝑋 = 𝑘 ∙ (𝜌 − 𝜌 )  (Equation 1.19) 
where 𝑋 is one property observed e.g., tablet strength, drug release, compactibility 
or electrical conductibility (Fuertes et al., 2006; Gonçalves-Araújo et al., 2008; Guyon 
et al., 1987; Hwang et al., 2017). The constant 𝑘  is a proportionality constant or 
scaling factor, ρ is the occupation probability, 𝜌  represents the percolation 
threshold and q is a critical exponent, also known as percolation coefficient. 
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Since the interest of this thesis is to work with tensile strength, the power law of 
percolation threshold (Equation 1.19) can be rewritten as Equation 1.20. 
𝜎 = 𝑘 ⋅ [𝜌 − 𝜌 (𝐴𝐵)] (Equation 1.20) 
Where 𝜎  is the tensile strength (Equation 1.21), 𝑇  is the percolation coefficient 
when is calculated for tensile strength, 𝜌 (𝐴𝐵) is the percolation threshold, and 𝜌 is 
the tablet relative density (Equation 1.22).  
Tensile strength can be calculated using Equation 1.25. 
𝜎 =
2 ⋅ 𝐻
𝜋 ⋅ 𝐷 ⋅ 𝑇
 (Equation 1.21) 




 (Equation 1.22) 
Tablet density,𝜌 , is obtained dividing tablet weight by tablet volume and 𝜌  
can be measured using a gas displacement pycnometer.  
Thus, Equation 1.20 can be applied by performing the linear fit  
𝜎 = 𝑎 ⋅ 𝜌 + 𝑏, in which tensile strength (𝜎 ) and tablet relative density (𝜌) are 
values obtained empirically, Tf can be found in the literature or determined using a 
modified Heckel Model, and 𝜌 (𝐴𝐵) = −𝑏/𝑎. 
1.6.5.1 Determination of the percolation coefficient using modified Heckel 
Model 
Heckel equation is valid only when 𝜀 «𝜀  i.e., at high pressures, not in the vicinity of 
bulk porosity (Kuentz and Leuenberger, 1999). Critical porosity (𝜀 ) is the maximum 
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porosity of a powder bed. There is no rigid structure existing above𝜀 . If 𝜀 ≥𝜀 there 
is a fluid with particles moving without resistance. On the other hand, percolation 
threshold applies for lower pressure, under which there is a rearrangement of the 
particles inside the die. In order to modify Heckel equation so that it can be used for 
𝜀 <𝜀  or 𝜌 > 𝜌  i.e., under low pressures, a new parameter, 𝑋  (Equation 1.23), was 
introduced so that Equation 1.24 is obtained (Kuentz and Leuenberger, 1999). In 















 (Equation 1.24) 
Rewriting the last equation for relative density (𝜌, 𝜌 = 1 − 𝜀) and performing the 
integration, Equation 1.25 is obtained. This mathematical transformation was 




𝜌 − 𝜌 − (1 − 𝜌 ) ⋅ 𝐿𝑛
1 − 𝜌
1 − 𝜌
 (Equation 1.25) 
Equation 1.25 was simplified using Taylor expansion (Kuentz and Leuenberger, 2000). 
As a result, Equation 1.26 was obtained. This equation is only valid in the vicinity of 




(𝜌 − 𝜌 )
1 − 𝜌
 (Equation 1.26) 
Isolating (𝜌 − 𝜌 ) in Equations 1.20 and 1.26 and then matching them, the Equation 
1.27 is obtained. 
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𝜎 = 𝑘 ⋅ 𝑃  (Equation 1.27) 
Thus, the percolation coefficient 𝑇  can be determined by the exponential fit of 
Equation 1.27, where 𝑘  is a constant, P is the experimental compaction pressure, 
and 𝜎  is the tensile strength of tablets compacted at each compaction pressure.  
1.6.5.2 Percolation threshold and critical mass fraction  
Modelling percolation depends on the dimensionality of the cluster and the system. 
A tablet is a 3-D system and, in order to best fit the percolation theory, it is considered 
as a binary system, even though the blend has more than two substances 
(Leuenberger and Ineichen, 1997). In this case, there are three percolation 
thresholds: 𝜌 (𝐵) the percolation threshold of the API, and 𝜌 (𝐴) the percolation 
threshold of the excipient and 𝜌 ,  the total percolation threshold. Moreover, the 
tableting process can be divided into two stages to simplify.  
The first stage is when the blend is made by creating weak-bond percolation which 
corresponds to the vicinity of the relative density (𝜌 ≈𝜌 ) (Leuenberger and Leu, 
1992; Sharma et al., 2014). The pressure in this phase is low and the porosity is just 
smaller than the critical porosity (Kuentz et al., 1999). When this simplification is 
made, many properties can be described by a straight line. The second stage occurs 
when the compaction happens forcing the blend to undergo deformation and/or 
fracture. This phase happens under higher pressure and the compaction process can 
be considered as a two-dimensional process due to a uniaxial compression where the 
stress is transmitted from particle to particle (Sharma et al., 2014). This stage is more 
complex to calculate. Fortunately, for some properties it is possible to consider the 
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entire process happening as the first stage, so that the property can be approximated 
by a straight line. This approach works for tensile strength (σT) for microcrystalline 
cellulose compacts (Kuentz and Leuenberger, 2000). 
Tensile strength can be explained with a law of percolation theory for a blend in 
which one component dominates the overall strength of the tablet (Kuentz and 
Leuenberger, 2000). For each ρ defined empirically, there is a corresponding 𝜎  
calculated. Therefore a straight line equation (𝑦 = 𝑎. 𝑥 + 𝑏) is observed ( 𝑦 = 𝜎 / , 
𝑥 = 𝜌, −𝐾𝜌 = 𝑏 and 𝐾 = 𝑎).  
𝜎 / = 𝑎 ⋅ 𝜌 + 𝑏 (Equation 1.28) 




 (Equation 1.29) 
The values of the percolation threshold of each blend, ρc (AB), are then used to obtain 
two other percolation threshold values 𝜌 (𝐴) and 𝜌 (𝐵) (Equation 1.30). While 
𝜌 (𝐵) represents the minimum relative density, or solid fraction, above which there 
is a change in tensile strength behavior, 𝜌 (𝐴) is related to the dilution capacity of 
substance A. Thus, 𝜌 (𝐴) provides the fraction of substance B that could be loaded 
into the blend with substance A in such a way that substance A still leads the overall 
properties of the blend. 
𝜌 (𝐴𝐵) = 𝑋 ∙ 𝜌 (𝐴) + (1 − 𝑋 ) ∙ 𝜌 (𝐵) (Equation 1.30) 
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A dilution capacity model was applied in order to express the 𝜌 (𝐴) in terms of mass 
fraction (Xc), Equation 1.31 (Kuentz and Leuenberger, 2000). This conversion was 
performed as dilution capacity which is a useful parameter to consider when 







− ∅ (Equation 1.31) 
In which ϕ and φ are parameters dependent of the true density of substances A and 
B respectively and calculated using Equations 1.32 and 1.33, respectively.  
∅ =
𝜌 (𝐴)
𝜌 (𝐴) + 𝜌 (𝐵)
 (Equation 1.32) 
𝜑 =
−2 ∙ 𝜌 (𝐴) ∙ 𝜌 (𝐴) − 𝜌 (𝐵)
𝜌 (𝐴) ∙ [𝜌 (𝐴) + 𝜌 (𝐵)]
 (Equation 1.33) 
1.7 Background to aspects of pharmaceutical development investigated in this 
thesis 
1.7.1 Raw material CQAs variability 
ICH Q11 highlights the importance of linking material attributes and process 
parameters to CQAs as part of the QbD approach (International Council for 
Harmonisation, 2012). Raw material attributes has been considered by many authors 
as a potential source of process variability and an important aspect of pharmaceutical 
manufacturing to be investigated within the QbD framework (Burke and Zylberberg, 
2019; Kushner IV, 2013; Kushner et al., 2011; Mockus et al., 2015; Stauffer et al., 
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2019, 2018; Thoorens et al., 2014). The effects of raw material variability on a process 
is also important based on the QbC approach.  
In this thesis, microcrystalline cellulose (MCC) (Figure 1.10) was used as a case study 
excipient for the development of models to quantitatively determine raw material 
variability and its impact on processes. MCC is one of the most commonly used 
excipients in solid dosage pharmaceutical formulations (Thoorens et al., 2014). MCC 
is inert to most pharmaceutical formulations, has high compactability and some 
lubricant functionality, and therefore it is widely used as bulking agent for tablet and 
capsules formulations (Rowe et al., 2009; Thoorens et al., 2015, 2014). MCC also acts 
as an effective tablet disintegrant (Järvinen et al., 2013). Besides being used in 
pharmaceutical formulations as binder and filler, MCC is used in other industries as 
fat replacement and stabilizer in food products, as rheology control agent in 
cosmetics, and as composite in biodegradable polymers and wooden products (Gibis 
et al., 2015; Terinte et al., 2011; Thoorens et al., 2014; Vonbehren et al., 2010; Yang 
et al., 2018).  
MCC is obtained by acid hydrolysis of wood or cotton cellulose followed by rinsing 
and drying (Sun, 2008). Microcrystalline cellulose is a semi-crystalline material with 
inherent variable crystallinity due to raw material source and variable processing 
conditions (O’Regan, 2018). Due to its natural origin, batches of microcrystalline 
cellulose can show significant variability in properties such as crystallinity, moisture 
content, surface area, porous structure and molecular mass (El-Sakhawy and Hassan, 
2007). The different drying processes used to produce MCC are also causes of 
variability in physicochemical properties of MCC (Sinha et al., 2018). When MCC is 
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used as a component of solid dosage formulation, batch variability can affect the final 
product CQAs e.g., tablet hardness and dissolution rates (Thoorens et al., 2014).  
 
Figure.1.10. Chemical structure of microcrystalline cellulose. 
1.7.2 Active pharmaceutical ingredient engineering 
More than 35% of frequently prescribed APIs are classified as poorly water soluble 
according to the Biopharmaceutics Classification System (International Council for 
Harmonisation, 2019) (Wu and Benet, 2005). A poorly water soluble drug substance 
is not well absorbed after oral administration, which results in reduced drug 
bioavailability and efficacy (Vasconcelos et al., 2007). In the aspect of manufacturing, 
many APIs are not suitable for direct compression with many others not being 
suitable in high-dose formulations (Leane et al., 2018; Patel et al., 2006; Sun et al., 
2017). API engineering approaches have an important role to play in order to address 
these and other issues that prevent APIs being commercialised or require drug 
products manufactured through high-cost processes. Examples of API engineering 
are solvation, hydration, salting, polymorphism, and co-crystallization (Vishweshwar 
et al., 2006). 
Co-crystallization is a crystal engineering approach that has been used to improve 
API solid state properties (Vishweshwar et al., 2006). Co-crystallization emerged in 
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recent years and has been widely investigated to enable drug substances to be 
manufactured for oral administration with high-level bioavailability (Goud et al., 
2012; Qiao et al., 2011; Remenar et al., 2003; Rodrigues et al., 2018a; Shan et al., 
2014; Silva Filho et al., 2018; Trask et al., 2005). The European Medicine Agency 
defined co-crystals as “homogenous (single phase) crystalline structures made up of 
two or more components in a definite stoichiometric ratio where the arrangement 
in the crystal lattice is not based on ionic bonds (as with salts)” (European Medicines 
Agency, 2015). Co-crystal can be formed by an API and a coformer, by a co-crystal 
and a nutraceutical molecule, or by two APIs (Rodrigues, 2019).  A coformer is a 
pharmaceutical substance that meets safety and quality standards (European 
Medicines Agency, 2015). A nutraceutical molecule is a substance that is part of a 
food and shows medical or health benefits (Schultheiss et al., 2010). 
The development of new co-crystals is an area in significant development. Entresto® 
and Odomzo® from Novartis, and Steglatro®, Segluromet® and Steglujan® from Merk 
are among the marketed products containing co-crystals (Rodrigues, 2019). In this 
thesis, PAT tools and models that yield product and process understanding and 
process control during co-crystal formation were investigated.  
1.7.3 Tablet manufacturing  
Solid oral administration is the preferable route of drug delivery due to high stability, 
small bulk, accurate dosage and easy production (Patel et al., 2006; Rathbone et al., 
2003; Vasconcelos et al., 2007). Tablet manufacturing through granulation involves 
blending the API with excipients to form denser and larger particles. The larger 
particles produced show improved tableting performance (Mangal and Kleinebudde, 
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2018). There are different granulation operations such as high shear and fluidized 
bed, which are employed in wet granulation processes. There are also dry 
granulation processes, such as roller compaction. Roller compaction is considered 
the most suitable granulation process when granulation must be performed in 
continuous manufacturing (Betz et al., 2003). When tablets are produced by direct 
compression the powder blend does not need to be pre-processed. That is why tablet 
direct compression has been researched for the implementation of continuous 
manufacturing and advanced quality approaches (Engisch and Muzzio, 2014; 
Hausner, 2018; Järvinen et al., 2013). 
Direct compression is the simplest tablet manufacturing system. In this process, 
powder blends of API and excipients are directly compacted into tablets (Figure 1.11) 
(Gohel and Jogani, 2005). This process has the total operation units reduced, which 
decrease production costs and time to market (Mangal and Kleinebudde, 2018).  
 
Figure 1.11. Flowchart of a direct compression process. 
In this context, compaction is the unit operation in which pressure is applied to a 
powder bed so that a coherent compact is formed (Patel et al., 2006). This is a critical 
unit operation because it determines physical and mechanical properties of tablets, 
such as hardness, friability and density. Those properties are discussed in the next 
section. 
Raw material Blending Compaction Final product
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Powder blends containing high-dose, poorly compressible APIs may exhibit 
compaction problems such as capping, lamination, sticking and picking (Patel et al., 
2006). Those problems are expected to increase as the API dosage is increased (Teng 
et al., 2009). Percolation threshold is a hybrid model that has been investigated to 
predict the levels of high-dose poorly compressible drug in solid dosage formulations 
that can be direct compacted with optimal process performance and product quality 
(Leane et al., 2018, 2015; Leu and Leuenberger, 1993) (See section 1.6.1). 
Risk assessment, as part of the control strategy, requires the identification of 
potentially risky effects of critical material attributes (CMAs) and process variables 
on product CQAs. Yu, L. X. et al. listed input materials, process parameters and quality 
attributes that are typically relevant to tableting (Table 1.1) (Yu, 2008). From those, 
content and uniformity of mass, strength (hardness/friability), disintegration and 
dissolution are generally considered tablet physicochemical CQAs (FDA, 2015, 2012; 
International Council for Harmonisation, 1999). Case studies were designed in this 
thesis to investigate the effects of input material (excipient and formulation) 
attributes listed by Yu L.X. et al. on the CQA attributes outlined above. 
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Table 1.1. Input materials, process parameters and quality attributes that are 
typically relevant to tableting. Adapted from (Yu, 2008) 
Input material attributes Quality attributes 
Particle/granule size and distribution Tablet appearance 
Fines/oversize Tablet weight 
Particle/granule shape Weight uniformity 
Cohesive/adhesive properties 
Hardness/tablet breaking force/tensile 
strength 
Electrostatic properties Thickness/dimensions 
Hardness/plasticity Tablet porosity/density/solid fraction 
Bulk/tapped/true density Friability 
Viscoelasticity Tablet defects 
Brittleness Moisture content 
Elasticity Disintegration 
Solid form/polymorph Dissolution 
Moisture  
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1.8  Aims and objectives 
The overall goal of this thesis is to increase understanding of pharmaceutical 
materials attributes and processes performance. For that intensive characterization 
of CMAs, interactions between API and excipient, and CQAs were investigated. PATs 
are designed for quantitative characterization and for predicting drug substance and 
drug product critical properties in order to support the overall goals of this thesis. 
Different aspects of pharmaceutical manufacturing were used as case studies and 
the following objectives were established and split into the following chapters: 
Chapter 2 
 To develop a PAT technique to quantify variability in MCC crystallinity batch 
to batch. 
 To develop a PAT tool to predict MCC moisture sorption based on the output 
of the PAT technique to determine MCC crystallinity. 
Chapter 3 
 To develop PAT tools for co-crystallization process control. 
 To develop PAT tools to quantitatively evaluate co-crystal purity. 
Chapter 4 
 To predict blend direct compression behavior using percolation threshold 
model and multivariate analysis. 
Chapter 5 
 To investigate tablet dissolution behavior through the application of PAT tools 
for tablet characterization and disintegration analysis. 
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2.1 Abstract 
Microcrystalline cellulose (MCC) is a semi-crystalline material with inherent variable 
crystallinity due to raw material source and variable manufacturing conditions. MCC 
crystallinity variability can result in downstream process variability. The aim of this 
study was to develop models to determine MCC crystallinity index (%CI) from Raman 
spectra of 30 commercial batches using Raman probes with spot sizes of 100 µm (MR 
probe) and 6 mm (PhAT probe). MCC moisture sorption is critical for several industrial 
processes. Thus, the relationship between %CI and moisture content for those MCC 
batches was also investigated. A principal component analysis model separated 
Raman spectra of the same samples captured using the different probes. The 
differences were attributed to the larger sampling area and depth of the PhAT probe. 
The %CI was determined using a univariate model based on the ratio of the peaks at 
380 and 1096 cm-1. The univariate model was adjusted for each probe. The %CI was 
also predicted from spectral data from each probe using partial least squares 
regression models, where Raman spectra and univariate %CI were the dependent 
and independent variables, respectively. A web application, MCCrystal, containing all 
the models developed was developed and is available at https://sspc.ie/mccrystal/. 
A correction between %CI and moisture sorption behaviour could not be established. 
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2.2 Introduction 
Microcrystalline cellulose is widely used and has diverse applications across different 
industry sectors. MCC is used as a binder and filler in pharmaceutical formulations, a 
fat replacement and stabilizer in food products, a rheology control agent in 
cosmetics, and as a component of biodegradable polymers and wooden products 
(Gibis et al., 2015; Terinte et al., 2011; Thoorens et al., 2014; Vonbehren et al., 2010; 
Yang et al., 2018). The most common source of MCC is wood. Cellulose chains are 
present in wood pulp in the form of packed layers that are held together by lignin, 
and strong hydrogen bonds (Thoorens et al., 2014). MCC is obtained by purification 
of wood pulp using mineral acid solution i.e., acid hydrolysis, followed by rinsing and 
drying. The presence of hydroxyl groups in the product of this purification process 
and the relatively large surface to volume ratio of micro fibrils give rise to MCC’s 
hygroscopic character (Sun, 2008). 
MCC has an atypical semi-crystalline structure and its attributes can vary between 
suppliers and batches. Batch to batch variability can be caused by different factors, 
such as wood source (hard or soft wood), climate differences from region to region, 
harvesting time, the process of pulp delignification, hydrolysis reaction time, and the 
process of drying (O’Regan, 2018). The term crystallinity index (%CI) refers to the 
percentage by weight occupied by the crystallites (Foster et al., 2018). During 
depolymerization (hydrolysis) the acid preferentially attacks the amorphous regions 
of the pulp (Landín et al., 1993) and increases percentage crystallinity. 
MCC crystallinity has been reported to influence its behaviour during processing.  
Tabletability was investigated with differences observed between batches with 
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substantial differences in crystallinity. Suzuki and Nakagami used a rod mill to reduce 
crystallinity of a MCC batch from an initial %CI of 65%. A reduction in tabletability 
was observed for batches with a %CI below 12%, and an increase in dissolution rate 
was observed for acetaminophen tablets produced with MCC that had a %CI less than 
26% (Suzuki and Nakagami, 1999). The crystallinity of MCC has also been shown to 
influence water sorption (Amidon and Houghton, 1995; Bolhuis and Chowhan, 1996; 
Nokhodchi, 2005). Increased water sorption was observed with decreased MCC 
crystallinity, as moisture sorption occurs predominantly in amorphous regions which 
are more hydrophilic than the crystalline regions (Mihranyan et al., 2004; Segal et al., 
1959; Suzuki and Nakagami, 1999).  
A range of techniques has been utilised to determine MCC crystallinity. 
Diffraction techniques are most widely reported, employing the Segal peak 
height method (Segal et al., 1959), peak decomposition or deconvolution (Lanson 
1997; Park et al. 2010; Ahvenainen et al. 2016, Yao et  al. 2020), and Rietveld 
refinement based methods (Madsen et al. 2011; Ling et al. 2019). Other 
spectroscopic techniques proposed include Fourier transform infrared (Liu and Kim 
2015), solid state NMR (Atalla and Vanderhart 1984; Harris et al. 2012; Wickholm et 
al. 1998), and Sum frequency generation (Ling et al. 2019). Raman spectroscopy, the 
focus of this study, has been investigated to determine cellulose crystallinity. An 
initial Raman approach for quantifying MCC crystallinity employed relatively weak 
bands at 1462 and 1481 cm-1 (CH2 bending modes) in conjunction with spectral 
deconvolution (Schenzel et al., 2005). Two further methods were proposed 
employing bands at 380 and 93 cm−1 (Agarwal et al., 2018, 2010). The 93 cm−1 method 
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is advantageous compared to the 380 cm-1 method as it differentiates crystalline and 
organized cellulose and an aggregated form which is not crystalline. However, the 93 
cm−1 method requires an FT-Raman instrument with 1064 nm excitation to avoid 
Rayleigh scattering that masks the sample Raman scattering at 93 cm−1. 
The quantification of cellulose crystallinity using Raman spectroscopic analysis has 
primarily employed Raman instruments with laser spot sizes between 50 μm and 1 
mm and limited depth of penetration (Agarwal et al., 2018, 2010; Foster et al., 2018). 
The irradiation area of such instrumental setups results in a limited area being 
sampled. Therefore, analysis requires the acquisition of multiple spectra across a 
number of locations to obtain a representative profile of the sample. Reduced depth 
of penetration also results in spectra that focus on surface spectral features. To date 
Raman probes with larger laser spot sizes and depth penetration, designed for non-
contact analysis of solids, have not been applied to the quantification of cellulose 
crystallinity. It was hypothesised the larger sample volume irradiated using these 
probes would reduce the requirement for multiple spectra acquisition and surface 
mapping. Contact probes are usually used for suspensions/solutions and the probe 
window of a contact probe is in contact with the suspension. Non-contact probes are 
usually used for solid samples and the probe window needs to be placed at the 
minimum distance specified by the equipment supplier. 
The objective of this study was to demonstrate the capability of Raman spectra 
acquired using non-contact Raman probes to predict the %CI of commercial MCC 
batches. Raman spectra acquired for 30 commercial MCC batches, using two probes 
with spot sizes of 100 µm (MR probe) and 6 mm (PhAT probe), were used to develop 
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models to determine %CI. The relationship between MCC %CI and moisture sorption 
behaviour was also investigated. 
2.3 Materials 
Thirty batches of microcrystalline cellulose were studied. Samples comprised MCC 
manufactured by 3 different suppliers; 25 batches from Dupont Nutrition & 
Biosciences, 4 batches from JRS Pharma, and 1 batch from Asahi Kasei 
Corporation. All MCC grades analysed compiled with USP/NF, Ph.Eur and JP 
pharmacopeia. Wood pulp was confirmed as the botanical source for 29 of the 30 
batches analysed, for one batch the botanical source could not be confirmed.    
2.4 Methods 
2.4.1 Milling standards to produced reference amorphous 
Milling was performed in order to obtain amorphous reference spectra. Prior to 
milling, the samples were kept in the oven at 40 °C for 24 hours. To produce 
amorphous reference materials for each batch 1 g of MCC was milled at 25 Hz in an 
oscillatory ball mill, Mixer Mill MM400 (Retsch GmbH, Germany), in order to 
decrease the crystallinity (Mattonai et al., 2018). All samples were milled for 90 min 
to replicate the methodology of previous studies (Agarwal et al., 2010). A break of 15 
minutes was performed after every 30 min of milling 
operation.  Samples of 7 batches were confirmed to be amorphous after 90 min 
milling by powder X-Ray diffraction (PXRD). These batches included MCC batches 
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from each supplier and each grade. PXRD diffractograms of these batches before and 
after ball milling are included Fig. S2-S8 in the supplemental material.  
2.4.2 Powder X-ray diffraction  
Powder X-Ray Diffraction (PXRD) analysis was performed using a Stoe Stadi MP 
diffractometer operating in transmission mode, with a tube voltage of 40 kV and 
current of 40 mA, using Cu Kα1 monochromated radiation (1.5406 Å) and a gas-filled 
PSD detector. MCC powder samples were held between acetate foils and the 
diffraction was recorded over 5 to 45° 2θ in steps of 2° 2θ at 90 sec/step.    
2.4.3 Preparation of pellets for Raman spectroscopy 
Cylindrical, flat, 13 mm diameter, 250 mg pellets were produced using an Atlas 15T 
Manual Hydraulic Press (Specac Ltd, Orpington, UK). Three tonnes force were applied 
for a duration of 30 seconds. Two pellets were produced for each batch; one from 
the powder as received and one from the corresponding ball milled sample. 
2.4.4 Raman spectroscopy 
Raman spectra for each pellet were acquired using two different probes. The first 
was a MR probe connected to a RamanRxn™ instrument (Kaiser Optical Systems Inc., 
Ann Arbor, USA), with nominal laser beam diameter at a focal position of 100 μm. 
The exposure time set was 60 s, using a laser power of 785 mW, over the range 200-
1500 cm-1, and analysis was performed in triplicate. The second was a PhAT probe 
connected to a RamanRxn2PhATTM instrument (Kaiser Optical Systems Inc., Ann 
Arbor, USA), with nominal laser beam diameter at a focal position of 6 mm. The 
exposure time was set to 15 s, using a laser power of 785 mW, over the range 200-
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1500 cm-1, and analysis was performed in duplicate. Moreover, while the MR probe 
is primarily a surface technique, the PhAT probe has a collection zone depth of 
around 2 mm.  
In addition to the sample Raman fingerprint, the spectra obtained contained a 
background contribution that may be caused by fluorescence or thermal fluctuations 
on the Charge Coupled Device (CCD detector) (Bocklitz et al., 2011; Gautam et al., 
2015). The fluorescence background was removed by pre-processing. The spectra 
underwent a baseline subtraction of an interpolated linear fit between the anchor 
points fixed on the X axis: 1500, 1200, 952, 857, 743, 632, 550, 260, and 200 cm-1 
(Figure 2.1). The intensity differences observed between the spectra were removed 
by standard normal variate (SNV). This normalization consisted of subtracting each 
spectrum from the mean and dividing the result by the spectrum standard deviation. 
 
Figure2.1. Representation of the interpolation between the 9 anchor points 
defined. The baseline was obtained by subtracting the line interpolated between 
the 9 points (red) from the spectra (black), and it was performed individually for 
each spectrum. 
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2.4.5 Univariate determination of crystallinity index  
Crystallinity index was calculated according to the method proposed by Agarwal et 
al., which is based on the ratio between the intensity of the peaks at 380 cm-1 and 
1096 cm-1 deconvoluted from a reference amorphous spectrum (referred to 
henceforth as the “380-method”) (Equation 2.1) (Agarwal et al., 2010). 
Deconvolution is required because cellulose Raman spectra are composed of the 
amorphous and crystalline spectra superimposed (Agarwal et al., 2010). 
Deconvolution in this study refers to the extraction of the amorphous and the 
crystalline spectral contributions from the actual measured spectrum. The ratio of 
these peaks was compared to other peaks ratios and showed efficiency and great 
sensitivity to cellulose crystallinity changes (Agarwal et al., 2018, 2010). 
%𝐶𝐼 =
𝐼 − 𝐼 _





𝐼  and 𝐼 _  are the intensities at the Raman shift 380 cm-1 of the commercial 
batch as received and its corresponding amorphous sample, respectively. 𝐼  and 
𝐼 _  are the intensities at the Raman shift 1096 cm-1 of the commercial batch as 
received and its amorphous corresponding sample, respectively.  
The spectra of corresponding amorphous samples were obtained by ball milling a 
sample of the batch (section 2.4.1), pressing the powder into a pellet (section 2.4.2), 
and acquiring spectra of the pellet. Following the method previously reported by 
Agarwal et al (Agarwal et al., 2010), each Raman spectrum was pre-processed and 
peak normalized by equalizing the intensity values at Raman shifts above 857 cm-1 to 
the intensity at 857 cm-1 (Agarwal et al., 2010). The resulting spectrum was 
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considered to represent the amorphous contribution to the Raman spectra of the 
sample as received (Agarwal et al., 2010). Thus, in Equation 2.1, 𝐼 _  and 𝐼 _  
are equal to the intensity of the peaks at 380 cm-1 and 857 cm-1 in the spectrum of 
the milled sample, respectively. 
2.4.6 Correction of 380-method due to Raman instrument-dependence  
The 380-method (Equation 2.1) was developed using the Raman instrument RFS-100 
(Bruker Inc.) (Agarwal et al., 2010). Crystallinity values determined by the 380-
method show instrument-dependence and therefore a set of calibration samples 
have to be prepared and analysed on each instrument employed (Foster et al., 2018). 
A calibration study was therefore performed to correct this methodology for the 
Raman instruments used in the current study i.e., the MR and the PhAT probes 
connected to a RamanRxn™ and a RamanRxn2PhATTM), respectively. A single MCC 
batch was randomly chosen to create the calibration set. The crystallinity of this 
batch, referred to as “control”, was determined by PXRD (Equation 2.2) in triplicate.  
%𝐶𝐼 =  
(𝐼 . − 𝐼 . )
𝐼 .
 (Equation 2.2) 
The %𝐶𝐼  is the PXRD crystallinity index, I200 is the intensity at 22.6o 2 theta 
representing the crystalline peak, and I18.7 is the baseline intensity at 18.7o 2 theta 
corresponding to the amorphous scatter (Segal et al., 1959). PXRD diffractograms 
were measured in transmission mode using a D8 ADVANCE (Bruker AXS Inc., GmbH, 
Germany) using Cu Kα (λ = 1.5406 Å) radiation. The samples were analysed over the 
2 theta range 3.5 to 45 in steps of 0.5 ° at 1.7 sec per step. A representative 
diffractogram is shown in Figure 2.2. 
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Figure 2.2. Representative PXRD diffractogram of microcrystalline cellulose. 
Binary mixtures of control (MCC as received, prior to ball milling) and amorphous 
(MCC ball milled) were prepared at a total mass of 0.50 ± 0.03 g. The blends analysed 
contained 83%, 72%, 58%, 44%, 33%, and 22% w/w of control sample. The 100% 
control and the 100% amorphous samples were also used in the calibration. The 
theoretical crystallinity index (%𝐶𝐼 ) of each blend prepared was calculated from 







where 𝑚  is the mass in gram of the control and 𝑚  is the total mass of the 
blend (grams of control plus amorphous MCC). 
The values of the theoretical crystallinity indexes determined by PXRD (Equation 3) 
were plotted against the peak ratio of the Raman wavenumbers 380/1096 cm-1 after 
amorphous contribution subtraction. A linear regression between the theoretical % 
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equation obtained was used to determine the % CI by the 380-method for all other 
batches. 
2.4.7 Principal Component Analysis 
Principal component analysis (PCA) was performed in order to identify differences 
between the Raman spectra obtained for the 30 commercial batches of MCC 
investigated. Unscrambler® X 11.0 software (CAMO software, Norway) was used to 
perform the analysis on the treated (baseline corrected and normalized) Raman 
spectra. The algorithm NIPALS and cross validation were performed with 29 
segments determined so that spectra of the same batch acquired using both probes 
were kept within the same segment to avoid overfitting. A total of 145 spectra were 
used to build the PCA model. These spectra were acquired for the 30 different 
batches using two different probes. 
2.4.8 Partial least squares Regression 
Two partial least squares regression models were built using Unscrambler® X 11.0 
software (CAMO software, Norway) aimed at predicting the crystallinity index from 
Raman spectral analysis of the 30 commercial MCC batches. One model was built 
using the treated (baseline corrected and SNV) Raman spectra acquired using the MR 
probe and another model using the treated spectra acquired using the PhAT probe. 
The intensity of the treated Raman spectra between 1500-250 cm-1 were used as X 
variables. For both models, the Y variable was the % CI determined by the 380-
method. The algorithm Kernel was used. A total of 24 batches were used to calibrate 
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the model and 6 batches were used to validate the model. The number of spectra 
used were 85 and 60 for MR probe and PhAT probe models, respectively. 
2.4.9 Determination moisture monolayer  
A commonly used approach to quantify moisture content in hydrated polymers is % 
loss on drying. However, strongly associated water molecules are not accurately 
quantified by this technique (Agrawal et al., 2004) and ambient humidity influences 
the moisture content quantified by % loss on drying. Therefore, dynamic vapour 
sorption (DVS) was applied to provide a more in-depth analysis of moisture sorption 
behaviour of MCC across a range of relative humidity.  
A Dynamic Vapour Sorption, DVS Intrinsic® (Surface Measurement Systems, London, 
UK) system was used to quantify the equilibrium moisture sorption of all MCC 
samples. Samples were analysed over relative humidity range of 0-90 % RH with a 10 
% relative humidity (RH) stepwise humidity change for both sorption and desorption 
cycles (n=2). The sample weight was maintained between 10-15 mg. All samples were 
analysed at 25 C, with 5 s data collection intervals and a total flow rate of 200 sccm 
(standard cubic centimetre per minute). The actual humidity values were controlled 
to ± 0.5 % of the target RH and the mass change in samples was recorded every 
minute. Initially a drying step was completed at 0% RH for six hours. Equilibrium 
moisture sorption was deemed to have been achieved when the total mass change 
was < 0.002 %/min for greater than 10 min. When the equilibrium condition was met, 
the RH was automatically increased/decreased by 10 % RH until a 
sorption/desorption cycle of 0-90-0 % RH was completed.  
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Moisture monolayer value was determined using the Guggenheim, Anderson and de 
Boer (GAB) sorption isotherm (Blahovec and Yanniotis, 2008; Timmermann, 2003). 
The GAB equation (Equation 2.4) was converted to a second-order polynomial 
equation (Equation 2.5). The monolayer moisture sorption value was calculated by 
fitting the isotherm sorption values obtained for each batch to Equation 2.5 using R 
studio software (Agrawal et al., 2004) 
𝑊 =
𝑊 ⋅ 𝐶 ⋅ 𝐾(𝑃 𝑃⁄ )
[1 − 𝐾(𝑃 𝑃⁄ )][1 − 𝐾(𝑃 𝑃⁄ ) + 𝐶 ⋅ 𝐾(𝑃 𝑃⁄ )






+ 𝛽(𝑃 𝑃⁄ ) + 𝛾 (Equation 2.5) 
where W is the weight of moisture per weight of dry solid absorbed by the MCC 
sample at a particular relative pressure (P/Po), Wm is the weight of vapour per weight 
of dry solid assumed to be associated with all primary binding sites, and Cg and K are 
constants related to free energy of sorption. The constants α, β and γ values in 
Equation 2.5 are determined from quadratic regression analysis and used to calculate 




 (Equation 2.6) 
2.4.10 Correlation of DVS moisture monolayer and crystallinity index 
A Pearson correlation (Benesty et al., 2009) between moisture monolayer and % CI 
for each batch was performed in order to investigate if the layer of water tightly 
bound to the MCC structure (moisture monolayer obtained by fitting the GAB 
equation to DVS isotherms) can be predicted from the crystallinity index determined 
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using the 380 method. Two linear equations were built; one fitting to the moisture 
monolayer and % CI determined using the MR probe, and a second fitting to the 
moisture monolayer and the %CI determined using the PhAT probe. PLS models were 
also investigated. The intensity of the treated Raman spectra between 1500-250 cm-
1 were used as X variables. For both models, the Y variable was the moisture 
monolayer determined by GAB equation applied to the DVS isotherms. The algorithm 
Kernel was used. A total of 24 batches were used to calibrate the model and 6 
batches were used to validate the model. The number of spectra used were 85 and 
60 for MR probe and PhAT probe, respectively. 
2.4.11 Shiny web application 
A web application, MCCrystal, was built using ‘shiny’ (Chang et al., 2019) version 1.4.0 
in R (R Core Team, 2019) using the development environment RStudio (RStudio 
Team, 2019). This application was built to facilitate the dissemination of the models 
developed in this study. The web application framework for R was developed in tab 
set panels using the package ‘shinydashboard’ (Chang and Borges Ribeiro, 2018) 
version 0.7.1. The package ‘RcppArmadillo’ (Eddelbuettel and Sanderson, 2014) 
version 0.9.800.3.0 was used to manipulate matrices, graphics were built using the 
package ‘ggplot2’ (Wickham, 2016) version 3.2.1, the spectra were normalized using 
the package ‘prospectr’ (Stevens and Ramirez-Lopez, 2013) version 0.1.3, and 
manipulated using the package ‘spectrolab’ (Meireles et al., 2018) version 0.0.8. 
Spectra baseline correction i.e., linear interpolation between predetermined points, 
was performed using the package ‘spftir’ (Pozo Valenzuela and Rodriguez-
Llamazares, 2016) version 0.1.0. Principal component analysis was performed using 
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‘pracma’ (Borchers, 2019) version 2.2.9. Partial least squares regression was 
performed using the package ‘PLS’ version 2.7.2 (Mevik and Wehrens, 2015). The 
package ‘basicTrendline’ (Mei and Yu, 2018) version 2.0.3 was used to plot the 
trendline between %CI determined by the univariate model (380-model) and the PLS 
model. MCCrystal can be accessed at https://sspc.ie/mccrystal/. 
2.5 Results 
2.5.1 Raman spectra fluorescence background removal 
Prior to designing models to predict MCC %CI from Raman spectra, it was necessary 
to remove spectral interference. Fluorescence background, baseline shifts and 
intensity differences were observed (Figure 2.3). The baseline subtraction method 
developed eliminated the fluorescence background and SNV eliminated intensity 
differences observed between the spectra. All spectra used in this study were 
baselined and SNV normalized accordingly. 
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Figure 2.3. Spectra acquired by the PhAT probe (A) raw spectra exhibiting the 
fluorescence background and intensity shifts, (B) spectra following baseline 
transformation, and (C) spectra following SNV and baseline transformation. 
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2.5.2 Principal component analysis 
A PCA model was used to explore spectral differences due to the probe set-up used. 
For this purpose, the model was built from treated spectra (baseline and SNV) 
acquired using both MR and PhAT probes. The scores plot (Figure 2.4a) shows a clear 
separation of the samples into two groups based on the spectra acquired using either 
the MR probe or the PhAT probe. The Raman shifts that lie within the upper and 
lower bounds of the correlation loadings plot are the regions where the variability 
was modelled by that principal component (Figure 2.4b and 2.4c). Variability in the 
regions containing the peaks at 380 and 1096 cm-1 are captured by the PCA model. 
Spectral comparisons showed that the peak intensity at 1096 cm-1 is higher and at 
380 cm-1 is lower for the PhAT probe in comparison to the MR probe. Figure 2.5 
provides representative spectra for a single batch highlighting that differences in 
intensities were observed for spectra acquired using the different probes, and these 
differences could not be removed by baseline correction or SNV. This is a strong 
indication that the %CI determined using spectral data from a MR probe cannot be 
compared to the crystallinity index determined using spectra data from a PhAT 
probe.   
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Figure 2.4. (A) PCA scores plot, (B) correlation loadings of the first principal 
component and (C) correlation loadings of the second principal component of the 
model built using spectra of 30 MCC batches acquired with MR (n= 85 spectra) and 
PhAT (n= 60 spectra) probes. 
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Figure 2.5. Spectra acquired using MR and PhAT probes after baseline correction 
and SNV normalization for a sample of single batch. 
2.5.3 Development of specific 380-method equations for MR and PhAT Raman 
instruments 
Linear regression plots of theoretical crystallinity index determined from PXRD (%CIT) 
and the ratio between the Raman intensities at 380 and 1096 cm-1 showed 
correlation for spectra acquired using both the MR and PhAT probes. Pearson’s r 
values of 0.960 and 0.986 for the MR probe and PhAT probe, respectively were 
obtained (Figure 2.6). Differences in the linear relationship can be explained by the 
capacity of each probe to capture the intrinsic crystallinity heterogeneity of MCC 
samples. A PhAT probe averages a larger area (12.57 mm2) in comparison to a MR 
probe (7.85 x 10-3 mm2). Thus, the PhAT probe was able to capture a more 
representative measurement of the sample. This may explain why the PhAT probe 
showed a marginally better correlation to the theoretical crystallinity index, %CIT. 
Replicate spectra acquired by the PhAT probe also provided more consistent peak 
ratio values for the same sample. Figure 2.6 contains replicates (n=3 for MR probe 
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and n=2 for PhAT probe) and it was clear that the replicate PhAT probe measurement 
deviated less than the MR probe measurements.  
 
Figure 2.6. Correlation between the ratio of the Raman intensities at 380 and 1096 
cm-1, and the theoretical crystallinity index determined using PXRD. Pre-treated 
spectra obtained for blends using MR and PhAT probes were used. 
Based on the correlations shown in Figure 2.6, specific 380-method equations were 
proposed for MR and PhAT instrumental systems, Equations 2.7 and 2.8, respectively. 
%𝐶𝐼 =
𝐼 − 𝐼






𝐼 − 𝐼 _





2.5.4 Determination of MCC crystallinity indices for commercial batches 
The %CI for a set of 30 commercial batches was determined using the corrected 380-
method (Equations 2.7 and 2.8) applied to spectral data acquired using the MR and 
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PhAT probes, respectively. Amorphous spectra were obtained for each MCC batch 
with both probes. From the processed amorphous spectra from each 
batch obtained using the MR probe (n=70) and PhAT probe 
(n=55), an averaged amorphous spectrum was generated for both probes. The 
averaged intensities and standard deviations for the peaks of interest for the MR 
probe averaged amorphous spectrum were 𝐼 _  (0.627 ± 0.246) and 𝐼 _  (-
0.886 ± 0.042) and for the PhAT probe averaged amorphous spectrum were 
𝐼 _  (1.194 ± 0.277) and 𝐼 _ (-0.907 ± 0.022). These averaged amorphous 
spectra were used in the determination of %CI for each batch. The % CI values 
obtained for all MCC batches investigated are shown in Figure 2.7.  
 
 
Figure 2.7. Crystallinity index (%CI) determined for commercial batches using 
spectra obtained for pellets and different probes (MR probe n = 3, and PhAT probe 
n = 2, using Equation 2.7 and 2.8, respectively). 













 Chapter -2 
 
Ana Luiza Pinto Queiroz Page 94 
2.5.5 Partial least squares regression models 
A PLS model was built as an alternative to the 380-method in order to avoid having 
to undertake milling and spectra deconvolution steps. Agarwal et al. also used a PLS 
model to determine %CI (Agarwal et al., 2010). However, the present study involved 
a greater number of MCC batches and reflects the variability across commercial 
batches, while the study published by Agarwal et al. included several blends of 
commercial batches as received and their reference milled sample, at different mass 
fractions. 
Statistically significant PLS models were determined for both probes (Table 2.1, 
Figures 2.8 and 2.9). The optimal number of factors for both models was considered 
to be three, which represented 97.82 % of variance for the MR probe data and 98.57 
% of the variance for PhAT probe data. The variability captured by the first factor of 
both models included the Raman shifts known to be correlated to MCC crystallinity 
(and used to calculate MCC crystallinity by the 380-method), which was not 
surprising because the independent variable used to build the model was the %CI 
from the 380-method. This can be seen in the correlation loadings where the Raman 
shifts that fall within the upper or lower outer lines are the Raman shifts used by that 
factor to build the model (Figures 2.8 B-D, and 2.9 B-D).  
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Table 2.1. Summary statistics of the Partial least squares Regression models. N is the 
Number of factors, RMSEC is the Root Mean Square Error of Calibration, RMSEP is 
the Root Mean Square Error of Prediction. 
Statistical descriptors MR probe PhAT probe 
Number of calibration samples 67 48 
Number of validation samples 18 12 
Optimal number of factors 3 3 
N 1 2 3 1 2 3 
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Figure 2.8. (A) Values of crystallinity index (%CI) predicted by the Partial least 
squares Regression model vs Reference values for the MR probe and considering 
three factors, and (B, C, and D) correlation loadings of factors 1, 2, and 3, 
respectively, obtained from the model designed using baselined and normalized 
spectra. The further the correlation loading is from the zero, the stronger the 
Raman shift contributed to explain the variability encountered by the factor. In blue 
are the calibration and in red the validation sets. 
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Figure 2.9. (A) Values of crystallinity index (%CI) predicted by the Partial least 
squares Regression model vs Reference values for the PhAT probe and considering 
three factors, and (B, C, and D) correlation loadings of factors 1, 2, and 3, 
respectively, obtained from the model designed using baselined and normalized 
spectra. The further the correlation loading is from the zero, the stronger the 
Raman shift contributed to explain the variability encountered by the factor. In blue 
are the calibration and in red the validation sets. 
The scores plot of the PLS models was used to investigate spectral differences 
between batches of different average particle size and grades. However, the model 
was not able to separate the batches by average particle size nor grade i.e., the PLS 
model was not able to identify patterns in the Raman spectra to cluster the batches 
in groups of the same average particle size nor groups of the same grade (Figure 
2.10).  
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Figure 2.10. Scores plots of factors one and two highlighted by (A and B) average 
particle size for the calibration set, (C and D) manufacturer for the validation set, (E 
and F) manufacturer for the calibration set for the MR and PhAT probes, 
respectively. 
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2.5.6 Relationship between %CI and monolayer moisture content 
Finally, a correlation between MCC sample crystallinity index and moisture 
monolayer values of all 30 batches was investigated. The set of samples used in this 
study was not sufficient to build a predictive linear regression model. Pearson’s 
correlation coefficients of -0.459 and -0.476 were obtained using the PhAT probe and 
MR probe, respectively (Figure 2.11). PLS models (Raman spectra as independent 
variable, moisture monolayer as dependent  variable) and correlation models 
(between %CI and the moisture absorbed at different relative humidity, determined 
using DVS) were also investigated, and they showed similarly poor correlations 
between %CI and moisture sorption. Among the batches analysed, two batches 
showed greater %CI and lower moisture monolayer in comparison to the other 
batches (~1.5 and 1.7 mM/g). These samples contributed to an increase in the 
correlation coefficient value. 
 
Figure 2.11. Correlation between crystallinity index (%CI) determined from Raman 
spectra acquired using a PhAT and a MR probe.  
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2.6 Discussion 
It is challenging to determine the properties of microcrystalline cellulose compared 
to other materials. MCC shows great variability due to its natural source i.e., wood 
pulp, and the different processes from which the commercial grades are produced, 
especially different drying processes. As a result, there is a lack of standards and 
references and most techniques give relative results (Foster et al., 2018). In this study 
the application of two models to determine the crystallinity index of MCC commercial 
batches was investigated. Both models showed predictive power.  
The crystallinity of MCC was firstly determined using the 380-method proposed by 
Agarwal et al. (Agarwal et al., 2010). A calibration curve was developed and used to 
correct the model for each instrument employed in this study (MR and PhAT probes, 
Kaiser Optical Systems Inc., USA). This modification was previously performed for a 
different instrument (Foster et al., 2018). Reference amorphous spectra for each 
batch were produced and an averaged spectrum (n=30 batches) was determined for 
each probe. As a result, the production of a reference amorphous material and 
spectral subtraction for new batches are no longer required for future analysis. The 
time for analysis was shortened and milling and PXRD analysis steps (required to 
confirm that the sample is indeed amorphous) can be eliminated from the analytical 
procedure.  
Crystallinity of MCC was also determined by partial least squares regression models. 
The crystallinity values used in this regression analysis were those determined using 
the established 380-method. The ability of the models to predict crystallinity from 
Raman spectra were 97.82 % for MR and 98.57 % for PhAT probes and the predicted 
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values for the test set showed a small prediction error (RSMEP equal to 1.0522 and 
1.3189 for MR and PhAT probe, respectively). The correlation loadings showed that 
the main wavenumbers used to build the model were 380, 437, 458, 521, 1,096, 
1,120, 1,330, 1,340, 1,380, and 1,475 cm-1. Those wavenumbers were correlated to 
a change in cellulose crystallinity due to contributions from OH rocking and bending, 
CH and CH2 bending, CO and COC stretching, CH wagging, and anhydroglucose ring 
stretching, twisting, and torsion modes (Agarwal et al., 2010). The models built may 
be used to rapidly determine crystallinity for future MCC batches without the 
necessity to produce an amorphous reference spectrum. A PLS model had been 
previously used to predict crystallinity (Agarwal, 2019; Agarwal et al., 2010), 
however, the model was built with only ten samples (a control, 4 mixtures, 3 samples 
milled during different times and 2 commercial MCC grades). The present study 
investigated thirty MCC commercial batches including ones with different particle 
sizes (from 50 to 180 µm average particle size) and MCC grades. Thus, the present 
study confirmed the finding of the previous study reported by Agarwal et al. and 
enriched the validation of the models by investigating the variability encountered in 
commercial grades of MCC.  
In this study Raman probes that can scan large surface areas and give an averaged 
spectrum in a short time were used (1 min for MR probe and 15 sec for PhAT probe). 
Previous studies used Raman spectra of microscopic surface areas (Agarwal, 2019; 
Agarwal et al., 2010; Foster et al., 2018). The PhAT probe used in the present study 
acquires spectra from an area of 12.57 mm2 and the MR probe from an area of 7.85 
x 10-3 mm2. A PhAT probe also has a depth of analysis of approximately 2 mm. Thus, 
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less replicates are necessary to achieve a representative sample when a PhAT probe 
is used. As a result, Raman spectrum containing more averaged information of the 
overall semi-crystalline structure of MCC samples is obtained. Comparing the PhAT 
and the MR probes, the larger coverage area of the PhAT probe resulted in better fits 
for both the 380-method and PLS models. This was quantified by Pearson’s 
coefficients obtained from the calibration of the 380-method (Figure 6, Pearson’s-r 
of 0.986 and 0.960 for PhAT and MR probes, respectively) and the PLS model 
(correlation of 0.986 and 0.978 for PhAT and MR probes, respectively). LaPlant and 
Zhang also observed that in comparison to the MR probe, the PhAT probe gave more 
consistent and representative results in a study of polymorphic content in a drug 
product (LaPlant and Zhang, 2005). In the current study, variability observed 
between duplicate values determined using the PhAT probe was greater than when 
using the MR probe, for a number of the commercial samples. A possible explanation 
may be due to spectra being acquired on the same surface of the pellet (top surface) 
for the MR probe, while for the PhAT probe one spectrum was acquired on the top 
surface and another was acquired on the bottom surface of the pellet. The difference 
in %CI due to the differences in the positions from which the Raman spectra were 
may be due to the characteristic of uniaxial compression, which does not hold a 
homogeneous stress distribution in the interior of the pellet (Takeuchi et al., 2004).  
It is important to also emphasis the limitations of quantifying the %CI of cellulose 
materials, including MCC, using the Raman spectroscopy. Key 
limitations include the lack of 100% crystalline or amorphous 
cellulose standards or references and the need to adjust model parameters for each 
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instrumental set-up by calibration against diffraction 
data. Therefore, the %CI determined by Raman analysis is dependent on 
the diffraction analysis methodology. In this study, a simplistic approach was 
undertaken which mimicked that of Agarwal et al. 2010. The %CI of calibration set 
samples were determined using the Segal peak height method and theoretical 
%CI values were determined based on the %CI of a single MCC batch. It is 
proposed that an improvement to this approach should include a wider 
calibration set of samples in the calibration study to improve model robustness. It is 
also important to extend the diffraction methodologies employed to measure %CI of 
the calibration sample set. Advancement from the Segal peak height method during 
calibration, towards more advanced methods such as decomposition or 
deconvolution of peak area during calibration (Lanson 1997; Park et al. 2010; 
Ahvenainen et al. 2016, Yao et  al. 2020), and Rietveld refinement based methods 
(Madsen et al. 2011; Ling et al. 2019) could further improve the models proposed in 
this study. The respective strengths and limitations of more commonly diffraction 
method discussed by French 2020, as are standards for conducting crystallographic 
work to study cellulose crystallinity (French 2020).   
It was not possible to establish a relationship between MCC moisture monolayer and 
calculated crystallinity. Moisture monolayer was determined from DVS moisture 
sorption isotherms and used to build a regression model with crystallinity 
determined by the univariate 380-method. Moisture monolayer was also used as a 
response variable in a PLS model in order to investigate if moisture monolayer could 
be predicted from Raman spectra. Neither of the models, univariate or multivariate, 
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showed a relationship between the moisture monolayer and crystallinity (or Raman 
wavenumbers related to changes in cellulose crystallinity). The relationship between 
moisture sorption and crystallinity observed by other authors (Awa et al., 2015; 
Mihranyan et al., 2004) was not conclusively confirmed for the set of commercial 
grades analysed in this study (correlation coefficients of -0.459 and -0.476 were 
obtained using moisture monolayer and the %CI determined using Raman spectra 
collected using a PhAT probe and MR probe, respectively). This may be due to the 
range of crystallinity values within the set of samples studied which did not result in 
a large variability in the moisture monolayer values measured. The finding of this 
study indicates that moisture sorption of MCC commercial grades may depend not 
only on crystallinity, but also on other structural factors such as surface area and pore 
volume, as suggested by Mihranyan et al. (Mihranyan et al., 2004). 
A R Shiny web application was designed (i) to perform baseline correction and SNV 
normalization, (ii) to predict MCC crystallinity using the 380-method for the MR and 
the PhAT probes, (iii) to predict MCC crystallinity from PLS models, and (iv) to perform 
PCA from Raman spectra within the range of 1500 to 250 cm-1. This application was 
developed based on the knowledge generated in this study. Thus, baseline 
correction, SVN normalization, and the PCA model can be applied to Raman spectra 
of microcrystalline cellulose obtained using different Raman instruments. However, 
the prediction of the crystallinity index can only be undertaken if a MR or a PhAT 
probe was used to acquire the Raman spectra. Even if those Raman instruments are 
used, results should be evaluated with caution since different units of a same 
instrument design might require instrument-specific correction of the model. 
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2.7 Conclusions 
Crystallinity index was determined for 30 commercial batches of microcrystalline 
cellulose using two different models i.e., 380-method and PLS regression. Both 
models showed adequate predictive power. However, the development of the PLS 
model takes substantially less time for analysis because it eliminates the need for 
milling and deconvolution of the spectra of the milled sample into amorphous and 
crystalline contributions before the actual %CI determination. For these models a 
general reference amorphous Raman spectrum was proposed for each instrument. 
Spectral comparison and principal component analysis showed that values of 
crystallinity index were relative to the instrument used to acquire the Raman spectra. 
Also, larger laser spot sizes give more reproducible and representative information 
on the overall crystallinity of the sample. The crystallinity index values obtained with 
either model depend on the XRD methodology and calibration sample set employed 
during calibration. The methodology presented can be further advanced by 
employing a broader sample set and more advanced XRD methodologies to measure 
microcrystalline cellulose crystallinity during calibration of the model. A web 
application, MCCrystal, was developed which facilitates the use of the predictive 
models developed in this study to measure MCC crystallinity. It was not possible to 
establish a regression model to predict moisture monolayer from crystalline indices 
determined from the Raman spectra, indicating that in addition to crystallinity, other 
structural properties such as pore volume and surface area need to be considered in 
predicting MCC moisture monolayer.  
 Chapter -3 
 




Chapter 3 - Application of Multivariate 
Curve Resolution to determine co-




Revised from publication in: International Journal of Pharmaceutics (2021) 
https://doi.org/10.1016/j.ijpharm.2021.120246 
  
 Chapter -3 
 
Ana Luiza Pinto Queiroz Page 107 
3.1 Abstract 
Multivariate Curve Resolution (MCR) was used to determine the phase purity of 
pharmaceutical co-crystals from mid infrared spectra. An in-silico coformer screening 
was used to choose one of ten potential coformers. This analysis used quantum 
chemistry simulation to predict which coformers are thermodynamically inclined to 
form co-crystals with the model drug, hydrochlorothiazide. The coformer chosen was 
nicotinamide. An experimental solvent screening by ultrasound assisted slurry co-
crystallization was performed to evaluate the capacity of the MCR method to 
determine phase purity. Afterwards, slurry and slow evaporation co-crystallizations 
were performed at 10, 25, and 40 °C using 7 solvent systems, and two levels of 
agitation for the evaporation co-crystallization (on and off). MIR analysis of the 
products of these co-crystallisations were used to develop an MCR model to 
determine co-crystal phase purity. Loadings related to component 1 of the MCR 
model correlated with the MIR spectra of a reference co-crystal. MIR, PXRD and DSC 
were used to assess the reference co-crystal form and phase purity. Experimental 
design (DoE) was used to investigate the effect of solvents, temperature, and 
agitation on the purity of co-crystals produced by slurry and evaporation. Principal 
component analysis of on-line Raman spectra captured the co-crystal formation 
process and allowed to determine slurry co-crystallization endpoint. The MCR phase 
purity model developed from MIR spectra was employed to determine co-crystal 
phase purities of products. DoE revealed that evaporation co-crystallization with 
agitating at 65 rpm formed co-crystals with greater phase purity. The optimal 
temperature varied with the solvent used.  
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3.2 Introduction 
Co-crystallization is a crystal engineering approach that has been used to enhance 
mechanical and physicochemical properties and chemical stability of drugs 
(Rodrigues et al., 2018a; Sun, 2013). According to the European Medicines Agency 
(EMA), pharmaceutical co-crystals are “homogenous (single phase) crystalline 
structures made up of two or more components in a definite stoichiometric ratio 
where the arrangement in the crystal lattice is not based on ionic bonds (as with 
salts)”. The components of a co-crystal may, nevertheless, be neutral as well as 
ionized (European Medicines Agency, 2015). Also, co-crystals differ from solvates 
because all the molecules in co-crystals are solid at ambient temperature, while in 
the solvates at least one component is liquid at ambient temperature. There are also 
co-crystals solvates in which the solvent is trapped in the crystal lattice during co-
crystallization (Sarraguça et al., 2015). During crystal engineering development, 
modelling tools such as quantum chemistry simulation have been used to predict the 
propensity of co-crystal formation, preferably to those other crystal structures 
(Loschen and Klamt, 2015). The crystal structure of the predicted product is then 
confirmed experimentally using analytical techniques such as X-ray powder 
diffraction (XRD) and vibrational spectroscopy (Datta and Grant, 2004). 
The nature of the interaction and the molecular structure of API and coformer are 
different from that observed for the starting material (Ross et al., 2016). Therefore, 
the most relevant advantage of co-crystallization to the pharmaceutical industry is 
that critical material attributes such as flowability, compressibility, compactability, 
and solubility can be designed to improve drug processability and bioavailability. 
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Also, co-crystallization processes can be designed to be scalable and can be 
performed in continuous manufacturing plants within a quality by design framework 
(Rodrigues et al., 2018a). Rodrigues et al. described and compared several co-
crystallization methods reported to date, such as isothermal slurry, slow evaporation, 
spray drying, neat grinding, freeze drying, and hot melt extrusion. Solvent-based 
methods are the most common co-crystallization approaches deployed at laboratory 
scale and they are also reportedly used in industrial scale in continuous 
manufacturing (Zhao et al., 2014). This can be explained by the fact that solvent-
based procedures are relatively simple, as are the apparatus required to perform 
them.  
Solid-state analysis must be employed in order to be able to determine co-crystal 
phase purity,  since most solvents, including water can destroy the non-covalent 
bonds in co-crystals (Chi et al., 2013). Instead, a variety of combined solid-state 
techniques are used, with particular emphasis on crystallographic and vibrational 
spectroscopy methods (Emami et al., 2018). Vibrational spectroscopic techniques are 
the most commonly used for in-line and on-line process monitoring because they are 
rapid, non-destructive and the spectroscopic techniques can be built into the 
manufacturing process by means of immersion probes, flow-through cells, and 
quartz windows (Pomerantsev and Rodionova, 2012). Spectroscopic techniques can 
assess differences between crystalline forms, crystalline form transformations, 
differences between amorphous and crystalline forms and between anhydrous and 
hydrate forms (Erxleben, 2016). Thus, vibrational spectroscopic techniques are of 
great interest when it comes to the development of process analytical technology for 
co-crystal phase purity control. In this paper, phase purity relates to the lack of solid 
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phases other than a specific co-crystal e.g., co-crystal (pseudo)polymorphs or starting 
materials and/or their (pseudo)polymorphs. The spectroscopic techniques most used 
for industrial process control and product characterization applications are near-
infrared spectroscopy (NIR), Raman spectroscopy and mid-infrared spectroscopy 
(MIR) (Pomerantsev and Rodionova, 2012). The application of those techniques to 
co-crystal production has also been investigated. Table 3.1 shows studies in which 
vibrational spectroscopic techniques were applied to monitor and control co-
crystallization processes (in-line and online) and to characterize co-crystals (offline). 
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Table 3.1 Application of vibrational spectroscopic techniques to co-crystallization 
process monitoring and co-crystal characterization. NIR = near-infrared spectroscopy 
and MIR = mid-infrared spectroscopy. 
Technique 
References 
On-line In-line Offline 
NIR (Silva et al., 2017) (Kelly et al., 
2012; Markl et 
al., 2013; 
Sarraguça et al., 
2016) 
(Gagniere et al., 2012; Kelly 
et al., 2012; Sarraguça and 
Lopes, 2009; Silva et al., 
2017) 
MIR (Ishihara et al., 
2019) 
(Gagniere et al., 
2012) 
(Alshahateet, 2010; 
Mittapalli et al., 2019; Zhao 
et al., 2014) 
Raman (Inoue et al., 
2017; Otaki et al., 
2018; Sheng et al., 
2016; Tanaka et 
al., 2019) 
(Kojima et al., 
2010; Lee et al., 
2014; Soares and 
Carneiro, 2017, 
2013) 
(Aher et al., 2010; Markl et 





- - (Goud et al., 2012; 
Rodrigues et al., 2018b) 
NIR and 
Raman 
- (Islam et al., 
2015) 
(Allesø et al., 2008) 
NIR and 
MIR 
(Sarraguça et al., 
2014) 
- (Sarraguça et al., 2014) 
MIR and 
Raman 
(Powell et al., 
2016) 
(Bian et al., 
2013; Du et al., 
2017) 
(Barmpalexis et al., 2018; 
Basavoju et al., 2006; Childs 
and Hardcastle, 2007; Du et 
al., 2017; Emami et al., 
2018; Powell et al., 2016) 
Multivariate analysis methods such as principal component analysis (Pearson, 1901) 
can be used to investigate co-crystal phase purity from a reference co-crystal 
spectrum (Rodrigues et al., 2018b). However, during the co-crystal development, 
products of sufficient purity may not be available to obtain a high-quality reference 
spectrum. Multivariate Curve Resolution (MCR) (Lawton and Sylvestre, 1971; 
Martens, 1979) is a group of algorithms developed to implement constraints on 
 Chapter -3 
 
Ana Luiza Pinto Queiroz Page 112 
loadings and scores obtained from a matrix decomposition. That means that loadings 
have an exact physical interpretation i.e., spectra of different components of a 
mixture. The scores also assume a physical meaning, the concentration of the 
component in the mixture. The loadings also explain the variance in the data (De Juan 
and Tauler, 2006; Mendieta et al., 1998). Thus, MCR can potentially be used to 
extract the spectrum corresponding to co-crystal present in a mixture.  
De Juan et al. listed and compared the main MCR algorithms available and discussed 
the benefits of the algorithm Multivariate Curve Resolution-Alternating Least 
Squares (MCR-ALS) (De Juan et al., 2014). MCR-ALS is an iterative algorithm that 
performs alternating optimization by applying constraints in each iterative cycle. The 
constraints applied to MCR model for optimization can be divided into (i) 
mathematical conditions, (ii) natural constraints, and (iii) process constraints. De 
Juan et al. provides a detailed explanation of these constraints (De Juan et al., 2014). 
There is a small number of publications in which MCR and MCR-ALS were applied to 
co-crystallization. Co-crystal concentration estimation (Mazivila et al., 2019; Mazivila 
and Olivieri, 2018), co-crystal formation (Inoue et al., 2017; Ishihara et al., 2019; 
Soares and Carneiro, 2013), and polymorphism (Lukin et al., 2017; Soares and 
Carneiro, 2017) were investigated for different co-crystals. However, co-crystal 
phase purity was only investigated applying MCR-ALS to PXRD and Raman spectral 
data. Substances that present weak Raman signals are usually analysed using MIR 
(Abbas et al., 2012). Fluorescence is frequently observed during acquisition of Raman 
scattering. Since fluoresce has much stronger intensity, the Raman signal can be 
masked. This problem can be diminished with increase in the laser wavelength or 
using Coherent Anti-stokes Raman Scattering (CARS) (Alula et al., 2018; Paudel et al., 
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2015; Rodrigues et al., 2020). Alternatively, MIRS can be used. Determination of co-
crystal phase purity applying MCR to MIR spectral data has not been investigated to 
date without a reference spectrum.  
The overall aim of this study was to use MCR-ALS to determine co-crystals phase 
purity using MIR spectra, and apply the methodology developed to establish a co-
crystallization process design space. For that end, hydrochlorothiazide (HTZ) was 
used as model drug. The co-crystallization of this API has been well studied by 
Rodrigues et al. (Rodrigues et al., 2019, 2018b). Hydrochlorothiazide is a poorly 
water-soluble drug substance chemically classified as a thiazide, a diuretic class 
mainly used in the treatment of hypertension and is a good candidate to produce co-
crystals with improved solubility. An in-silico study was performed to determine the 
best coformer for the experimental co-crystallization. Afterwards, the ability of MCR 
to determine co-crystal phase purity model was investigated by applying the model 
to MIR data from a screening slurry co-crystallization. 
3.3 Materials and methods 
3.3.1 In-silico coformer screening 
Quantum chemistry simulations were performed to select one coformer to be 
investigated experimentally, and to generate thermodynamic understanding of the 
co-crystal formation. Propensity for co-crystallisation of an API molecule with 10 
potential coformers was estimated using fluid phase thermodynamic modelling 
accessible in the COSMOthermX computational platform, version 19.0.1 
(COSMOlogic GmbH & Co. KG Imbacher, Germany). COSMOS-RS thermodynamics 
used in this contribution is based on the statistical physics of interacting molecular 
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surface segments. The polar and hydrogen bond interaction energies are quantified 
based on the surface screening charge densities, which result from a quantum 
chemical continuum solvation calculation (Abramov et al., 2012). 
COSMO-RS (COnductor like Screening MOdel for Real Solvents) was employed to 
predict propensity for co-crystal formation assuming that more negative the excess 
enthalpy (which reflects stronger intermolecular interactions between the active 
pharmaceutical ingredient (API) and the coformer), the higher the probability of 
forming a co-crystal. The model considers a fluid phase only, thus a long-range order 
and specific packing within a crystal phase is not considered here (Sinnecker et al., 
2006). 
The API molecule investigated was hydrochlorothiazide and the coformers were 
mannitol, caffeine, para-aminobenzoic acid, malic acid, arginine, tromethamine, 
adenine, citric acid, tryptophan, and nicotinamide. To prepare input structures for 
the coformer screening, molecular geometry of the API and all the considered 
coformers were optimized using quantum chemistry TURBOMOLE software 
(COSMOlogic GmbH & Co. KG Imbacher, Germany). All the compounds were 
modelled as neutral molecules, so no extra charge or charge separation was 
considered. For that, the Density Functional Theory level BP-TZVPD-FINE was used. 
This level uses a Becke–Perdew (BP) functional (Becke, 1988) and a triple-z valence 
polarized basis set (TZVP) (Schäfer et al., 1994) with a fine grid marching tetrahedron 
cavity (FINE) and delivers the best quality results. However, it demands the most 
computational power (Paduszyński, 2017). The optimised geometries, along with the 
charge density maps of the API and the coformer molecules were then used to 
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predict propensity for co-crystal formation with the proposed coformers in the ratios 
1:1 and 1:2. 
3.3.2 Materials  
Hydrochlorothiazide (HTZ) ≥ 99.0% and nicotinamide (NCT) ≥ 99.5% were obtained 
from Sigma-Aldrich, USA. The analytical grades of the following solvents were used 
in this study: chloroform (CF) (Sigma-Aldrich, Portugal), methanol (MeOH) and 
acetone (Ace) (VWR Chemicals, France), acetonitrile (ACN) (Fisher Scientific, UK), 2-
propanol (iPro) and and Ethyl acetate (EtOAc) (Sigma-Aldrich, USA), and ethanol 
(EtOH) (Chem-Lab, Belgium). 
3.3.3 Methods 
3.3.3.1 Experimental solvent screening 
Solvent and ratio screenings was performed to produce co-crystals with varying 
phase purities. This analysis produced data for the development of models to predict 
phase purity and optimal ratio of co-crystal formation. The API:coformer ratios 
investigated were 1:1 and 1:2. Co-crystallization was performed by ultrasound 
assisted slurry co-crystallization in a well plate. Five different solvents were used in 
the screening study: methanol, ethanol, acetone, 2-propanol, and acetonitrile.  
3.3.3.2 Reference co-crystal preparation  
One gram of hydrochlorothiazide and the equivalent amount of coformer 
(stoichiometric ratio of 1:1) were weighted. The powder blend was then dissolved in 
50 ml of acetone at 40 °C. Solvent was left to evaporate at 25 °C using a water bath 
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with a thermostat (microprocessor control MPC, Huber Kältemaschinenbau AG, 
Germany) without agitation. The reference co-crystal was characterized by X-ray 
diffraction and differential scanning calorimetry.  
3.3.3.3 Laboratory-scale co-crystallizations 
3.3.3.3.1.1 Experimental design 
Full factorial design of experiments was performed to determine the design space of 
the laboratory-scale co-crystallization. The specific aim of this analysis was to 
investigate how the co-crystal phase purity was affected by different solvent choices, 
temperature and, for evaporation co-crystallization, the presence or absence of 
agitation. The three factors of the model were agitation (2 levels), solvent (7 levels), 
and temperature (3 levels) (Table 3.2). A reduced fifth model was fit to the designed 
experiments using the phase purity obtained from the MCR model as response. The 
results of the experimental trials were analyzed using Analysis of Variance (ANOVA). 
Design-Expert® DOE Software (Stat-Ease Inc., Minneapolis, USA) was used to perform 
the DoE. 
Table 3.2. Experimental design factors for the determination of the co-crystallizations 
design space. EtOH = ethanol, MeOH = methanol, ACN = acetonitrile CF = chloroform, 
Ace = acetone, DCM = dichloromethane, EtOAc = ethyl acetate. *For evaporation co-
crystallization only 







10; 25; 40 
EtOH; MeOH; ACN; CF:Ace 1:1; DCM:Ace 1:1; 
EtOAc:Ace 4:1; DCM:Ace 1:1 
0; 65  
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3.3.3.3.1.2 Solvent evaporation co-crystallization 
Approximately 300 mg of HTZ with the corresponding stoichiometric ratio in mass of 
coformer was added to 100 mL beakers followed by the addition of 50 mL of solvent. 
The systems were agitated until reaching complete dissolution on a stirrer table 
(RSLAB-5C 10-chanel analogical stirrer table with heating option) at room 
temperature.  
The flasks were then transferred to water bath (Huber K15 Bath with MPC Controller, 
Heating/Cooling recirculating Unit) with temperature controlled with or without 
agitation (see Table 3.2) to allow solvent evaporation. The powder obtained was kept 
on a hot plate at 30 °C for 3 hours prior characterization in order to ensure total 
solvent release. 
3.3.3.3.1.3 Co-crystallization in slurry 
3.3.3.3.1.4 Determination of slurry co-crystallization endpoint 
The endpoint of the co-crystallization in slurry was determined by a PCA model of 
Raman spectra obtained during online monitoring. Approximately 600 mg HTZ and 
the corresponding amount of coformer (ratio 1:1) were added to a glass flask 
followed by the addition of 20 mL of solvent (MeOH, EtOH, Ace, EtOAc, DCM, ACN or 
CF) and a magnetic stirrer. The flask was sealed and placed on a stirrer table (RSLAB-
5C 10-chanel analogical stirrer table with heating option) where the system was kept 
under agitation at 120 rpm for five days. Raman spectroscopy was used to monitor 
the co-crystallization process online. Co-crystallization endpoint was considered the 
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time point at which the scores of the first principal component of PCA achieved 
steady state.   
3.3.3.3.1.5 Slurry co-crystallization 
Approximately 300 mg of HTZ and the corresponding amount of coformer (ratio 1:1) 
were added to a 100 mL Erlenmeyer flask followed by the addition of 10 mL of solvent 
and a magnetic stirrer. The flask was sealed and transferred to the water bath (Huber 
K15 Bath with MPC Controller, Heating/Cooling recirculating Unit) with temperature 
control, and with or without agitation (Table 3.2) for 120 hours. The flasks were then 
unsealed and left in a fume hood at room temperature to allow solvent evaporation. 
The powder obtained was kept on a hot plate at 30 °C for 3 hours prior to 
characterization in order to ensure total solvent release.  
In a slurry co-crystallization, the slurry is normally filtered at the end point in order 
to isolate the solids. However, the goal of these experiments was to produce co-
crystals with different purities in comparison to evaporation co-crystallization. 
Hence, at the end of the slurry co-crystallization, filtration was not performed, and 
solvent was evaporated at room temperature.  
3.3.3.4 Characterization techniques 
3.3.3.4.1.1 Mid infrared spectroscopy  
The co-crystals produced were characterized by mid infrared spectroscopy (MIR). 
Spectra (n=5) were acquired using a Frontier Spectrometer (PerkinElmer, UK) 
equipped with an attenuated total reflectance (ATR) accessory (PerkinElmer, UK). 
The co-crystal samples were placed directly on the crystal of the ATR accessory and 
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each spectrum was the resultant of 32 accumulations at a resolution of 4 cm-1 over 
the range 4000-600 cm-1. The background spectrum was acquired for the crystal 
following cleaning.  
3.3.3.4.1.2 Raman spectroscopy 
For online monitoring a Raman spectrometer equipped with a probe (i-Raman® Plus 
BWS415-785H, BW Tek, USA) was used. Raman spectra were acquired every 20 min, 
with exposure time of 20 seconds, 2 accumulations, and laser power of 785 mW at 
100% over the range 300-1800 cm-1. The probe was placed perpendicular to the flask 
containing the sample. The flask and the end of the probe were inserted in a bespoke 
black box of polylactic acid constructed in-house to avoid external light interference. 
The system was kept under agitation at 120 rpm and at the temperature of 40 °C on 
a stirrer table (RSLAB-5C 10-chanel analogical stirrer table with heating option).  
3.3.3.4.1.3 X-ray diffraction 
X-ray diffraction patterns and DSC thermograms were collected for the isolated pure 
reference co-crystals for phase purity characterization. Powder X-ray analysis was 
performed in reflection mode using a benchtop X-ray diffraction (XRD) instrument 
Rigaku Miniflex II (Rigaku, Tokyo, Japan) equipped with a Cu Kα X-ray source and 
Haskris cooling unit (Grove Village, IL, USA). The samples were front-loaded by gently 
pressing using a glass slide on a zero-background silicon sample holder. The PXRD 
patterns were recorded for a 2θ ranging from 3 to 40 degrees with a step-size of 0.05 
degrees per second. 
 Chapter -3 
 
Ana Luiza Pinto Queiroz Page 120 
The experimental X-ray diffractogram collected was compared with the simulated 
theoretical diffractogram generated from a Crystallographic Information File (CIF) of 
hydrochlorothiazide-nicotinamide co-crystal (CCDC ref. code PIRXUL) using Mercury 
software v. 3.10.3. 
3.3.3.4.1.4 Differential scanning calorimetry 
A TA Instruments DSC Q1000 differential scanning calorimeter and thermal analysis 
controller (TA Instruments, New Castle, DE, USA) was used to determine the enthalpy 
and the melting point of the reference co-crystal. Approximately 2–3 mg of co-crystal 
was heated at a heating rate of 10 °C/min from 25 to 275 °C. Nitrogen was used to 
purge the system at 50 ml/min. 
3.3.3.5 Data Analysis 
3.3.3.5.1.1 Principal Component analysis 
PCA was performed as an exploratory technique in the screening experiments and to 
analyze the Raman spectra from the online monitoring. The raw spectra were pre-
treated by mean centering and Standard Normal Variate (SNV). PCA was performed 
using the algorithm Nonlinear Iterative Partial least squares (NIPALS). Internal cross-
validation was performed by categorical variable (solvent type), so that every 
segment had one solvent missing. The optimal number of components was 
determined by the minimal number of components that resulted in a minimal 
residual variance. 
PCA was performed using the software Matlab 8.3 (MathWorks, Natick, USA) and the 
PLS Toolbox version 7.5 (Eigenvector research Inc., Wenatchee, USA). 
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3.3.3.5.1.2 Multivariate Curve Resolution 
MCR decomposes the data matrix (X) i.e., the table containing one MIR spectra per 
line, into a matrix of the variation among the spectra, named concentration profiles 
(C), a transpose variance matrix associated with the variation among the variables, 
named spectra profiles (ST), and a matrix of residuals not explained by the model (E) 
(Equation 1). As a result, it is possible to extract the spectra fingerprint of each single 
component of a mixture. 
X = C ∙ S + E (Equation 3.1) 
MCR-ALS applies constraints to optimize MCR results. PCA was used to determine 
the number of components and the spectra were pre-processed by Standard Normal 
Variate (SNV). A constraint of non-negativity was applied to the concentration 
profiles using fasternnls algorithm(Lawson and Hanson, 1995). No spectral 
estimation was used.  
MCR loadings obtained were compared to the spectra of a reference co-crystal and 
to spectra of the reference starting materials. The aim of this analysis was to identify 
which components loading represented the co-crystal information and which 
components loading represented unreacted individual components information. In 
other words, it was necessary to investigate if the model expressed the co-crystal 
information as loadings of component 1 or of component 2. For that, Pearson 
correlation analysis (Ntschi and Bolboac, 2006) was performed between the 
spectrum obtained from the MCR i.e., MCR loadings, and the average spectrum of a 
reference co-crystal (n=5), using Origin data analysis and graphing software 
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(OriginLab, USA). Spectral analysis was also performed to support the statistical 
analysis. 
Equation 3.2 was used to calculate percentage phase purity (% phase purity). 
MCRconc,x is concentration (obtained by MCR) of the component that holds the co-
crystal information, and MCR , + MCR ,  is the sum of the 
concentrations (obtained by MCR) of the 2 first components. The component that 
holds the co-crystal information was the component which the loadings had the 
greatest Pearson correlation coefficient with the spectra of a reference co-crystal. 
% phase purity =  
100 ∙  MCR ,  
MCR , + MCR ,
 (Equation 3.2) 
Values of phase purity obtained with ratios 1:1 and 1:2 were compared to determine 
which ratio produces the co-crystal with higher purity. The optimum ratio for co-
crystal formation should show greater phase purity. Another indication for the 
optimum ratio for phase purity is the component explained variance. The optimum 
ratio should show the greatest percentage variance explained by the component that 
holds the co-crystal information. 
MCR-ALS was performed using the software Matlab 8.3 (MathWorks, Natick, USA) 
and the PLS Toolbox version 7.5 (Eigenvector research Inc., Wenatchee, USA). 
3.4 Results 
3.4.1 In-silico coformer screening  
In order to aid selection of a model co-crystal system for this study, the propensity 
for co-crystallisation of hydrochlorothiazide was assessed computationally 
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considering 10 different coformers at two API:coformer molar ratios: 1:1 and 1: 2 
(Table 3.3). Excess enthalpies (Hex), Gibbs free energies of mixing (Gmix) and 
contributions from hydrogen bonding to intermolecular interaction of API and 
coformer (HB) were computed using fluid phase thermodynamic modelling 
framework implemented in COSMO-RS. The model assumes that the interactions in 
the crystal are similar to those in a virtual supercooled liquid. Thus, the strength of 
the interactions in the co-crystal, as compared with the pure reactants, can be 
estimated via the mixing enthalpy (or equivalently the excess enthalpy) of the API-
coformer with given stoichiometry; Gibbs free energy of mixing and the contribution 
of H-bonding to the mixing energy are other descriptors of the mixing efficiency. It is 
generally assumed that the higher (more negative) values of Hex, Gmix, and HB, the 
stronger the interaction between API and coformer, and higher propensity for 
forming co-crystal. The computed values of Hex, Gmix, and HB are relatively higher for 
the compounds possessing carboxyl groups (COOH), such as malic acid, citric acid, 
and tryptophan, suggesting that the mixing between API and coformer is not 
thermodynamically preferred. On the other hand, the negative values of Hex, Gmix, 
and HB were computed for caffeine, arginine, tromethamine, adenine, nicotinamide, 
and mannitol indicating stronger API-solvent interaction, and suggesting overall 
higher propensity for co-crystallisation. The computations also suggest that for those 
coformers the 1:1 molar ratio is preferred (more negative values) over the 1:2 ratio.  
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Table 3.3. Propensity for solvate formation computed with COSMO-RS fluid phase 
thermodynamics modelling at 1:1 and 1:2 API to coformer molar ratio. Hex, Gmix, 
and HB given in (kcal/mol). 
Coformer 
Ratio 1:1 Ratio 1:2 
Hex Gmix HB Hex Gmix HB 
Caffeine -1.514 -0.723 -1.363 -1.349 -0.64 -1.237 
Arginine -1.009 -0.796 -0.856 -0.989 -0.756 -0.849 
Tromethamine -0.717 -0.471 -0.69 -0.669 -0.425 -0.661 
Adenine -0.635 -0.62 -0.57 -0.614 -0.572 -0.557 
Nicotinamide -0.435 -0.564 -0.426 -0.411 -0.503 -0.422 




0.148 -0.311 0.025 0.137 -0.232 0.063 
Malic acid 0.148 -0.26 0.077 0.139 -0.281 0.021 
Citric acid 0.22 -0.236 0.143 0.201 -0.216 0.123 
Tryptophan 0.273 -0.151 0.069 0.249 -0.139 0.058 
Comparing the results from the experimental screening (Rodrigues et al., 2020; 
Rodrigues et al., 2018b) with the in-silico results some differences can be discussed. 
From the experimental screening the coformers caffeine, adenine and tryptophan 
did not form a cocrystal, and the cocrystallization with arginine was inconclusive. 
Additionally, except for the cocrystal with nicotinamide, all the cocrystals obtained 
were in the ratio of 1:2. The difference between the in-silo studies and the 
experimental screening can be due to the approximations made in the in-silico 
studies, or by experimental factors. It is well known that different co-crystallization 
methods, different solvents, and experimental conditions such as temperature can 
affect the co-crystallization output. However, since the main objective of the work 
was to use multiple curve resolution to determine co-crystal phase purity, we 
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decided to use the coformer in which the experimental results were in accordance 
with the in-silico studies. Therefore, nicotinamide was the coformer chosen to be 
further investigated in this study due to its relatively high negative values of mixing 
enthalpy/energy computed for the co-crystal of nicotinamide and 
hydrochlorothiazide. Also, the reference co-crystal HTZ-NCT had already been 
successfully produced and extensively characterized (Rodrigues et al., 2019). 
Therefore, the models produced in this study can be validated with the knowledge 
about this co-crystal already available in the literature. The chemical structure of HTZ 
and the coformer investigated in this study along with the structure of the 1:1 co-
crystal synthon are shown in (Figure 3.1). 
 
Figure 3.1. Chemical structure of hydrochlorothiazide and nicotinamide – top, and 
3D representation of the co-crystallisation reagents and the final co-crystal synthon 
present in the crystal lattice of the HTZ-NCT 1:1 co-crystal – bottom. H-bonds 
(NH…O=S and NH…O=C) between the coformer and the API molecule shown as 
black dots. 
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3.4.2 Reference co-crystal characterization 
Phase purity of the reference co-crystal obtained was confirmed by comparing the 
XRD pattern of the prepared co-crystal with the simulated XRD derived from single 
crystal data (Figure 3.2). The small intensity differences between the experimental 
and the theoretical diffractograms, and the noise observed in the experimental 
diffractogram can be related to the nature of the sample (powder vs. single crystal) 
and the XRD instrument resolution. However, all peaks predicted in the theoretical 
diffractogram were observed in the experimental diffractogram. The differential 
scanning calorimetry endotherm obtained (Figure 3.3) was comparable to the 
endotherm published for this co-crystal (onset x of 173.65 °C and temperature peak 
at 174.55 °C) , an additional small endotherm was observed in the present study and 
by Sanphui and Rajput (Sanphui and Rajput, 2014). This was attributed to a small 
amount of non-co-crystallized material present in the final product. However, none 
of the other characterization techniques showed any presence of unreacted 
components. Therefore, this additional broad endothermic peak can also be due to 
co-crystal degradation.   
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Figure 3.2. PXRD diffractograms of the prepared co-crystal (experimental) and 
the simulated XRD derived from single crystal data (theoretical) for the co-crystal of 
hydrochlorothiazide and nicotinamide, stoichiometric ratio 1:1. 
 
Figure 3.3. Differential scanning calorimetry endotherms of HTZ 1:1 NCT reference 
co-crystal.  
3.4.3 Experimental screening experiments 
The spectra of all products of the experimental solvent screening were used to 
calculate the MCR models. An MCR model was produced for each ratio, using MIR 
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spectra of the co-crystals produced to predict phase purity. The total percentage 
variance explained by 2 components were 99.82% for the model of ratio 1:1 and 
99.89% for the model of ratio 1:2.  
Pearson correlation was used to compare the spectra of hydrochlorothiazide, 
nicotinamide and co-crystal ratio 1:1 with the loadings of each component, for each 
model. MCR loadings of HTZ:NCT 1:1 showed that component 1 had the strongest 
correlation and carried most of the reference co-crystal spectral information (Table 
3.4). Component 2 also showed a significant correlation coefficient with the spectra 
of the reference co-crystal. Phase purity of co-crystals obtained using this ratio was 
high for all solvents, except for MeOH. The phase purity of samples used to build the 
model may have resulted in component 2 also holding co-crystal information. For the 
ratio 1:2, loadings of component 1 showed co-crystal information, while component 
2 showed a greater correlation to NCT. This shows that the co-crystal was formed in 
the ratio 1:1, hence, there was excess of NCT which was captured by the component 
2. 
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Table 3.4. Pearson correlation coefficient for MCR model loadings correlated with 
the MIR spectra of the reference co-crystal produced at the ratio of HTZ:NCT 1:1 and 
reactants (HTZ and NCT). The closer the coefficient is to 1 the stronger the 
correlation. 
Model component 
(% variance explained) 
HTZ:NCT 1:1 Co-crystal HTZ NCT 
HTZ:NCT 1:1 Comp. 1 (78.80%) 0.9994 0.8963 0.7351 
HTZ:NCT 1:1 Comp. 2 (21.02%) 0.9560 0.8734 0.8187 
HTZ:NCT 1:2 Comp. 1 (80.56%) 0.9992 0.9019 0.7286 
HTZ:NCT 1:2 Comp. 2 (19.33%) 0.8995 0.7766 0.9497 
Spectral analysis confirmed the MCR models results. MIR spectral analysis showed 
that component 2 of HTZ:NCT 1:1 ratio was somewhat similar to those observed in 
the co-crystal spectra, however it showed a different peak in the region of 3429-3389 
cm-1, and significant differences in intensity in the regions of 1800-1600 cm-1, 1500-
1350, 1295-1175 cm-1, and 1139-1060 cm-1 (Figure 3.4). Component 2 of HTZ:NCT 1:2 
ratio was also similar to NCT spectra, however, it showed peaks (3462-3422 cm-1) and 
patterns (1551-1489 cm-1, and 1350-100 cm-1) somewhat similar to the observed in 
the co-crystal spectra (Figure 3.5). This may indicate that the co-crystal was formed, 
however there is unreacted NCT. The above differences highlight that these MCR 
loadings for component 2 may carry some co-crystal information, but they also 
contain information related to one the reactants indicating some phase impurity. 
MCR loadings that carry the greatest co-crystal information (component 1 of each 
ratio) showed good semblance to the reference co-crystal MIR spectrum; presence 
of different peaks or significant intensity differences were not observed. 
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Figure 3.4. MIR spectrum of the HTZ:NCT 1:1 reference co-crystal (average n=5), 
MCR loading plots from the samples produced with the stoichiometric ratio of 
HTZ:NCT 1:1, NCT MIR spectrum (average n=5), and HTZ MIR spectrum (average 
n=5). 
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Figure 3.5. MIR spectrum of the HTZ:NCT 1:1  reference co-crystal (average n=5), 
MCR loading plots from the samples produced with the stoichiometric ratio of 
HTZ:NCT 1:2, NCT MIR spectrum (average n=5), and HTZ MIR spectrum (average 
n=5). 
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MCR scores of component 1 for co-crystal systems, prepared at both ratios in a range 
of solvents, were used in Equation 3.2 to determine phase purity. Greater phase 
purity was obtained using the ratio of HTZ:NCT 1:1, except when ACN and MeOH was 
used as solvent (Figure 3.6). The percentage variance explained by the component 
that represents the co-crystal information was similar to both ratios, around 80%. 
However, greater purity was reached using the ratio 1:1. 
 
Figure 3.6. Percentage phase purity calculated using Equation 2 for screening 
samples produced with the stoichiometric ratio of HTZ:NCT 1:1 and HTZ:NCT 1:2. 
IPro = 2-propanol, ACN = acetonitrile, EtOH = ethanol, MeOH = methanol, Ace = 
acetone. 
3.4.4 Laboratory scale co-crystallization 
Prior laboratory scale co-crystallization of NCT:HTZ 1:1 co-crystals, it was necessary 
to determine the slurry co-crystallization time. Slurry experiments were performed 
and monitored by Raman spectroscopy. PCA of Raman spectra acquired was used to 
determine the co-crystallization endpoint for all solvents investigated. The results 
showed that for complete co-crystal formation the endpoint was dependent on the 



















HTZ 1:1 NCT Comp 1 (78.80%) HTZ 1:2 NCT Comp 1 (80.56%)
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intermediate forms to co-crystal formation. That was observed for the CF solvent 
system, in which an intermediate may have been formed at 40 h and transformed 
into the co-crystal 10 hours later (Figure 3.7a). After the co-crystal formation, further 
transformations were not observed up to 120 h for all the solvents investigated. Thus, 
slurry co-crystallization time used for the scale up experiments was 120 h to 
standardize the time across the different solvents and ensure completion of co-
crystal formation. The abrupt shifts observed may be due to the formation of bonds 
as the co-crystal is formed, since those bonds have strong Raman shifts. 
Table 3.5. Endpoint of NCT:HTZ 1:1 co-crystal formation for different solvents used 
in slurry co-crystallization at room temperature. Endpoint was determined by PCA of 
Raman spectra acquired online. EtOH = ethanol, MeOH = methanol, Ace = acetone, 
EtOAc = ethyl acetate, DCM = dichloromethane, CF = chloroform, and ACN = 
acetonitrile. *Solvent showed overwhelming Raman signal; therefore, no spectral 
differences were captured during the time analyzed and it was not possible to 
monitor the process using Raman spectroscopy 
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Figure 3.7. (A) Online multivariate Raman tracker of slurry co-crystallization from 
ethyl acetate, at room temperature, and (B) Raman spectra acquired after 14h and 
82h. 
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Figure 3.8. (A) Online multivariate Raman tracker of slurry co-crystallization from 
dichloromethane, at room temperature, and (B) Raman spectra acquired after 25 h, 
60 h and 86 h. 
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Figure 3.9. (A) Online multivariate Raman tracker of slurry co-crystallization from 
chloroform, at room temperature, and (B) Raman spectra acquired after 30 h, 46 h 
and 109 h. 
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Figure 3.10. (A) Online multivariate Raman tracker of slurry co-crystallization from 
acetonitrile, at room temperature, and (B) Raman spectra acquired after 13 h and 
80 h. 
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Figure 3.11. (A) Online multivariate Raman tracker of slurry co-crystallization from 
methanol, at room temperature, and (B) Raman spectra acquired after 27 h and 
119 h. 
3.4.4.1 Co-crystallization design space 
Response surface models were developed to investigate solvent effect and find the 
optimal temperature (and agitation for evaporative co-crystallization) to obtain co-
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crystals with high phase purity. A full-factorial DoE was performed for both semi-
slurry (21 runs) and evaporation (42 run) co-crystallization processes (Table 3.6). 
Phase purity was calculated using data from the MCR model developed, Equation 2. 
Phase purity values determined for the semi-slurry were lower than those obtained 
for the evaporation co-crystallization for each corresponding solvent and 
temperature for a number of systems investigated (Figure 3.12). 
Table 3.6. Design of Experiment of laboratory scale evaporation and slurry co-
crystallizations. MeOH = methanol, Ace = acetone, DCM = dichloromethane, EtOAc = 
ethyl acetate, ACN = acetonitrile, iPro = 2-propanol, and EtOH = ethanol. 
Slurry Evaporation 




















10 CF:Ace 1:1 67.30 10 DCM:Ace 1:1 65 85.83 




73.29 25 EtOH 0 41.02 
40 CF:Ace 1:1 70.58 25 Ace 0 95.01 
10 DCM:Ace 1:1 68.36 25 DCM:Ace 1:1 65 99.83 
25 MeOH 3.91 40 MeOH 0 77.89 
25 EtOH 53.72 40 ACN 65 92.01 




70.69 10 Ace 65 84.84 




10 MeOH 55.16 25 Ace 65 70.68 
25 ACN 70.14 10 CF:Ace 1:1 65 86.35 
40 ACN 70.36 25 MeOH 65 76.62 
40 DCM:Ace 1:1 71.13 40 Ace 0 95.46 
10 CAN 67.79 10 MeOH 0 5.23 
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40 EtOH 30.01 40 EtOH 0 58.08 








25 CF:Ace 1:1 78.41 25 CF:Ace 1:1 65 99.12 
10 Ace 75.95 40 CF:Ace 1:1 0 72.47 




- - - 25 MeOH 0 56.26 
- - - 40 DCM:Ace 1:1 65 93.39 
- - - 40 Ace 65 95.40 
- - - 10 CF:Ace 1:1 0 89.39 
- - - 40 DCM:Ace 1:1 0 91.30 
- - - 25 ACN 65 97.86 
- - - 10 Ace 0 88.93 
- - - 40 MeOH 65 95.31 
- - - 40 EtOH 65 93.64 
- - - 25 ACN 0 95.57 
- - - 10 ACN 65 88.09 












- - - 25 EtOH 65 68.09 
- - - 10 EtOH 65 71.71 
- - - 10 MeOH 65 33.74 
- - - 40 CF:Ace 1:1 65 85.50 
- - - 10 ACN 0 78.05 
- - - 40 ACN 0 89.23 
- - - 25 CF:Ace 1:1 0 94.78 
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Figure 3.12. Comparison of co-crystal phase purity determined using MIR spectra 
and results of MCR model (Equation 2) for the system HTZ:NCT 1:1, at 25ºC. (n=5). 
EtOH = ethanol, MeOH = methanol, Ace = acetone, EtOAc = ethyl acetate, DCM = 
dichloromethane, and ACN = acetonitrile. 
Overall, agitation optimized the evaporation co-crystallization process (Figure 3.13). 
The optimal conditions for evaporation co-crystallization observed were the 
following. The solvent systems ACN, CF:Ace 1:1, and DCM:Ace 1:1 produced the co-
crystals with greatest phase purities at all temperatures investigated (Figure 3.13a). 
At 40 °C EtOAc:Ace 4:1, Ace and EtOH also produced co-crystal with high phase 
purity. Methanol and ethanol showed considerably lower co-crystal phase purity in 
comparison with the other solvent systems. There was a statistically significant 
association between the response variable and the factors (F-value of 9.88 and p-
value less than 0.0001). Adjusted r2, predicted r2 and adeq. precision were found to 
be 0.7055, 0.5187 and 15.49, respectively, indicating that the model could be used 
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The DoE model of slurry co-crystallization also showed a statistically significant 
association between the response variable and the factors. (F-value of 5.30 and p-
value of 0.025). Adjusted r2, predicted r2 and adeq. precision were found to be 
0.7505, -5.467 and 10.10, respectively, indicating that the model could be used to 
navigate the design space. However, additional runs would be required if the model 
was to be used for predictions. The internally studentized residuals were normally 
distributed. The solvent systems Ace and DCM:Ace 1:1 produced co-crystals with 
greater phase purities (Figure 3.14). This was represented in the contour plot of the 
design space in which the relative purity obtained using those solvent systems fell 
within the same contour level for all temperatures. The solvent system CF:Ace 1:1 at 
the temperatures of 25 °C and 10 °C also produced co-crystals with great phase 
purities. Solvents EtOH and MeOH showed the lowest phase purity, similarly to 
evaporation co-crystallization. 
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Figure 3.13. DoE contour plots of evaporation co-crystallization (A) with agitation of 
65 rpm and (B) without agitation. Solvent indexes are 1 = Ace, 2 = ACN, 3 = CF:Ace 
1:1, 4 = DCM:Ace 1:1, 5 = EtOAc:Ace 4:1, 6 = EtOH, 7 = MeOH. Temperature in °C. 
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Figure 3.14. DoE contour plots of slurry co-crystallization. Solvent indexes are 1 = 
Ace, 2 = ACN, 3 = CF:Ace 1:1, 4 = DCM:Ace 1:1, 5 = EtOAc:Ace 4:1, 6 = EtOH, 7 = 
MeOH. Temperature in °C.  
3.5 Discussion 
This study addressed challenges of co-crystallization monitoring and co-crystal phase 
purity control. Quantum chemistry simulation was used for in-silico screening and 
selection of a coformer that was thermodynamically inclined to form a co-crystal with 
hydrochlorothiazide. All coformers screened had been previously investigated 
(Rodrigues et al., 2019, 2018b; Sanphui et al., 2015; Sanphui and Rajput, 2014). 
Interestingly, the relatively unfavourable mixing enthalpies/energies predicted in this 
study for the co-crystallisation of HTZ with malic and citric acids successful confirm 
the findings of a previous study that reported very low phase purity for products of 
such co-crystallizations (Rodrigues et al., 2018b). The co-crystal, HTZ-NCT ratio 1:1 
was selected based on the quantum chemistry simulations was hydrochlorothiazide 
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that revealed high negative values of mixing enthalpy/energy computed for this 
system. The main goal of this study was the development of a model to predict co-
crystal phase purity. Thus, the model co-crystal was also chosen based on the depth 
of characterization and the information available to confirm and validate the 
predictions.  
A novel methodology was developed to quantify co-crystal phase purity using MIR in 
combination with MCR-ALS without a reference spectrum. Soares and Carneiro 
(2013, 2017) used Raman and MCR-ALS to investigate co-crystallization, however, 
initial estimates of both the pure substances and the co-crystal were used (Soares 
and Carneiro, 2017, 2013). In this study, the MCR-ALS model was performed without 
any initial estimate. The co-crystal spectra obtained from the model was later 
compared with reference substances: the co-crystal, and the physical mixture of drug 
and coformer, to confirm that the model was able to extract the co-crystal spectra 
without the initial estimates. 
Another novel finding of the MCR model designed was the determination of the 
statistically optimal ratio of co-crystal formation. This includes the combined analysis 
of the percent variance captured by the two components of the MCR model and 
Pearson Correlation coefficient analysis (Table 3.4). This methodology was also 
confirmed by spectral analysis. 
Comparison of MIR spectra of the reference co-crystals, HTZ, coformer and MCR 
loadings highlighted differences in regions related to co-crystal formation. Key 
differences were observed in the spectral regions related to O‒H and N‒H stretching. 
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HTZ co-crystals were reported to involve the primary and secondary sulfonamide 
groups from HTZ (Rodrigues et al., 2019; Silva et al., 2017).  
HTZ:NCT co-crystals were reported to be formed due to hydrogen bonding between 
the NH of sulfonamide group of HTZ and the NCT carbonyl group (Rodrigues et al., 
2019). Formation of new bands was observed in the region of OH stretch (peaks 
centered at 3440 and 3190 cm-1), NH stretch of primary amine (3374 cm-1), and 
C=O/C=C stretching (1654 cm-1). Peaks in typical regions of S=O stretching were also 
observed, with new peaks forming at 1324, 1303, 1268, and 1076 cm-1. Therefore, 
the results obtained in this study are in agreement with those previously reported in 
the literature. 
In this study, the application of Raman combined with PCA was used as a non-contact 
and non-destructive PAT tool to quantify co-crystals formation and co-crystallization 
endpoint. MIR spectroscopy combined with MCR-ALS was shown to be a useful PAT 
tool to determine co-crystallization endpoint and quantify co-crystal phase purity 
(Mazivila et al., 2019). Substances that show weak MIR signal may have strong Raman 
signal (Larkin, 2017). Thus, Raman is a complementary technique to MIR, and the PAT 
tool developed in this study is complementary to the PAT tool developed by Mazivila 
et al. Fluorescence problems frequently encountered when Raman is used, are not 
observed when MIR is used (Rodrigues et al., 2019). The decision about which 
methodology should be used is dependent on the properties of the solvent and the 
substances used to produce the co-crystal. PCA of Raman spectra acquired online 
also showed whether the co-crystal formation happens via intermediate formation, 
as shown in Figure 3.7a in which co-crystals of NCT:HTZ 1:1 appeared to form an 
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intermediate when chloroform was used. Ishihara et al. (2019) showed that MIR and 
MCR were also able to investigate intermediate formation (Ishihara et al., 2019). 
Again, this shows that MIR and Raman spectroscopy can be used as complementary 
techniques to investigate co-crystallization process.  
The final contribution of this study to the scientific development of co-crystallization 
processes was the comparative investigation between evaporation and slurry 
methodologies. Overall, evaporation co-crystallization produced co-crystals with 
greater phase purity than the slurry technique. This finding agrees with the study 
reported by previous studies that revealed that evaporation always shows greater 
yield if the drug and the coformer have similar solubility values (Rodrigues et al., 
2018a; Rodrigues et al., 2020; Rodrigues et al., 2018b). The design of experiments 
also confirmed this finding. According to the results of the DoE model, DCM:Ace 1:1 
was the only solvent system that produced co-crystal with the greatest purity in both 
slurry and evaporation co-crystallization, at all temperatures. Thus, co-crystals 
produced using DCM:Ace 1:1 could be used as a reference system for comparison of 
both techniques. In the evaporation co-crystallization with agitation the phase 
purities obtained using this system were 85.83, 99.83, and 93.39 % at 10, 25, and 40 
°C, respectively. In the slurry co-crystallization the phase purities obtained at the 
same temperatures were considerably lower (i.e. 68.36, 75.59, and 71.13 % at 10, 25, 
and 40 °C, respectively). It is very difficult to discuss how the solvent affects co-
crystallization outcome. There are several factors that can contribute to the co-
crystal purity which is also dependent on the co-crystallization technique. For solvent 
evaporation co-crystallization, the choice of solvent is always dependent on the 
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solubility of each component in the solvent. Furthermore, the two components need 
to have a similar solubility in the solvent. In this way the phase diagram is symmetric, 
and it would be easier to obtain a pure co-crystal by solvent evaporation (Aitipamula 
et al., 2014; Sarraguça et al., 2016). Since normally, the co-former and API have 
different solubilities in a pre-determined solvent a mixture of solvents is usually used, 
as was in the case of this work in which the highest purity was obtained by a mixture 
of acetone and dichloromethane. Also, it is important that the solvent has a low 
vapor pressure to be able to evaporate at low temperatures. For slurry co-
crystallization other physicochemical properties might be important such as polarity, 
dielectric constant, surface area, among others. An extensive and detailed analysis 
relating the physicochemical properties of the solvents and the purity of the 
cocrystals must be done to be able to define a systematic approach to solvent type 
co-crystallizations. 
3.6 Conclusions  
An MCR model was developed to determine co-crystal phase purity and identify the 
stoichiometric ratio for the formation of co-crystals. MCR-ALS was able to extract the 
spectrum of the co-crystal from a complex mixture i.e., non-reacted starting material 
mixed with co-crystals, even though a reference co-crystal spectrum was not 
provided, and determine the phase purity of co-crystallization products. Phase 
purities determined showed to be dependent on the solvent. The ratio of co-crystal 
formation determined by the MCR model proposed revealed that 1:1 was the optimal 
ratio, which is in accordance with the literature. A design space was determined by 
DoE using the % phase purity as response variable. The % phase purity obtained using 
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the proposed model coupled with MCR. The response surface models showed that 
in addition to the solvents, the process employed (evaporation versus slurry) also 
affects phase purity. In this study, co-crystals produced by evaporation co-
crystallization with agitation of 65 rpm showed greatest phase purity.  
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4.1 Abstract 
Percolation theory provides a statistical model which can be used to predict the 
behaviour of powder blends based on particle-particle interactions. The aim of this 
study was to investigate if percolation theory could be used to predict the drug 
loading concentration of pharmaceutical tablets, and the relative density of a blend, 
above which tablet tensile strength is reduced, resulting in the production of 
unsatisfactory products.  The model blend studied contained ibuprofen as the API, 
which exhibits poor flow and compressibility, and microcrystalline cellulose (MCC) as 
the excipient, which exhibits good flowability and compressibility. Two MCC grades 
with differing physical properties were investigated, Vivapur® 102 (air streamed 
dried quality), and Emcocel® 90 (spray dried quality) to test the theory. Blends 
containing 2.5 to 40 % w/w of ibuprofen were compacted at a range of pressures and 
the values of the powder true density, compaction pressure, tablet envelope density, 
and tablet tensile strength were used to calculate the percolation thresholds 
mathematically. The drug loading threshold values predicted with the model (19.08% 
w/w and 17.76% w/w respectively for Vivapur® 102 and Emcocel® 90) were found to 
be in good agreement when compared to experimental data and the percolation 
threshold was visually confirmed using Raman imaging. The capability of multivariate 
analysis to predict the drug loading threshold was also tested. Principal component 
analysis was unable to identify the threshold. However, it provided an overview of 
the changes of the analysed properties as ibuprofen drug loading increased. It was 
also able to identify differences between blends containing Vivapur® or Emcocel®. In 
conclusion, percolation theory was able to predict the maximum acceptable drug 
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loading for this binary system of API and excipient. This methodology could be 
employed for other binary systems to predict maximum drug loading potential 
without the need for time consuming and expensive tablet production. 
4.2 Introduction 
Multi-component powder blends are critical components of numerous process trains 
across a wide variety of manufacturing sectors. Solid dosage forms manufactured 
from powder blends compose a large proportion of pharmaceutical production 
(Järvinen et al., 2013) Pharmaceutical powder blends are composed of a drug 
substance (active pharmaceutical ingredient) and inactive excipients to aid 
processing, stability and delivery (Leane et al., 2015). Drug load is an important factor 
to be considered during the design of these blends. The higher the drug load, the 
higher the probability of the drug’s properties impacting the blend’s 
manufacturability and finished dosage form properties. For instance, Wenzel et al. 
showed how the increase of drug load negatively affected granulation, compression, 
tablet disintegration and dissolution (Wenzel et al., 2017). In contrast to a gradual 
change in blend properties with increasing drug load, a threshold drug concentration 
was proposed, referred to as the percolation threshold (Leane et al., 2015). It is 
proposed that issues can be expected to occur in manufacturability and drug product 
quality above the percolation threshold concentration of drug (Leane et al., 2018, 
2015). Within a QbD pharmaceutical approach, the percolation threshold model can 
aid identification of a threshold drug loading. The formulation should contain drug 
loadings below the percolation threshold to ensure critical quality attributes 
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compliance. Knowing the percolation threshold drug level can aid robust formulation 
development by maintaining the drug below this threshold.  
Percolation is a geometrical-statistical theory that includes two model types: (i) 
lattice model, and (ii) continuum model. The lattice percolation model has been 
previously reported in the literature as appropriate to model tablet tensile strength 
for systems containing microcrystalline cellulose (Kozicki, 2007; Kuentz and 
Leuenberger, 2000, 1998; Leuenberger, 1999). In a lattice model, percolation 
threshold is described the random occupation of a lattice of one substance by 
particles of a second substance (Leuenberger, 1999). Consider initially a matrix of A 
being percolated by particles of B. As the concentration of B increases in the system, 
a threshold concentration will be reached, and a property phase transition will be 
noticed. Above this threshold the system is a matrix of B percolated by particles A. 
The property phase transition occurs because of the formation of clumps of particle 
B that are connected or close enough to each other in such a way that they are linked 
across the entire volume of the tablet, forming an infinite cluster i.e., a drug cluster 
that spans throughout the entire volume of the tablet. When this cluster is formed 
properties of the blend may undergo significant changes (Leuenberger, 1999). This 
theory can be extrapolated to the random distribution of a group of substances A in 
a lattice formed by a group of substances B (Leuenberger et al., 1992). In this case, 
the substances that form the group A need to have at least one similar property and 
at the same time this property must be dissimilar to the substances of group B. For 
example, in a tablet blend, drug substance and excipients that have poor flow could 
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be grouped together as A, while all the substances within the formulation that have 
good flow would belong to group B.  
One of the critical quality attributes to consider during the development of a tablet 
blend for compaction is the tablet’s tensile strength. Tensile strength is defined as 
the resistance of a material to undergo fracture under tension (Fell and Newton, 
1970). It is considered a key physical property to ensure the quality of manufactured 
tablets. Tablets are required to have a minimum value of tensile strength to remain 
intact throughout downstream processing and handling. On the other hand, an 
increase in tensile strength can lead to an increase in the dissolution time (Bi et al., 
1999). The application of the percolation threshold model to tablet tensile strength 
provides valuable information in relation to blend design. The main input of this 
model is the tablet relative density, which replaces ρ in Equation 1.19. Tablet relative 
density is a parameter that is related to a number of individual raw material 
characteristics, process parameters and many subsequent tablet physical properties. 
The inclusion of tablet relative density makes this model a highly practical theory.  
Percolation thresholds have been estimated graphically in a number of previous 
studies; for binary blends of MCC and mannitol (Pérez Gago and Kleinebudde, 2017), 
for binary blends at different size ratios and for different grades of HPMC blended 
with hydrocortisone (Mohamed et al., 2015), and for complex blends of mefenamic 
acid and a range of excipients (Kimura et al., 2007). Kuentz and Leuenberger 
proposed a mathematical approach in which the percolation threshold of a blend of 
microcrystalline cellulose and paracetamol was modelled (Kuentz and Leuenberger, 
2000). The authors recommended additional investigation to confirm their findings. 
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However, there are limited publications in which the percolation threshold is 
predicted mathematically in the field of pharmaceutical sciences. Busignies et al. 
(Busignies et al., 2007) showed that if the mathematical approach is selected, it is 
necessary to begin with modelling the percolation coefficient in order to be able to 
model the percolation threshold for each specific formulation, as the percolation 
coefficient did not seem to be universal.  
The aim of this study was to define the percolation coefficient for a blend comprising 
MCC/ibuprofen based on a modified Heckel equation (Leuenberger, 1999). Having 
determined the percolation coefficient for the blend, Equation 1.19 was then 
employed to calculate the respective percolation thresholds. The blend considered 
contained a model drug, ibuprofen, and a commonly used excipient, MCC. These 
binary blend components were selected because ibuprofen exhibits poor flowability 
and compressibility and is prone to capping (Al-Karawi et al., 2018; Nokhodchi et al., 
1995; Rasenack and Mü, 2002). MCC is a widely used excipient due to its good 
flowability, high dilution potential and compactibility (Thoorens et al., 2014). 
Therefore, the contrasting properties qualifies the combination of these substances 
as an appropriate case to apply the percolation model. Particle pore and particle 
shape can have significant impact on percolation threshold (Lin and Chen, 2018; 
Meyer et al., 2015; Nigro et al., 2013), therefore, two MCC grades with differing 
particle properties were investigated in this study: Vivapur® 102, an air streamed 
dried grade, and Emcocel® 90, a spray dried grade. Raman image analysis of 
compacted blends was employed to visually determine whether an infinite cluster of 
drug particles could be detected on the surface of tablets prepared above the 
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percolation threshold. Properties of the powder blends and the tablets 
manufactured were investigated using univariate and principal component analysis 
(PCA) analysis to determine properties which are diminished above the percolation 
threshold and investigate if PCA is able to identify the critical concentration related 
to the percolation threshold.  
4.3 Materials and methods 
4.3.1 Materials  
Microcrystalline cellulose (Vivapur® 102, and Emcocel® 90) was supplied by JRS 
PHARMA Gmbh+Co. KG, Germany. Ibuprofen was obtained from Kemprotec Ltd., 
United Kingdom.  
4.3.2 Methods 
4.3.2.1 Powder characterization 
4.3.2.1.1.1 Surface area 
MCC samples were degassed for 3 h, at 120 oC and ibuprofen samples for 24 h, at 40 
oC in a FlowPrep 060 sample degas system (Micromeritics, USA). The mass of each 
sample was between 0.4 - 0.6 g. Surface area was determined using a Gemini VI 
surface area and pore size analyser (Micromeritics, USA). The modelling equation 
applied was the Brunauer Emmett-Teller equation (BET) (Brunauer et al., 1938). 
Liquid nitrogen at - 196 oC kept isothermal conditions and N2 was the absorbate gas 
utilized. The analysis was carried out in triplicate.  
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4.3.2.1.1.2 Laser diffraction particle sizing  
Particle size distribution was measured using a particle Mastersizer 3000 size 
analyzer (Malvern Panalytical, UK). A dry powder method was employed. Laser 
obscuration was controlled to a maximum of 5 %, and the feeding was set to a rate 
of 20 % for MCC and 35 % for ibuprofen, both at 1.5 bar. The height of the feeder 
was set to 2.5 cm. Measurements were taken for a period of 10 seconds, in triplicate.  
4.3.2.1.1.3 Thermogravimetric analysis 
Microcrystalline cellulose moisture content was quantified using thermogravimetric 
analysis (TGA) (TA Q500 TGA, TA instruments, USA). N2 was used as the controlled 
atmosphere. Samples between 5 - 7 mg were loaded on the platinum pan. A ramp 
operation module was set up following a heating rate of 10 oC/min up to 270 oC. The 
weight loss measured was assumed to be moisture loss as no other thermal events 
occur in MCC between 0°C and 120°C as confirmed by differential scanning 
calorimetry (DSC).  
4.3.2.1.1.4 Morphology 
MCC morphology was characterized using a Malvern Morphologi G3® particle 
characterization system (Malvern Instruments, Malvern, UK). This instrument allows 
characterization of the shape, form and size of particles. A sample volume of 7 mm3 
was automatically dry dispersed by the Sample Dispersion Unit (SDU) which injects 
compressed air for 20 ms at 1 bar through the sample, onto a glass plate. A settling 
time of 60 seconds was held between the air injection and presentation of the sample 
for analysis. Malvern Morphologi G3® recorded individual pictures of particles and 
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these images were acquired over 3 circular areas of the plate. The size parameters 
analysed were circle equivalent (CE) diameter, length and width, and the shape 
parameter analysed was aspect ratio. CE diameter is the corresponding diameter of 
a circular particle with the same area as the particle analysed. Aspect ratio is given 
by dividing width by length for each particle. Particles with an aspect ratio below 0.5 
were classified as needle shaped. 
4.3.2.1.1.5 Scanning electron microscopy (SEM) 
Scanning electron microscopy (SEM) was used to obtain images of Vivapur® and 
Emcocel®. A JSM-5510 SEM, (Jeol, UK) was used with heated tungsten. The 
morphology and particle size of the samples were measured using an electron beam 
source. The voltage was constant at 3 kV. Samples were gold coated in SEM gold 
coater (Jeol, UK) prior to analysis to prevent charging of the samples by the SEM 
electron beam. A coating time of approximately 45 seconds was used to deposit a 
thin layer onto the samples. 
4.3.2.2 Blend preparation  
Binary blends of ibuprofen and Vivapur®, and ibuprofen and Emcocel®, were 
prepared at concentrations between 2.5 and 40 % w/w ibuprofen in MCC. A total of 
300 g of each formulation was blended in Cube Mixer KB, ERWEKA (Universal Gear 
UG, Germany) at 30 rpm for a duration of 30 min.   
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4.3.2.3 Blend characterization 
4.3.2.3.1.1 Bulk and tapped densities 
Bulk and tapped densities were calculated as outlined in the European 
Pharmacopoeia (Ph Eur 9.0) (Council of Europe, 2019). A 100 ml cylinder was filled 
up to the mark with powder of a known mass, and the bulk density (ρbulk) was 
calculated by dividing the mass of the powder by the volume of the cylinder. The 
loaded cylinder was then placed in an SVM 122/222 tapped density tester, (Erweka 
GmbH.). The cylinder was tapped 500 and 750 times which compacted the powder 
by removing air from voids within the sample. The tapped density (ρtapped) was 
calculated by dividing the powder mass by the final volume that the powder occupied 
in the graduated cylinder.  
4.3.2.3.1.2 True and relative densities 
The true density (ρtrue) of materials was measured using a helium pycnometer 
Accupyc 1330 microprocessor-controlled gas pycnometer (Micromeritics, USA). The 
jar volume was 11.2 cm3 and weight of the samples was 2 g. The results presented 
are the average of ten measurements. The relative density of powder blends (ρrelative) 
was calculated by dividing ρbulk from Powder Flow Tester by ρtrue. 
4.3.2.3.1.3 Flowability and compressibility 
Flowability was determined by the calculation of the Hausner ratio (HR) (Equation 
4.1) using the tapped and bulk densities determined (Council of Europe, 2019).  
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 (Equation 4.1) 
Hausner ratio measures the loose and dense packing conditions to which the powder 
is subjected (Council of Europe, 2019, Santomaso et al., 2003). 
Powder flowability classification was also determined using an annular shear cell 
tester, Powder Flow Tester (PFT), Brookfield Engineering Laboratories, Inc., USA. This 
methodology is considered to be a more consistent and reliable method to 
determine powder flow compared to the Hausner ratio. The Hausner ratio can be 
variable depending on the procedure employed (Liu et al., 2008; Santomaso et al., 
2003; Yu et al., 2012). A vane lid was used in order to perform a standard flow 
function test. The cell volume of 43 cm3 was chosen and the mass to fill up the cell 
varied from 14 to 16 g across the different formulations. The major principal 
consolidation stresses were defined in a geometric progression that resulted in 
values of between 0.02 to 6.07 KPa for MCC and 0.02 and 2.98 KPa for ibuprofen. The 
maximum principal consolidation stresses were chosen based on earlier literature 
(Liu et al., 2008; Yu et al., 2012). 
Compressibility was determined for each blend using the same set up as the 
flowability test, however the consolidation stresses were approximately between 
0.02 and 25.5 KPa and a flat lid was used. The results were expressed as bulk density 
vs. major principal consolidation stresses (McGlinchey, 2005).   
 Chapter -4 
 
Ana Luiza Pinto Queiroz Page 161 
4.3.2.4 Direct compression 
The formulations were directly compacted to form cylindrical and flat tablets with 8 
mm diameter and weight of 270 ± 10 mg in a ten-station rotary tablet press (Riva™ 
Piccola, Argentina), at a speed of 20 rpm. The relative air humidity was 50 ± 5%. The 
compaction of each blend was performed under 14 different compaction pressures, 
between approximately 20 and 400 MPa. After compaction the tablets were stored 
for 48 hours under ambient conditions before further analysis.  
4.3.2.5 Tablet characterization  
Tablets’s hardness, weight, thickness and diameter were measured using a semi-
automatic tablet testing system, SmartTest 50 (Sotax, Switzerland) (N=20 per blend). 
Tablet envelope density, (ρtablet) was obtained by dividing tablet weight by tablet 
volume. Tablet relative density, ρ, was calculated by dividing the tablet envelope 
density by the true density obtained from the annular shear cell tester for the 
respective powder formulation, according to Equation 1.23. 
Tablet porosity was determined using Equation 4.2. Tablet envelope density was 
determined dividing the mass by the volume of each tablet. The blend true density 
values were previously determined. 
𝑃𝑜𝑟𝑜𝑠𝑖𝑡𝑦 = 100 × 1 −
𝑡𝑎𝑏𝑙𝑒𝑡 𝑒𝑛𝑣𝑒𝑙𝑜𝑝𝑒 𝑑𝑒𝑛𝑠𝑖𝑡𝑦
𝑏𝑙𝑒𝑛𝑑 𝑡𝑟𝑢𝑒 𝑑𝑒𝑛𝑠𝑖𝑡𝑦
 (Equation 4.2) 
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4.3.2.6 Heckel analysis  
The Heckel model was used to calculate the constant K according to Equation 1.18. 
Then the yield pressure (𝑃 ) for each blend was obtained from 𝑃 =
1 (3 ∙ 𝐾)⁄ .  
4.3.2.7 Percolation coefficient and percolation threshold 
Tablet tensile strength was determined for all blends produced at each compaction 
pressures using Equation 1.21. Percolation coefficient (Tf) was modelled using 
Equation 1.27. The percolation threshold, ρc (AB), as a critical solid fraction, was then 
determined by the linear correlation between tablets relative density (ρ) and 𝜎 , 
expressed by Equations 1.28 and 1.29, for each blend. Finally, the dilution capacity 
model of Equation 1.31 was applied in order to express the 𝜌 (𝐴) in terms of mass 
fraction (Xc). Substances A and B were MCC and ibuprofen, respectively. 
4.3.2.8 Raman spectroscopy  
Raman imaging was carried out using a RA802 Pharmaceutical Analyser (Renishaw, 
UK) using a 785 nm line-focussed laser. First, reference spectra of air stream dried 
MCC, spray dried MCC, and ibuprofen were acquired. Then, tablets of the blends of 
ibuprofen and MCC were screened using the StreamLineTM fast imaging method that 
acquired around 76,000 spectra over the entire surface of each tablet, with a pixel 
size of 10 µm/20 µm and area of 8.3 mm x 8.3 mm. Those spectra were averaged to 
a single resulting spectrum. The total time of measurement for each individual tablet 
was 15 min. Images of the drug distribution on the surface of the tablet were 
generated by non-negative least squares (NNLS) component analysis.  
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4.3.2.9 Multivariate analysis 
PCA was performed to investigate whether this technique could distinguish the 
behaviour of the blends below and above the percolation threshold, and, also to 
determine if there are differences between blends containing Vivapur® compared to 
those containing Emcocel®. Principal component analysis (PCA) was performed using 
Origin data analysis and graphing software (OriginLab, USA). The algorithm used was 
the singular value decomposition with full cross validation for all the blends and for 
the placebos of both grades of MCC. Three replicates of each blend were input into 
the model. The first was the mean value of each predictor, the second is the mean 
minus its standard deviation and the third is the mean plus its standard deviation. 
The optimal number of components was three, which explained 95.51% of the 
variance in the total data input. The results were represented graphically by bi-plots 
i.e., scores and loadings plotted in one single graphic. The scores represent the 
distance of each sample from the mean of all samples along each PC, therefore, 
blends (scores) located in close proximity are similar. The loading plot explains which 
variables are responsible for grouping the samples by similarity, if the grouping 
occurs. 
4.4 Results 
4.4.1 Powder characterization  
The particulate and bulk properties of both MCC grades and ibuprofen are 
summarised in Table 4.1. Particle size distribution determined using laser diffraction 
particle size analysis showed that Vivapur® had a slightly greater volume of particles 
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with a larger particle size in comparison to Emcocel® (Figure 4.1a) and hence a larger 
D50 value (Table 4.1). A second particle size analysis method, the Morphologi G3® 
which determines particle size distribution and shape using statistical image analysis, 
clearly showed that the Vivapur® sample contained a greater percentage of particles 
with a larger circle equivalent (CE) diameter in comparison to Emcocel® (Figure 4.1b). 
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Table 4.1. Particulate and bulk powder properties of Vivapur®, Emcocel®, and 
ibuprofen. Average values are shown ± standard deviation. 
Property Emcocel® Vivapur® Ibuprofen 
D10 (μm) (n=5) 30.0 ± 0.25 31.1 ± 0.30 16.5 ± 0.08 
D50 (μm) (n=5) 111.6 ± 0.73 118.0 ± 1.60 54.9 ± 0.21 
D90 (μm) (n=5) 236.8 ± 1.55 240.0 ± 2.17 129.0 ± 1.09 
Surface area (m2/g) (n=3) 1.32 ± 0.01 1.37 ± 0.01 0.22 ± 0.02 
True density (g/cm3) (n=10) 1.58 ± 0.00 1.57± 0.00 1.12 ± 0.00 
Bulk density (g/cm3) (n=3) 0.33 ± 0.00 0.31 ± 0.00 0.36 ± 0.01 
Relative density 0.21 0.20 0.32 
Tapped density (g/cm3) (n=3) 0.43 ± 0.01 0.40 ± 0.00 0.57± 0.01 






Flow function coefficient (n=3) 7.0 ± 0.91 
(easy flowing) 
6.9 ± 0.00 
(easy flowing) 
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Figure 4.1. Particle size distribution of Emcocel® and Vivapur® samples measured by 
(a) Malvern Mastersizer 3000 and (b) Morphologi G3. 
Despite containing larger particles, as shown by laser diffraction particle sizing and 
CE, Vivapur® sample was also determined to have a significantly higher surface area 
in comparison to Emcocel®. An inverse relationship between particle size and surface 
area was not observed as MCC has a highly porous structure, as observed in the SEM 
images (Figure 4.2). According to (Thoorens et al., 2014) approximately 90-95% of its 
surface is internal, therefore there is no relationship between particle size and 
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surface area.  A pronounced difference in the morphology between the two grades 
of MCC was also observed when the aspect ratio was analysed by the Morphologi 
G3®. The percentage of needle shaped particles of Vivapur® sample was 51%, while 
for Emcocel® sample this value was 34%. The model drug, ibuprofen, showed 
dissimilar properties to microcrystalline cellulose samples, exhibiting a smaller 
particle size distribution and surface area (Table 4.1, Figure 4.1a). 
 
 
Figure 4.2. SEM images of (a) Vivapur® and (b) Emcocel®. 
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The true, bulk, tapped and relative densities of both MCC samples were similar (Table 
4.1). Figure 4.3a shows that both MCC samples displayed similar powder 
compressibility with increase in consolidating stress. In comparison to MCC, the 
relative density and compressibility of ibuprofen was greater. Compressibility as a 
function of tapped and bulk density confirmed the findings. Both MCC grades 
exhibited good flowability, as expressed by Hausner ratio and flow function 
coefficient (Table 4.1). Ibuprofen was classified as cohesive when expressed by 
Hausner ratio and by flow function coefficient (Carr, 1965; Thomas and Schubert, 
1979). Ibuprofen/MCC blends were characterized in terms of density, flow and 
compressibility properties (Table 4.2, Figure 4.3b, 4.3c). It was observed that an 
increase in drug content resulted in increased bulk and relative density and poorer 
flow properties, as indicated by the blend Hausner ratio and powder flowability 
classification.   
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Figure 4.3. Plot of bulk density of (a) ibuprofen, Emcocel® and Vivapur®, blends of 
(b) Emcocel®, and blends of (c) Vivapur ® under increasing consolidating stresses. 
 Chapter -4 
 
Ana Luiza Pinto Queiroz Page 170 
4.4.2 Blend behaviour during tableting 
Ibuprofen/MCC blends with ibuprofen content between 0 % and 30 % w/w were 
compacted and tensile strength calculated with respect to compaction pressure. 
Formulations containing 40% w/w ibuprofen/MCC could not be tabletted due to poor 
flow from the hopper and incomplete filling of dies. Tabletability profiles (Figure 4.4) 
showed that both microcrystalline cellulose grades formed tablets with high tensile 
strength, even at low compaction pressures. As ibuprofen concentration was 
increased, a drop in tablet tensile strength was observed.  
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Figure 4.4. Tabletability profiles of ibuprofen/MCC blends (a) Vivapur® and (b) 
Emcocel®. N=20, y-error bars indicate standard deviation. 
Tablet weight variability, expressed as % relative standard deviation (%RSD), 
increased for blends with 20 % w/w ibuprofen and above (Figure 4.5). Increase in 
weight variability was attributed to a deterioration in blend flow and this behaviour 
is in agreement with blend flow behaviour measured for these blends (Table 4.2). 
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Figure 4.5. Tablet weight variation expressed as percent relative standard deviation 
(%RSD) (n=280 individual tablet weights). 
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Hausner Ratio Flow character 
2.5 0.34 0.43 1.52 0.22 1.26 Easy flowing 
5 0.34 0.45 1.51 0.23 1.30 Easy flowing 
10 0.34 0.44 1.49 0.23 1.28 Easy flowing 
15 0.35 0.46 1.47 0.24 1.32 Easy flowing 
20 0.35 0.47 1.45 0.24 1.36 Cohesive 












Hausner Ratio Flow character 
2.5 0.33 0.42 1.53 0.22 1.27 Easy flowing 
5 0.33 0.43 1.52 0.22 1.30 Easy flowing 
10 0.33 0.43 1.48 0.22 1.30 Easy flowing 
15 0.32 0.44 1.47 0.22 1.34 Easy flowing 
20 0.34 0.46 1.45 0.23 1.36 Cohesive 
30 0.33 0.46 1.40 0.24 1.40 Cohesive 
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4.4.3 Percolation threshold modelling 
Compaction pressures between 20 MPa to 60 MPa were selected to model 
percolation as the rearrangement of the particles inside the die, the phenomenon of 
interest, occurs at lower pressures. The modified Heckel model proposed by (Kuentz 
and Leuenberger, 1999) was applied for each ibuprofen/MCC blend and the 
respective percolation coefficient calculated (Table 4.3). No significant difference 
was observed between the percolation coefficients determined for blends prepared 
from Vivapur® and Emcocel® (t-value = 0.78, p-value of 0.449, p-value > 0.05). 
Therefore, the global mean of the individual percolation coefficients was calculated 
(𝑇 =3.5 ± 0.2) and used to determine the percolation threshold. 
Table 4.3. Percolation coefficient (Tf) values calculated for each Ibuprofen/MCC 




Tf r Tf r 
0% 2.96 0.997 3.23 0.996 
2.5% 3.23 0.996 3.29 0.979 
5% 3.57 0.994 3.81 0.995 
10% 3.52 0.996 3.80 0.996 
15% 3.51 0.996 3.67 0.998 
20% 3.62 0.997 3.66 0.995 
30% 3.70 0.997 3.41 0.998 
 
The linear correlation of Equation 1.28 is shown in Figure 4.6. The percolation 
threshold, ρc (AB), was determined for each blend according to Equations 1.28 and 
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1.29, using the empirical coefficient of 3.5 (Figure 4.7, Table 4.4). The minimum 
relative density required to produce tablets with significant strength, 𝜌 (𝐵), and 
solid fraction 𝜌 (𝐴) related to the dilution capacity of substance A (MCC) were 
calculated by fitting the mass fraction of MCC. 
Table 4.4. Critical solid fraction, ρc (ab), for each blend with increase in Ibuprofen 




ρc (AB) r ρc (AB) r 
1.000 0.156 1.000 0.169 1.000 
0.975 0.208 1.000 0.224 1.000 
0.950 0.211 1.000 0.233 1.000 
0.900 0.234 1.000 0.270 1.000 
0.850 0.247 1.000 0.292 1.000 
0.800 0.271 1.000 0.276 0.999 
0.700 0.318 1.000 0.351 1.000 
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Figure 4.6. Linear correlation between tablets relative density (ρ) and 𝜎 , as 
represented by Equation 1.27. 
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Figure 4.7. Relationship between blends percolation threshold, pc (AB), and 
microcrystalline cellulose mass fraction, as represented by Equation 1.30. 
Table 4.5 lists the value of 𝜌 (𝐵) expressed by the threshold relative density where 
there is a change in tensile strength behaviour. The values of 𝜌 (𝐵) were 0.646 and 
0.704 for blends of Emcocel® and of Vivapur®, respectively. Plots of tensile strength 
vs. relative density of all blends were investigated and confirmed the existence of the 
change in tablet strength behaviour at the predicted relative density of approx. 0.70. 
This behaviour is shown for selected blends in Figure 4.8.  
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Table 4.5. Comparison between theoretical (Kuentz and Leuenberger, 1998) and 
empirical percolation and mass fraction parameters modelled. r refers to Pearson’s 
correlation coefficient. 










pc(A) 0.180 0.267 0.200 0.288 
pc(B) 0.646 0.698 0.704 0.736 
r -0.970 -0.970 -0.938 -0.934 
% critical mass fraction 17.76 23.54 19.08 24.68 
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Figure 4.8. Tensile strength of Vivapur®/ibuprofen blends at different relative 
densities. A change in tensile strength behaviour was predicted to occur in the 
point of intersection of two linear fits, for each blend. 
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Finally, the critical mass fraction (Xc) was calculated from 𝜌 (𝐴) using Equation 1.31. 
The Xc values obtained for Emcocel® and Vivapur® were 17.76 % w/w and 19.08 % 
w/w ibuprofen, respectively. The percolation thresholds and the critical mass 
fractions were also calculated by applying a theoretical value of percolation 
coefficient previously published (𝑇 = 2.7) (Guyon et al., 1987) to the Equation 1.27. 
This theoretical percolation coefficient was proposed for binary mixtures in which 
one of the substances compacts well and the second is poorly compactable, which 
would apply to the ibuprofen/MCC blends. A comparison of percolation threshold 
values obtained using the empirical value and theoretical value is reported in Table 
4.5.  
4.4.4 Properties behaviour above and below the thresholds  
Raman imaging showed how ibuprofen and MCC particles were distributed at the 
surface of the tablets (Figure 4.9). At drug concentrations below 15 % w/w drug the 
drug was distributed within a MC matrix. Significant sized clusters were observed at 
the concentration of 15 % w/w. However, they do not form a complete pathway able 
to link the entire surface of the tablet. At 20 % w/w a phase transition was noticed. 
As predicted by the percolation threshold model, there was an infinite cluster of 
ibuprofen particles at the surface at drug concentrations of 20 % w/w ibuprofen. The 
properties of the blend are majority ruled by material that forms an infinite cluster 
i.e., by the ibuprofen above the threshold and by MCC below the threshold.  
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Figure 4.9. Raman imaging of (a) Emcocel® and ibuprofen and (b) Vivapur® and ibuprofen blends. The areas in blue correspond to the excipient 
particles while the areas in white to API particles. The percentage express the % w/w of ibuprofen in the blend with MCC. 
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PCA summarised the experimental data collected during the development of the 
model, classified the samples into different groups, and identified the variables 
responsible for the variance between the samples. Initially the data was grouped into 
three groups (i) Microcrystalline cellulose, which comprises the placebo samples, (ii) 
Blends Above Threshold (concentrations of > 20 % w/w API), and (iii) Blends Below 
Threshold (concentrations of < 20 % w/w API). In Figure 4.10a, scores of blends above 
the percolation threshold showed negative correlation to tensile strength (TS) 
loadings for all the pressures, therefore, above the threshold lower strength tablets 
were observed. In contrast, Hausner ratio (HR) and compressibility (ΔBD) showed a 
positive correlation to blends above the threshold, which means high compressibility 
and poor flowability. These relationships in compressibility and flowability 
highlighted by PCA, was also noted by univariate analysis of data (Table 4.2). Low 
porosity (Po) at different compaction pressures and true density (TRD) showed to be 
highly correlated with Blends Above Threshold, which highlights that tensile strength 
was not improved with the reduction of porosity for the blends studied. The 
confidence interval of the groups Blends Below Threshold and Blends Above 
Threshold overlapped. This showed that PCA was not able to precisely predict a 
threshold drug concentration. Placebo samples showed a clear clustering 
represented by the group Microcrystalline cellulose. The separation of the placebo 
from the blends was explained mainly by the higher tensile strength and lower values 
of tapped (TAD), bulk (BD) and relative (RD) densities.  
Figure 4.10b shows the second data grouping, which provides an overview of the 
differences between blends prepared with Vivapur® and blends prepared with 
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Emcocel®. PC-3 differentiated these blends, to some degree (Figure 4.10b). There is 
an overlap between the groups for a selection of samples with < 10% ibuprofen 
loading and interestingly blends with different grades of MCC separate from one 
another at higher drug loadings. This is surprising and may highlight that despite both 
MCC grades exhibiting similar properties, at high drug loadings their interaction with 
the drug differs in the blend resulting in small differences in density parameters. 
Overall, Emcocel® blends had slightly higher porosity and tensile strength. They also 
showed slightly higher tapped, relative and bulk densities, and were less 
compressible than those containing Vivapur®.  
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Figure 4.10. Principle component Bi-plot (scores and loadings) for (a) PC-1 vs. PC-2 
and (b) PC-2 vs. PC-3, eigenvalues of 11.36, 2.71, and 1.17 for PC-1, PC-2, and PC-3, 
respectively. The ellipses around each group represents a 95% confidence interval. 
The squares represent the scores while the arrows represent the loadings. 
  
 Chapter -4 
 
Ana Luiza Pinto Queiroz Page 185 
4.5 Discussion 
The percolation coefficient value determined in this study (𝑇 = 3.5) was higher than 
the theoretical coefficient (𝑇 = 2.7) published by (Guyon et al., 1987). According to 
(Busignies et al., 2007), the percolation coefficient is dependent on the excipient and 
does not present a universal character. Thus, a difference between theoretical and 
empirical percolation coefficients was expected to occur. Other empirical strength 
percolation coefficients available in the literature are 𝑇 = 3.2 for paracetamol and 
MCC (Avicel PH101) (Kuentz and Leuenberger, 2000), 𝑇 = 2.1 for Lactose, 𝑇 = 3.8 
microcrystalline cellulose, and magnesium stearate (Busignies et al., 2007), 𝑇 = 4.6 
for lactose powder, and 𝑇 = 6.6 for lactose granules (Leuenberger and Ineichen, 
1997), and , 𝑇 = 3.89 for colloidal silica (Ehrburger and Lahaye, 1989). The percolation 
threshold coefficient has not been published for ibuprofen/MCC blends. Moreover, 
it was observed that other coefficients reported in the literature follow the same 
trend of being slightly greater than the theoretical coefficient. 
In this study the percolation coefficient was modelled from compaction pressure and 
tensile strength, which can be easily measured. Also, the coefficient calculated could 
be generalised for both grades of MCC, as there was no statistically significant 
difference between the values calculated. This shows that the coefficient model is 
robust, and the resulting value did not vary for blends of the same substances, even 
though there may exist morphological differences (particle size and shape). 
The percolation threshold determined for the binary blends with Vivapur® 102 and 
Emcocel® 90 differed marginally, with values of 0.1884 and 0.1718, respectively. 
Percolation theory explains that the threshold is a range of values close to the 
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modelled percolation threshold, but it is not possible to determine how close (Kuentz 
and Leuenberger, 2000). Therefore, the slight difference in pc between different MCC 
grades may be negligible. The critical mass fraction calculated using the theoretical 
coefficient resulted in higher values, 23.54 % w/w and 24.68 % w/w for blends of 
Emcocel® and of Vivapur®, respectively. However, the flow behavior and Raman 
imaging showed experimentally that the threshold happens between 15 % and 20 % 
w/w ibuprofen. The Raman technique used gave information on the drug distribution 
on the tablet surface. In future studies it would be useful to consider techniques such 
as 3D tomographic technologies e.g., X-ray Computational Tomography or a 3D 
Raman model to confirm whether the infinite cluster observed on the surface 
extended throughout the structure. Overall, ideally, the coefficient should be 
calculated for each powder blend, rather than considered as a theoretical universal 
value. 
Blends below the critical mass fraction (≤ 15 % w/w) showed good powder 
flowability, which is characteristic of microcrystalline cellulose. On the other hand, 
blends above the critical mass fraction (≥ 20 % w/w) presented cohesive character, 
as the ibuprofen powder. Raman images were used to investigate ibuprofen domains 
in the tablets and showed for the first time ever, the visualization of the phase 
transition predicted for tablets using the percolation threshold model. For the blends 
analysed, this phase transition was observed between the mass concentrations of 
15-20 % w/w, because an infinite cluster consisting of ibuprofen domains connected 
to each other was observed at the concentration of 20 % w/w.  
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When the critical concentration has been estimated graphically (Kimura et al., 2007; 
Mohamed et al., 2015; Pérez Gago and Kleinebudde, 2017), it was a retrospective 
methodology and had to be modelled for data from more complex analysis e.g., 
dissolution. This more complex analysis would also include failure systems (above the 
threshold) that would need to be carried out unnecessarily. Due to advances in data 
processing software packages since the earlier paper (Kuentz and Leuenberger, 2000) 
it is no longer challenging to model the percolation threshold mathematically. The 
advantage of modelling the percolation threshold mathematically is that this is a 
predictive tool. Flowability behaviour and tablet tensile strength could be predicted 
in this study based on a simple model that was only dependent  on compaction 
pressure, tensile strength, and relative density. The other numerous characterization 
techniques used in this study had the aim to prove the values modelled and 
investigate differences between the two different grades of MCC; they are not 
necessary for the percolation threshold model. Therefore, the percolation threshold 
model shown in this study represents a simplified mathematical predictive tool that 
can easily be applied for different formulations.  
Principal Component Analysis was not able to identify a clear threshold level with 
increasing drug loading. However, PCA was able to summarize all the data collected 
and aided in clarifying differences between the blends according to the drug loading, 
and differences between the blends containing Vivapur® and the blends containing 
Emcocel®. Low porosity strongly and negatively correlated to blends with high drug 
loading which confirms that the porous regions present in the MCC placebo matrix 
were occupied by particles of ibuprofen as drug was introduced. The explained 
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variance of PC-3 (7.61 %) showed that the PCA model only captured a small 
difference between Vivapur® and Emcocel® blends. The most expressive differences 
between these two groups along PC-3 were bulk, tapped, and relative densities, 
which are related to the morphological differences between both grades of MCC, 
captured in the SEM and Morphologi G3® analysis.    
4.6 Conclusions 
In this study a percolation coefficient for an ibuprofen/MCC combination was 
successfully modelled and the value obtained (𝑇 = 3.5) was consistent with earlier 
reported values for similar drug/excipient combinations. Dilution capacities of 19.08 
% w/w and 17.76 % w/w ibuprofen were calculated for both Vivapur® and Emcocel® 
blends, respectively. A change in blend behaviour above the threshold value was 
confirmed by experimental flow data. Also, Raman imaging confirmed the presence 
of infinite clusters of drug particles on the tablet surface above the threshold value.  
The minor differences in physical properties between MCC grades did not result in 
significantly different dilution capacities. PCA of the data was not able to identify a 
clear threshold level with increasing drug loading. The modelling approach used in 
this study can be applied to early formulation development studies to identify 
optimal drug loading for robust pharmaceutical blend processing. 
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5.1 Abstract 
The study presented was conducted to determine whether a percolation threshold 
value, determined in Chater 4 for ibuprofen/ microcrystalline cellulose (MCC) blends 
using percolation theory and compression data (Queiroz et al., 2019), could also be 
observed during tablet disintegration and dissolution. The influence of MCC grade 
(air stream dried versus spray dried) on tablet disintegration and dissolution was also 
investigated. Complementary to conventional disintegration and dissolution testing, 
Raman imaging determined drug distribution within tablets, and in-line particle video 
microscopy (PVM) and focused-beam reflectance measurement (FBRM) monitored 
tablet disintegration. Tablets were prepared containing 0 to 30% w/w ibuprofen. 
Raman imaging confirmed the percolation threshold by quantifying the number and 
equivalent circular diameters of ibuprofen domains on tablet surfaces. Across the 
percolation threshold a step change in dissolution behaviour occurred, and tablets 
containing air stream dried MCC showed slower disintegration rates compared to 
tablets containing spray dried MCC. Dissolution measurements confirmed 
experimentally a percolation threshold in agreement with that determined using 
percolation theory and compression data. An increase in drug domains, due to 
cluster formation, and less efficient tablet disintegration contributed to slower 
ibuprofen dissolution above the percolation threshold. Slower dissolution was 
measured for tablets containing air stream dried compared to spray dried MCC. 
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5.2 Introduction 
Disintegration and dissolution behaviours are critical quality attributes assessed to 
evaluate drug release performance (Dressman and Krämer, 2005; Huang et al., 2011; 
Nickerson et al., 2018). Disintegration is often the rate determining step for drug 
release, particularly for poorly water soluble drugs (Caramella et al., 1988). 
Disintegration is the mechanical fragmentation of the compressed tablet into small 
granules or agglomerates. Disintegration is initiated by liquid penetration in the 
porous of the compact. Swelling is one of the most accepted disintegration 
mechanisms, which is characterized by an enlargement of the particles that builds up 
pressure to fragment the tablet matrix (Markl and Zeitler, 2017). The bonding 
mechanism during compression and the bonding surface area have a direct impact 
on tablet disintegration. Swelling depends on an optimal tablet porosity, such that 
the liquid can enter the tablet matrix, however, the void spaces are too large to 
suppress the swelling action of disintegrants (Desai et al., 2016). 
The application of modelling approaches to enhance product knowledge has been 
motivated by quality guidelines as an alternative to iterative testing approaches 
during formulation development (International Council for Harmonisation, 2012, 
2008, 2005a, 2005b; Kimura et al., 2013). The percolation threshold model has been 
used to explain how particle-particle interactions of drug and diluents alters 
dissolution performance of formulations containing different drug loadings (Bonny 
and Leuenberger, 1993, 1991, Kimura et al., 2007, 2013; Stillhart et al., 2017; Wenzel 
et al., 2017).  
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Previous studies determined the percolation threshold value from disintegration and 
dissolution experimental data (Kimura et al., 2007; Stillhart et al., 2017; Wenzel et 
al., 2017). These studies experimentally determined critical loadings at which 
disintegration times undergo a step change. These were then assumed to be the 
percolation thresholds. However, Kimura, Betz and Leuenberger, 2007 
recommended further studies to investigate if the change in disintegration behaviour 
was linked to the formation of the infinite cluster described by the percolation 
threshold theory (Kimura et al., 2007). Since these earlier studies, technological 
advancements have provided novel techniques to study drug distribution in tablets 
and tablet disintegration behaviour. These techniques can be key to providing data 
to support the percolation threshold concepts and the findings of previous studies. 
Spectral imaging techniques have been used to provide in-depth information related 
to drug distribution in pharmaceutical tablets. These techniques can be used to 
investigate the cluster formation predicted by the percolation theory. Fourier 
transform infrared spectroscopy (ATR-FTIR), X-ray diffraction (XRD), and Raman 
spectroscopy are the main techniques employed (Chan et al., 2005; Kazarian and 
Ewing, 2013; Miller and Havrilla, 2005; Zhang et al., 2005). Among those, 
advancements in Raman instruments has enabled the technique to rapidly map drug 
distribution in tablets. Raman imaging instruments have been designed to capture 
rich spectroscopic data which can be translated to provide high-resolution chemical 
information for tablets (as low as 1 µm per pixel) and require short acquisition times 
(approx. 15 min for a tablet of 13 mm diameter) (Ali et al., 2013). 
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Focused Beam Reflectance Method (FBRM) and in-line Particle Video Microscopy 
(PVM) are innovative techniques that can give real-time in-situ information regarding 
disintegration and dissolution performance of tablets. FBRM has been used to 
monitor the rate and the degree of change in the number of particles and particle 
structures in a process (Barrett et al., 2011; Gregory, 2009; Simon et al., 2019; Zhong 
et al., 2020). Measurement of the solid particles using FBRM is performed without 
the need for sampling and performing off-line analysis. The system gives particle 
count, dimension and shape information in real time by monitoring changes in the 
system as they occur (Barrett and Glennon, 1999). PVM provides real-time images of 
the system allowing the user to visually track changes in the solids over time (Barrett 
and Glennon, 2002). Alternatively, automatic algorithms of image analysis can be 
coupled to it. The imaging window measures an area of approximately 800 µm by 
1100 µm. PVM also records a Relative Backscatter Index (RBI) trend which can be 
used to track changes in the shape and size of solid particles as well as changes in the 
solids concentration (Werner et al., 2017). RBI is comparable to turbidity monitoring. 
Increased RBI indicates a larger amount of solids (Hartwig and Hass, 2018). As tablet 
disintegration progresses the number of particles in the slurry increase as larger 
particles fragment. Therefore, as disintegration proceeds, more particles are 
captured in the image and the RBI increases. 
FBRM and PVM techniques are commonly used in crystallization studies (mass 
transfer from solution to solid phase) (Barrett et al., 2011; Hartwig and Hass, 2018; 
Jiang et al., 2014; Liu et al., 2011; Mitchell et al., 2011; Simon et al., 2019; Simone et 
al., 2015). FBRM has also been utilized in previous studies for investigating tablet 
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disintegration and dissolution (Coutant et al., 2010; Han et al., 2009; Menning, 2016; 
Metzler et al., 2017). PVM has the potential to monitor tablet disintegration and 
dissolution because changes in particle size and shape in suspension are key features 
observed during tablet disintegration and dissolution. 
The aim of this study was to investigate if a step change in disintegration and 
dissolution behaviour was observed for tablets produced with drug loadings below 
and above a predetermined percolation threshold. The percolation threshold of 
these systems was determined in an earlier study using the physical principles of 
blending and compaction (Queiroz et al., 2019). The model system investigated was 
tablets produced from binary blends of microcrystalline cellulose (MCC) and 
ibuprofen (IBU) at a range of ibuprofen mass loadings. Tablets were prepared with 
two different MCC grades; one spray dried and one air stream dried. The percolation 
threshold values determined were 19.08% w/w and 17.76% w/w IBU for blends with 
air stream dried MCC and spray dried MCC, respectively (Queiroz et al., 2019). A 
secondary study aim was to determine if the grade of MCC altered any changes in 
disintegration and dissolution behaviour observed.  
In the context of the previous and the present study, percolation threshold is a 
geometric phase transition in which the concentration of ibuprofen particles is high 
enough to form a cluster that spans throughout the entire volume of the tablet. 
When this ibuprofen particle cluster is formed, it is anticipated that a step change in 
properties of the blend will occur. For example, a reduction in flow, compaction and 
dissolution would be anticipated with ibuprofen particle cluster formation, as 
ibuprofen has poor flowability and compressibility properties compared to MCC (Al-
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Karawi et al., 2018; Liu et al., 2008), and is considerably more hydrophobic (Kawabata 
et al., 2011). 
In addition to traditional pharmacopeial disintegration and dissolution techniques, 
process analytical technologies (FBRM and PVM) were employed to better 
understand tablet disintegration behaviour, and hence its influence on drug 
dissolution. Building on the application of Raman imaging to qualitatively identify 
clusters of ibuprofen particles (Queiroz et al., 2019), the present study demonstrated 
how Raman spectroscopy can be used to quantitatively determine the size and the 
number of ibuprofen clusters formed on tablets surfaces and hence confirm the 
percolation threshold determined from compaction data. The MCC grades studied, 
have similar specifications; average particle size of 130 µm determined by laser 
diffraction, and similar bulk density (0.28–0.33 g/mL for the air stream dried and 
0.25–0.37 g/mL for the spray dried). Queiroz et al. confirmed similarities in particle 
size distribution between grades by dry powder, laser diffraction analysis. Particle 
analysis employing an image analysis technique, identified morphological differences 
between MCC grades: the air stream dried grade contained a greater number of 
particles with needle shaped geometry, while the spray dried grade contained a 
greater number of spherical-shaped particles (Queiroz et al., 2019). 
5.3 Materials 
Emcocel®90 (spray dried) and Vivapur®102 (air stream dried) were supplied by JRS 
Pharma (Weissenborn, Germany) and ibuprofen by Kemprotec (Cumbria, UK). The 
two MCC products studied were medium size standard grades with theoretical bulk 
density of 0.28 - 0.33 g/mL for the air stream dried and 0.25 – 0.37 g/mL for the spray 
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dried MCC. A range of particulate and bulk powder properties of the batches of 
ibuprofen, air stream dried MCC and spray dried MCC used in this study had been 
previously determined in Chapter 4 (Table 4.1). Other materials used such as buffer 
components and HPLC mobile phase were all supplied by Sigma Aldrich, Ireland. 
5.4 Methods 
5.4.1 Tablet manufacture and characterization 
Binary blends of MCC and IBU were prepared containing a range of IBU 
concentrations: 2.5, 5, 7.5, 10, 12.5, 15, 20, and 30 % w/w. Each blend, total weight 
300 g, was prepared using a cube mixer KB 15 (Erweka, Heusenstamm, Germany) at 
30 rpm for a duration of 30 min. Tablets were prepared according to section 4.2.2.4. 
However, the tablet hardness was controlled to 120 ± 10 N, tablet weight variation 
to 270 ± 10 mg, the room air humidity to 50 ± 5 % and temperature to 19 ± 2 °C. The 
tablets were characterized according to the methods described in section 4.2.2.5. 
5.4.2 Raman imaging analysis of tablet surface 
Tablets had theirs Raman imaging acquired and then cut in horizontal and vertical 
layers. Raman imaging analysis of those segments were also performed. Drug and 
excipient distributions on external surfaces and surfaces of internal sections of 
tablets were investigated by Raman imaging analysis using a RA802 Pharmaceutical 
analyser (Renishaw, New Mills, UK) as described in section 4.2.2.8. Domains of each 
substance were determined based on the reference spectra acquired for the pure 
substances. Domains of each substance in the generated images were analysed using 
Particle Analysis in Renishaw’s WiRE software. This software resolves the image 
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domains and determines particle metrics. The numbers of domains of ibuprofen on 
the entire surface of each tablet and their average equivalent circle diameters were 
determined. 
Raman imaging also gives an averaged spectrum of the surface of the tablet. The 
spectra of the tablets were used to build a PCA. Unscrambler X (Camo Analytics, Oslo, 
Norway) was used to perform the PCA with full cross validation, using the algorithm 
Singular Value Decomposition (SVN). 
5.4.3 Disintegration analysis 
In vitro disintegration time was determined in water at 37 °C ± 2 °C, using a tablet 
disintegration tester ZT42 (Erweka, Edison, USA) which complies with Ph. Eur. 2.9.1 
(Disintegration of tablets and capsules) (Council of Europe, 2019). Each tablet was 
placed inside of one basket which were continuously and automatically agitated 
vertically in the disintegration medium. The disintegration process was observed 
until the tablets disintegrated into small enough particles that could escape the 
basket so that no substantial material remained in the basket. Analysis was 
performed in triplicate. 
5.4.4 FBRM and PVM analysis 
FBRM (FBRM G600) and PVM (PVM V19) (Mettler Toledo, Leicester, England) were 
used to monitor tablet disintegration using a Mettler Toledo EasymaxTM 102 system. 
The disintegration medium was phosphate buffer (pH 7.2). The system used 
consisted of 100 mL glass vessels with automated internal temperature and agitation 
control. System specific PTFE (polytetrafluoroethylene) lids allowed for integration 
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of the FBRM and PVM probes. A visual check of the system was possible through an 
inspection window at the front of the system. 
The working volume of the system was 50 mL. Experiments were performed at 37 °C 
and the agitation rate was 250 rpm using an upward pumping, pitch blade impeller 
for 30 minutes after the tablet was added to the vessel.  The powder or tablet was 
added to the glass vessel under agitation. PVM and FBRM monitoring was performed 
throughout the duration of the experiment; FBRM data was recorded every 2 
seconds and two PVM images were recorded every second.  
5.4.5 Dissolution studies 
The dissolution studies were carried out using a DT 600 dissolution tester of Ph. Eur. 
2.9.3 (paddle) (Erweka, Edison, USA). A volume of 500 mL of phosphate buffer pH 7.2 
equilibrated at 37 ˚C was used as the dissolution medium and the paddle rotation 
was kept at 50 rpm. Solubility of ibuprofen in the given conditions is 3.74 mg/ml 
(Dabbagh and Taghipour, 2007). The experiment was conducted using sink 
conditions; the theoretical concentration of Ibuprofen in the dissolution medium 
following complete dissolution of 30 % w/w ibuprofen tablets was 0.16 mg/ml. 
Following addition of the tablet sample to the dissolution medium, samples of      0.5 
ml volume were withdrawn at 1, 5, 15, 30, 60 and 120, 180, and 240 min intervals in 
order to determine the dissolution profiles. An additional sample was taken at the 24 
h time point to determine the total amount of drug in each tablet tested. At the 24 h 
time point the tablet had completely disintegrated and complete IBU dissolution was 
assumed. 
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All samples were filtered using 0.45 µm filter and 0.5 mL of fresh, pre-warmed 
medium was immediately added to the system in order to correct the volume to the 
sample volume withdrawn. Samples were analysed by HPLC. The % cumulative 
amount IBU released was calculated and plotted against time.  
HPLC analysis was performed using an Agilent 1200 series HPLC system with an 
UV/Vis detector (Agilent Technologies, Santa Clara, USA). A reversed-phase column 
(Gemini C-18, 250 × 4 mm x 5 μm, Phenomenex Ltd. UK), mobile phase of acetonitrile 
and water (60:40, pH adjusted to 2.5) at a flow rate of 1.5 ml/min and injection 
volume of 20 μL were employed. The wavelength for Ibuprofen detection was set at 
215 nm and retention time was 7 min. 
5.5 Results 
5.5.1 Tablet Characterisation  
The average content of ibuprofen was determined for all tablets analysed and 
compared to the theoretical content (Table 5.1). Greatest variance between actual 
and theoretical content was measured for the 30 % w/w ibuprofen loading. Drug 
content uniformity was also determined with the percentage relative standard 
deviation less than 7 % for all drug loading. Tablet porosity was also determined 
(Table 5.1) as it can influence tablet disintegration and dissolution (Ibrahim, 1985; 
Yassin et al., 2015). Porosity of tablets decreased as ibuprofen content increased. The 
porosity of tablets containing spray dried MCC was slightly greater than tablets 
containing the air stream dried MCC at all drug loadings except for 15%.
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Table 5.1. Tablet ibuprofen theoretical and average actual content ± % relative standard deviation (n=5), blend true density and tablet porosity. 







Air stream dried MCC Spray dried MCC 














2.5 % 6.75 6.63 ± 2.60 % 30.3 1.53 6.82 ± 1.57 % 32.3 1.52 
5 % 13.50 13.40 ± 2.21 % 30.9 1.52 13.17 ± 2.79 % 31.1 1.51 
10 % 27.00 27.33 ± 2.81 % 28.5 1.48 27.06 ± 1.38 % 29.7 1.49 
15 % 40.50 41.68 ± 1.78 % 28.6 1.47 41.94 ± 5.02 % 28.5 1.47 
20 % 54.00 54.13 ± 4.26 % 26.1 1.45 55.04 ± 2.01 % 28.4 1.45 
30 % 81.00 78.33 ± 6.77 % 23.1 1.40 85.34 ± 2.00 % 24.10 1.38 
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5.5.2 Raman imaging analysis of tablet surface 
Raman spectroscopy did not show differences between the characteristic bands of 
the MCC tablets (air stream dried and spray dried MCC only), indicating similar 
chemical identity of microcrystalline cellulose between grades. In respect to the 
ibuprofen loading, spectral peaks related to ibuprofen increased in intensity when 
ibuprofen loading was increased (Figure 5.1).  
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A 
B 
Figure 5.1. Average Raman spectra of the surface of (A) Spray dried MCC (Emcocel®) 
and (B) Air stream dried MCC (Vivapur®) tablets containing a range of ibuprofen 
loadings: (a) 30 %, (b) 20 %, (c) 15 %, (d) 12.5 %, (e) 10 %, (f) 7.5 %, (g) 5 %, (h) 2.5 
%, and (i) 0 % ibuprofen w/w. Vertical lines indicate characteristic peaks of 
ibuprofen. 
Raman images for tablets of all drug loadings were shown in Figure 4.9. In this study 
the number of ibuprofen domains on surfaces of each tablet was determined from 
these Raman images, as described in section 3.2. The number of ibuprofen domains 
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decreases for the tablets with drug loading above 15 % w/w (Table 5.2), despite an 
increase in the overall intensity peaks related to ibuprofen (Figure 5.1). Above the 
percolation threshold the domains of ibuprofen start to connect to the neighbouring 
ibuprofen domains. Thus, one single domain with larger area is counted, instead of 
numerous smaller neighbouring domains. In the case of the compacted tablets, it 
results in a change in the drug distribution from dispersion of drug particles in a 
matrix of MCC (large number of small drug domains) to distribution of MCC in a 
matrix of drug (smaller number of larger drug domains). The resulting larger domains 
were characterized by continuously increased equivalent circular diameter of 
ibuprofen domains with a more pronounced increase between the concentrations of 
15% and 20% w/w ibuprofen (Table 5.2). These results build on the results in the 
earlier study which qualitatively confirmed the percolation threshold values 
determined by visual appearance, which can be subjective. In this study the 
quantitative data obtained related to the number and size of ibuprofen domains 
provides a less subjective confirmation of the percolation threshold value. 
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Table 5.2. The number of ibuprofen domains (N) and the equivalent circular diameter 
(ECD) of ibuprofen domains on the surface of Air stream dried MCC and Spray dried 
MCC tablets containing a range of ibuprofen loadings (2.5 to 30% w/w ibuprofen). 
The number of domains and the equivalent circular diameter values were 
determined from images generated using Raman image analysis. 
% w/w 
Ibuprofen 
Air stream dried MCC Spray dried MCC tablets 
N 




ECD of ibuprofen domains 
(μm) 
2.5 % 158 69.2 130 62.0 
5 % 264 70.4 218 59.6 
7.5% 264 76.7 343 74.4 
10 % 462 79.5 475 71.8 
12.5% 377 74.3 469 77.1 
15 % 513 90.5 483 88.6 
20 % 377 103.5 376 103.4 
30 % 112 153.7 72 138.9 
PCA of Raman spectra of the surface of tablets showed that the first principal 
component (PC-1) captured the effect of drug loading i.e., what blend behaviours 
change as the drug loading increases, while the second principal component (PC-2) 
captured variability within the samples due to both MCC grade and due to ibuprofen 
drug loading. The scores plot showed samples that are similar or different from each 
other i.e., samples geometrically located at distance are dissimilar to each other 
while neighbouring samples are similar (Figure 5.2a). PC-1 and PC-2 explained 88% 
and 7% of the variance captured by the model, respectively. Raman shifts of 93, 
142.8, 639, 748, 835, 1184, 1209, and 1610 cm-1 were the variables that mostly 
contributed to discriminating the samples along the first component of the model 
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(PC-1) (Figure 5.2b). Those bands are characteristic of ibuprofen (Sütő et al., 2016) 
and they were not observed in the spectra of the tablets containing pure MCC (Figure 
5.1). As stated previously, these peak heights increased with the increase in drug 
loading. The PCA model showed that tablets containing air stream dried MCC differed 
from tablets containing spray dried MCC along PC-2. Loadings of PC-2 contained 
peaks assigned to both ibuprofen and MCC. PC-2 also showed a general upwards 
shifting of the baseline with reduction in Raman shift. Both chemical and physical 
attributes of the tablets may explain this variability in Raman spectra. Differences in 
tablet porosity was observed with increase in drug loading and between MCC grades 
(Table 5.1). Raman spectra can show stronger intensities for more compacted (less 
porous) samples due to an increased number of scattering molecules that will 
produce a Raman signal (Gómez et al., 2019). The upwards shift may also be due to 
Raman fluorescence, which is a material-dependent phenomenon; fluorescence is 
phenomena intrinsic to MCC. Microcrystalline cellulose is known to be fluorescent 
mainly due to the presence of lignin (Castellan et al., 2007). Variance related to 
ibuprofen peaks (e.g., at the shifts 835 and 1610 cm-1) and the main characteristic 
Raman bands assigned to cellulose (e.g., at 1096 cm-1 and within the region 275-550 
cm-1) (Wiley and Atalla, 1987) are also present in the loadings of PC-2. The region of 
275-550 cm-1 is known to hold crystallinity information of cellulosic materials 
(Agarwal et al., 2010). Thus, the separation of the samples along PC-2 may be an 
indication that the differences between the spray dried and the air stream dried MCC 
grades included crystallinity, lignin content, and compact density. The spectral 
comparison between the air stream and the spray dried samples is available in Figure 
5.3.  
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Figure 5.2 (A) Scores plot and (B and C) loading plots of the principal component 
analysis of Raman spectra acquired from Spray dried MCC (Emcocel®) and Air 
stream dried MCC (Vivapur®) tablets and tablets containing a range of ibuprofen 
loadings (2.5 % to 30 % w/w ibuprofen). PC-1 and PC-2 are the first and the second 
principal components, respectively.  
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Figure 5.3.Raman spectra of compacts (A) of spray dried microcrystalline cellulose 
(Emcocel®), and air stream dried microcrystalline cellulose (Vivapur®), and (B) of 
tablets containing 30 %w/w ibuprofen/microcrystalline cellulose. 
5.5.3 Disintegration and dissolution studies 
Tablet disintegration using Ph. Eur. 2.9.1 disintegration apparatus showed that all 
tablets had completely disintegrated in less than 5 min. Differences between tablets 
containing different drug loadings or MCC grades could not be accurately determined 
by the Ph. Eur. 2.9.1 apparatus. The tablets investigated contain a high percentage in 
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mass of MCC, which is highly hygroscopic and a noted disintegrant (Rowe et al., 
2009). Thus, disintegration happened fast independently of the MCC grade.  
The results of the Ph. Eur. 2.9.3 dissolution study showed that increased ibuprofen 
concentration had a negative impact on the dissolution behaviour of Ibuprofen/MCC 
tablets (Figure 5.4). The effect of ibuprofen loading on drug dissolution was evident 
for ibuprofen concentrations above the percolation threshold, 20 and 30% w/w of 
ibuprofen; time to achieve 100% ibuprofen release increased significantly (Figure 
5.5). Tablets containing the air stream dried MCC required statistically significantly 
longer durations to achieve 100% ibuprofen release for all drug loadings, in 
comparison to tablets containing the spray dried MCC. Tablets containing 30% w/w 
IBU and air stream dried MCC did not reach 100% release in 240 min. Complete 
release was confirmed after 24h. It is also interesting to note that an increase in time 
to reach 100% cumulative ibuprofen release was observed between 2.5 and 5% drug 
loading (air stream dried MCC) and 2.5 and 7.5% drug loading (spray dried MCC) 
(Figure 5.5). This change in dissolution behaviour was not related to a percolation 
threshold of ibuprofen in the MCC matrix but may have resulted due to other factors 
such as differences in porosity and particulate bonding disintegration behaviour 
(Desai et al., 2016) and hence dissolution. 
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Figure 5.4 Dissolution profiles of tablets containing (A) Air stream dried MCC 
(Vivapur®) and (B) Spray dried MCC (Emcocel®) and different ibuprofen w/w 
loadings (2.5 to 30% w/w). Dissolution was performed in phosphate buffer pH 7.2 at 
37oC. Average values shown with y-error bars indicating standard deviation, n= 5. 
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Figure 5.5 Time to reach 100% ibuprofen release during dissolution of tablets 
containing Spray dried and Air stream dried MCC and different ibuprofen w/w 
loadings (2.5 to 30% w/w). Tablets containing air stream dried MCC and 30% w/w of 
ibuprofen did not reach 100% release in 240 min. However, the complete release 
was confirmed after 24h. Dissolution was performed in phosphate buffer pH 7.2 at 
37oC. Average values shown with y-error bars indicating standard deviation, n= 5. 
5.5.4 FBRM monitoring 
FBRM was used as a PAT tool to determine if tablet disintegration played a role in the 
differences observed between dissolution of tablets containing air stream dried and 
spray dried MCC grades with increasing drug loading. Two aspects were investigated: 
the differences among tablets below and above the percolation threshold and the 
differences between both MCC grades. This analysis was complementary to the 
pharmacopoeial disintegration test which was not able to capture differences 
regarding these two aspects. As mentioned previously, FBRM gives particle count, 
dimension information in real-time (Barrett and Glennon, 1999). It was hoped that 
the ibuprofen clusters observed in the tablets by Raman imaging could be observed 
in the disintegration medium and potentially explain the differences in dissolution 
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observed between tablets containing spray dried and air stream dried MCC grades at 
different drug loadings.  
Initially, disintegration monitored by FBRM was performed using spray dried and air 
stream dried MCC tablets without ibuprofen to determine differences in 
disintegration due to MCC grade. Both tablets displayed very similar behaviour with 
a sharp increase in particle counts upon addition of the tablet to the phosphate 
buffer pH 7.2. Figure 5.6 shows that the counts vs time profile for the two MCC grades 
were very similar, indicating that the tablets disintegrated at the same rate. 
 
Figure 5.6. Focused Beam Reflectance Measurement (FBRM) counts 1-1000 µm 
versus time for tablets containing air stream dried and spray dried MCC in 
phosphate buffer pH 7.2, and temperature of 37 °C. 
Figure 5.7 shows the FBRM total counts vs time for ibuprofen tablets added to the 
disintegration medium for the first 30 minutes. All tablets show a rapid increase in 
counts for the first 5 minutes approximately, indicating that, as with the tablets of air 
stream dried and spray dried MCC without ibuprofen, tablet disintegration began 
 Chapter -5 
 
Ana Luiza Pinto Queiroz Page 212 
immediately upon addition of the tablet to the medium for all ibuprofen loadings. A 
similar profile is seen for each tablet of spray dried MCC regardless of ibuprofen 
loading. The counts increased sharply in the first 30 seconds after addition to the 
medium and then continued to increase at a slower rate for the following minutes. 
Overall, air stream dried MCC tablets showed a less consistent total counts versus 
time profile for different drug loadings in comparison to spray dried MCC tablets. 
When the different ibuprofen loadings were compared, the loadings of 20 % and 30 
% w/w ibuprofen showed reduced total counts profiles compared to lower drug 
loadings. The total counts profiles for tablets containing air stream dried MCC was 
also lower in comparison to tablets containing spray dried MCC, for all ibuprofen 
loadings (Figure 5.8). These differences were more pronounced above the 
percolation threshold > 15% ibuprofen. 
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Figure 5.7. Focused Beam Reflectance Measurement (FBRM) total particle counts 
(counts 1-1000 µm) versus time for tablet containing (A) Spray dried MCC and (C) 
Air stream dried MCC and different ibuprofen w/w loadings (2.5 to 30% w/w) in 
phosphate buffer pH 7.2 and temperature of 37 °C. 
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Figure 5.8. Focused Beam Reflectance Measurement (FBRM) total counts over time 
for Air stream dried MCC (Vivapur®) and Spray dried MCC (Emcocel®) tablets 
containing ibuprofen (A) 7.5 %, (B) 15 %, (C) 20 %, and (D) 30% w/w in phosphate 
buffer pH 7.2 and temperature of 37 °C. 
Due to the variability in the total number of counts for each tablet a relative increase 
in FBRM counts was measured for each tablet to enable comparison between tablets 
behaviour during the disintegration process. Figure 5.9 shows the time required to 
reach 50, 60, 70, 80, 90% total counts. All tablets were tracked for 30 minutes. Thus, 
100% was considered the total counts at 30 min for each tablet. After 30 minutes the 
disintegration process for all tablets was considered complete. The overall trend 
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showed a longer time for tablets containing air stream dried MCC compared to spray 





Figure 5.9. Time to reach percentage of total counts measured by FBRM for tablets 
during disintegration containing (A) Spray dried MCC and (B) Air stream dried MCC 
and different ibuprofen w/w loadings (2.5 to 30% w/w) in phosphate buffer pH 7.2 
























































 Chapter -5 
 
Ana Luiza Pinto Queiroz Page 216 
An indication of particle size distribution during disintegration was obtained from the 
FBRM chord length distributions and square weighted chord length distributions 
(SQWT). Representative tablets with 12.5, 15 % w/w, and 30 % w/w ibuprofen 
loadings after 5 minutes of dissolution are shown in Figure 5.10. These distributions 
are automatically generated for the user by the iC FBRM software. The CLD is 
comparable to a particle size distribution. It is the number of chord lengths recorded 
in the measurement scan time vs the chord length. The SQWCLD is useful for visual 
comparison of systems by emphasising differences in the coarse counts (100 – 1000 
µm). This is achieved by applying a channel (size intervals or bins) specific weight wi 
to counts ni. The weighted channels yi are obtained via: 
𝑦 = 𝑤 ∙𝑛  (Equation 5.1) 




∙ 𝑁 (Equation 5.2) 
Where γ is 2 for the square weight, N is the number of channels, which was 90 in this 
study, i = 1, 2, …, N and j =1, 2, …, N. 
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Figure 5.10. Focused Beam Reflectance Measurement (FBRM) chord length 
distributions and square weighted chord length distributions for Emcocel® (spray 
dried MCC) and Vivapur® (air stream dried MCC) tablets with ibuprofen loading (A) 
12.5 %, (B) 15%, and (C) 30 % w/w, 5 minutes after addition to the disintegration 
medium, phosphate buffer pH 7.2 and temperature of 37 °C. 
 Chapter -5 
 
Ana Luiza Pinto Queiroz Page 218 
Coarse counts account for a much larger proportion of the mass of material 
compared with fine counts (1-10 µm). While the CLDs for both systems have a similar 
shape profile, the increased number of total counts and shorter chord length counts 
was evident for the spray dried compared to the air stream dried MCC. Fine counts 
may be related to disaggregation of MCC particles during disintegration. MCC is 
composed of cellulose fibrils agglomerated into larger particles (Queiroz et al., 
2019.). Therefore, particle disaggregation during disintegration can result in smaller 
particle sizes observed in the buffer compared to the particle size distribution 
reported for dry MCC particles (Table 4.1). When the square weighted CLDs are 
compared there is a distinct shift to the right for air stream dried, highlighting the 
increased particle size present 5 minutes after the tablet addition to the buffer. An 
increase in fine counts (1-10 µm) in the CDL present in the spray dried MCC system 
suggested that tablets of the spray dried MCC disintegrated more effectively than 
tablets of the air stream dried MCC at a 30 % w/w ibuprofen loading. For loading 
below the percolation threshold, a similar trend was seen although the shift to the 
right for air stream dried in the square weighted CLD is less pronounced. This is 
exemplified by 12.5 % w/w ibuprofen tablets in Figure 5.10. 
The plots of chord length distributions at different time points during disintegration 
for all tablets were generated and selected profiles shown in Figure 5.11. The 
increase in counts over time happens similarly across all chord lengths for a same 
tablet i.e., the distribution did not show a shape change at different time points. 
Interestingly, the increase in count is clearly more significant up to 5 min. After 5 
minutes, the change chord length distributions were comparatively small. 
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Figure 5.11. Focused Beam Reflectance Measurement (FBRM) chord length 
distributions for tablets with ibuprofen loadings of 12.5 %, 15%, and 30 % w/w and 
(A, C, and D) Spray dried MCC (Emcocel®) and (B, D, and F) and Air stream dried 
MCC (Vivapur®), respectively, at different times after addition to the disintegration 
medium, phosphate buffer pH 7.2 and temperature of 37 °C. 
Based on the results shown in Figure 5.11, the greatest degree of disintegration 
occurred in the first 5 minutes, the cumulative drug release at 5 min was plotted 
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against drug loading to investigate the differences in drug release below and above 
the threshold during tablet disintegration (Figure 5.12). Similar graphical approaches 
have been previously used to determine the percolation threshold from 
disintegration and dissolution (Kimura et al., 2007; Wenzel et al., 2017). Cumulative 
ibuprofen release decreased sharply from 2.5 to 15% w/w of ibuprofen loading. 
However, at drug loadings above the reported percolation threshold (20% w/w and 
30% w/w ibuprofen) the reduction in drug release with increase in drug loading was 
decreased. Tablets containing the air stream dried MCC showed significantly lower 
drug release for all drug loadings in comparison to tablets containing the spray dried 
MCC. These findings confirmed a step change in drug dissolution behaviour at drug 
concentrations above and below the predicted percolation threshold following tablet 
disintegration.  
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Figure 5.12. Estimation of percolation threshold based on the dissolution 
cumulative release of ibuprofen from the tablets containing (A) Air stream dried 
MCC and (B) Spray dried MCC, at 5 min of dissolution. The time of 5 minutes was 
chosen to represent the differences in behaviour during disintegration. 
5.5.5 PVM analysis 
PVM analysis was performed to provide real-time images of particles in dissolution 
medium during tablet disintegration. Besides the images, PVM relative backscatter 
index was used as a quantitative measure of disintegration. Initially, images were 
y = -3.156x + 67.02
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collected using the PVM probe for ibuprofen powder and both MCC only tablets in a 
buffer. The ibuprofen particles had a distinct rod-shaped habit (Figure 5.13a). 
Dispersed ibuprofen powder was present as both discrete particles and aggregates. 
The ibuprofen particles appeared to be between 100 and 300 µm in length and 30 
and 50 µm in width. When compared with the particle size for the dry powder from 
laser diffraction (Table 4.1), where the D50 was 55 µm, it appears that larger 
ibuprofen particles in the PVM images may be aggregated. PVM images of the 
disintegrated spray dried MCC tablet (Figure 5.13b) indicated that fine material was 
present along with uniform distinct particles having a rough surface. Images of 
disintegrated air stream dried MCC tablets (Figure 5.13c) are similar to spray dried 
MCC. These images would support the presence of fine particles observed during 
FBRM analysis, Figures 5.10 and 5.11. These appeared to be rod shaped particles 
present which are similar in appearance to the ibuprofen particles. 
A B C
Figure 5.13. PVM images of (A) ibuprofen powder, and (B) Spray dried MCC 
(Emcocel®) and (C) Air stream dried MCC (Vivapur®) particles following tablet 
disintegration in phosphate buffer pH7.2 and temperature of 37 °C. 
 Chapter -5 
 
Ana Luiza Pinto Queiroz Page 223 
Side by side comparison of PVM images of disintegrated tablets containing spray 
dried and air stream dried MCC with equivalent ibuprofen loading showed that it is 
difficult to distinguish definite differences between the two systems. One difference 
noted was that air stream dried tablets showed more elongated particles (Figure 
5.14). There are rod shaped particles present in the air stream dried suspension 
(Figure 5.13), hence it was not possible to distinguish whether this rod-shaped 
material following the 15% w/w ibuprofen tablet disintegration is ibuprofen or MCC. 
Relative Backscatter Index (RBI) measured by PVM is the relationship between the 
incident and the detected light. As disintegration progresses the number of particles 
in the media increases due to fragmentation of larger particles to smaller particles 
and RBI increases. The change in the PVM RBI versus time during disintegration does 
indicate differences for tablets containing 20% and 30% ibuprofen loading tablets 
compared to tablets containing lower ibuprofen loadings (Figure 5.15). For ibuprofen 
loadings below the percolation threshold the RBI for both spray dried and air stream 
dried MCC tablets was similar. The air stream dried MCC tablets with a 20 and 30% 
w/w ibuprofen had a significantly lower final RBI during disintegration compared to 
air stream dried MCC (Figure 5.15d). 
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A B
Figure 5.14. Representative PVM images of particles following disintegration of (A) 
Spray dried MCC and (B) Air stream dried MCC tablets with a 15 % w/w ibuprofen 
loading in phosphate buffer pH7.2 and temperature of 37 °C. 
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Figure 5.15. Relative Backscatter Index (RBI) vs time following disintegration of Spry 
dried MCC (Emcocel®) and Air stream dried MCC (Vivapur®) tablets (A) 0% w/w, (B) 
15% w/w, (C) 20% w/w and (D) 30% w/w ibuprofen in phosphate buffer pH7.2 and 
temperature of 37 °C. 
5.6 Discussion 
The research presented was conducted to determine whether a percolation 
threshold value, previously determined for ibuprofen/MCC blends using percolation 
theory and compression data (Queiroz et al., 2019) could also be observed during 
tablet disintegration and dissolution data. Previous studies determined a percolation 
threshold value experimentally from disintegration and dissolution data (Kimura et 
al., 2007; Stillhart et al., 2017; Wenzel et al., 2017). For ibuprofen/ MCC blends, the 
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existence of a percolation threshold was predicted mathematically and confirmed 
experimentally from blend properties and a compaction behaviour perspective 
(Queiroz et al., 2019). In the present study, disintegration and dissolution 
experiments were carried out to confirm experimentally whether the percolation 
threshold, previously predicted for ibuprofen/ MCC blends, causes a step change in 
tablet disintegration and dissolution behaviour. 
Dissolution testing confirmed the presence of the percolation threshold in the region 
previously reported. A change in behaviour above the percolation threshold was 
observed during dissolution; % drug released at 5 min during the tablet disintegration 
process (Figure 5.12), and in relation to the time to achieve complete dissolution 
(Figure 5.5). Blends above the percolation threshold showed slower dissolution 
profiles. Kimura, Betz and Leuenberger, 2007 also revealed a decreased 
disintegration performance above the critical loading of a poorly water-soluble drug. 
In the case of tablets containing MCC and ibuprofen, it was hypothesised that the 
connected MCC particles would form the water-conducting clusters promoting 
disintegration. Above the threshold predicted a continuous cluster of ibuprofen 
particles is formed. Relative to MCC, ibuprofen is poorly water soluble, and the 
formation of continuous ibuprofen clusters would decrease disintegration. Thus, the 
explanation for the reduction in dissolution above the percolation threshold can be 
attributed to the combined effect of decreased drug surface area to mass due to the 
presence of continuous clusters evidenced by Raman imaging and a change in the 
disintegration process. 
In this study, Raman imaging and image domain analysis were combined to confirm 
percolation threshold in pharmaceutical tablets. The methodology developed 
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confirmed the percolation threshold previously predicted for the binary blend 
investigated (Queiroz et al., 2019) by an increasing number of drug clusters up to the 
percolation threshold and reduction above due to the formation of continuous 
clusters. For the drug loading above 15%, the number of ibuprofen domains 
dramatically decreased, and their equivalent circle diameter increased which 
confirms the cluster formation and would contribute to a slower rate of ibuprofen 
dissolution due to a reduced surface area to mass ratio.  
The influence of the presence of continuous ibuprofen clusters on tablet 
disintegration was difficult to establish by pharmacopoeial disintegration testing. 
However, the use of FBRM and PVM to interrogate the tablet disintegration process 
with respect to drug loading demonstrated a change in behaviour above the 
percolation threshold, particularly for tablets containing air stream dried MCC 
(Figures 5.8 and 5.15). In this study, the dissolution of the disintegrated particles 
could not be monitored by FBRM nor PVM due to similarity in morphology of the 
disaggregated MCC particles and ibuprofen particles (Figure 5.14) and the insoluble 
nature of MCC in the disintegration medium. However, it may be possible to monitor 
drug dissolution for formulations with high drug loadings and soluble excipients, such 
as lactose, using PVM and FBRM techniques. 
The secondary objective of this study was to investigate the influence of MCC grade 
on disintegration and dissolution behaviour relative to the percolation threshold. 
Despite the MCC grades having similar bulk properties, the interaction of each grade 
with the model drug ibuprofen resulted in differing dissolution behaviour. In all cases, 
the tablets containing the air stream dried grade showed slower disintegration and 
dissolution rates. Air stream dried MCC tablets showed a reduction in disintegration 
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rate above the percolation threshold value while spray dried MCC did not (Figure 5.7 
and 5.15). Air stream dried MCC tablets displayed slower dissolution rates (Figure 
5.5) across all drug loading.  
The mechanistic explanation for the differences in disintegration and dissolution 
behaviour observed between MCC grades investigated is unclear. Raman image 
analysis showed similar distribution and size of ibuprofen clusters for both tablets 
containing both MCC grades (Table 5.2). However, tablet porosity differed between 
MCC grades, with tablets produced from the air stream dried MCC grade being 
slightly less porous (Table 5.1). Tablet porosity is a function of drug loading and for 
blends of poorly compressible drugs with MCC porosity is reduced above the 
percolation threshold value. Porosity is also a dependent on the grade of MCC 
(Queiroz et al., 2019). MCC samples with less dense crystalline regions were reported 
to swell more as they are more accessible for the water molecules, and the cohesive 
forces between the chain segments are weaker, in comparison to the crystalline 
domains (Desai et al., 2016; Schott, 1992). Therefore, differences in MCC crystallinity 
could also contribute to differences in tablet disintegration behaviour. Further 
studies are required to determine the exact mechanisms causing the reduced 
dissolution rates for tablets containing air stream dried MCC compared to the spray 
dried grade.  
It was challenging to discriminate between the effects of tablet porosity and 
percolation threshold in relation to tablet disintegration. The compaction 
parameters and bonding mechanism of particles during compaction directly impact 
tablet porosity, the ingress of the disintegration medium, MCC swelling and hence 
tablet disintegration (Yassin et al., 2015). Despite confounding variation observed in 
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tablet porosity in this study, a clear step change in dissolution behaviour was 
observed for tablets with drug loadings above the percolation threshold.  
5.7 Conclusions 
Dissolution data showed that a percolation threshold value previously determined 
for ibuprofen/MCC binary blends, from compaction data, translated to tablet 
dissolution data. Slower ibuprofen dissolution behaviour was observed for tablets 
above the predetermined percolation threshold. This confirmed the presence of the 
percolation threshold and its relevance to dissolution studies. In addition, slower 
dissolution was observed for all tablets containing an air stream dried MCC grade, 
compared to a spray dried MCC grade. FBRM and PVM showed less efficient 
disintegration above the percolation threshold for tablets containing air stream dried 
MCC. The results experimentally demonstrate that both larger drug domains, 
quantified by Raman imaging, and a less efficient tablet disintegration measured by 
FBRM and PVM (in the case of air stream dried MCC) contributed to slower ibuprofen 
dissolution profiles above the percolation threshold.
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6.1 General Discussion 
The technological advances of the 4th industrial revolution have brought 
opportunities for process development and knowledge growth in the pharmaceutical 
sector. One important innovation is the adoption of continuous manufacturing. 
Technologies that can support the understanding, design, operation, and control of 
continuous processes must be developed in order to progress towards Pharma 4.0 
and implement advanced quality approaches. 
The overall aim of this thesis was to increase understanding of pharmaceutical 
materials attributes and processes performance by (i) characterization of CMAs, 
API/excipient interactions, and CQAs, and (ii) the development of descriptive and 
predictive models and PAT tools applied to tableting and co-crystallization process 
development and monitoring.  
The focus of this thesis was to address challenges around direct compression, which 
is the preferential process for continuous tableting manufacturing. Three main stages 
of the process were investigated; raw material characterization and variability were 
investigated in Chapters 2, 4, and 5, crystal engineering process development and 
process characterization was investigated in Chapter 3, and process characterization 
and analysis of the impact of constituent raw material attributes on process 
performance was investigated in Chapters 4 and 5 (Figure 6.1).  
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Figure 6.1. Tablet direct compression (DC) scheme.  
6.2 Knowledge related to Microcrystalline Cellulose variability 
Microcrystalline cellulose is important excipient used in most solid dosage 
formulations. However, it is necessary to improve knowledge about MCC CMAs in 
order to control the effects of MCC CMA on process and product performance (Foster 
et al., 2018; Rowe et al., 1994; Shi et al., 2011; Trache et al., 2016). Several MCC 
attributes were investigated in this thesis (Table 6.1). 
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Table 6.1. Microcrystalline cellulose attributes investigated in this thesis.  
Material attribute Model Chapter 
Crystallinity by Raman PLS, univariate model 2 
Moisture sorption by DVS GAB equation 2 
Moisture sorption by TGA LOD - 4 
 Surface area BET 4 
Laser diffraction particle size - 4 
Morphology and particle size by 
morphology G3 
- 4 
Morphology and particle size by SEM - 4 
Bulk, tap, true and relative densities - 4 
Flowability Hausner ratio 4 
Flowability by Powder Flow Tester (PFT) - 4 
Compressibility, tabletatibility and 
Compactability 
Compaction triangle 4 
Yield pressure Heckel equation 4 
Capacity of dilution of ibuprofen Percolation threshold 
theory 
4 
Disintegration  - 5 
Disintegration and dissolution of ibuprofen - 5 
Knowledge related to MCC batch-to-batch, supplier to supplier and grade to grade 
variability was obtained by investigating MCC moisture sorption and crystallinity 
variability in Chapter 2. Raman spectroscopy was used with a univariate model that 
is a function between the ratio of the peaks at 380 and 1096 cm-1, and with partial 
least squares regression model, to provide a PAT tool to determine the MCC 
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crystallinity index. The PAT tool designed was packaged into a free online calculator, 
MCCrystal. This work is a further development of the work developed by Agarwal et 
al. (Agarwal, 2019; Agarwal et al., 2018, 2010). The contributions of this thesis to the 
previous work were the application of the models to 30 commercial grades of MCC, 
which proved the efficiency of those models to commercial grades, and the 
development of an online, free access, PAT tool that can be used by other academics 
and industry personnel. 
A range of MCC crystallinity was noted between samples. While variability in 
moisture sorption behaviour was also noted between samples, a PAT tool to predict 
MCC moisture sorption based on crystallinity of MCC could not be designed. A 
correlation between moisture sorption and crystallinity index was investigated. 
However, it was not possible to build a model with predictive power. It was found 
that for the set of 30 MCC commercial batches investigated, moisture sorption was 
not solely dependent on the crystallinity index of the sample. Mihranyan et al. 
suggested that moisture sorption in MCC may be also dependent  on other structural 
attributes such as pore volume and surface area (Mihranyan et al., 2004).  
Excipient variability has been highlighted by many authors as a critical part of the 
design and control strategies of new drug products (Badawy et al., 2016; Kushner IV, 
2013; Kushner et al., 2011; Narang, 2015; Zarmpi et al., 2020). In Chapters 4 and 5, 
the impact of excipient variability on tablet CQAs was highlighted by investigating 
two different MCC grades. One grade was air stream dried and the second spray 
dried. Grades had similar average particle size distribution determined by laser 
diffraction, but different morphology determined by image analysis. Tablets were 
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prepared from binary blends of MCC with ibuprofen. The use of PAT tools to 
determine tablets CQAs was proposed and compared to traditional methodologies. 
The PAT tools used, PVM and FBRM, are widely used to track in-process particle 
changes (Barrett et al., 2011; Gregory, 2009; Simon et al., 2019; Zhong et al., 2020). 
However, they have not been used to monitor disintegration and dissolution 
behaviours. Both traditional testing and tests assisted by PAT tools showed that the 
morphological differences due to grade-to-grade variability resulted in significant 
differences in tablet dissolution. The PAT tools, PVM and FBRM, provided more 
sensitive information regarding tablet disintegration compared to the traditional 
disintegration test. The study highlights the applicability of those PAT tools to identify 
differences in the disintegration of immediate release tablets. Furthermore, 
disintegration is a limiting step to dissolution. Therefore, in Chapter 5, the 
disintegration differences observed using the PAT tools indicated that dissolution 
differences could be expected. Indeed, significant dissolution differences were 
confirmed by traditional dissolution testing with HPLC analysis of the % cumulative 
drug release.  
The impact of MCC grade variability on formulation processability during tableting 
was also investigated in Chapter 4. This contrasts with Chapter 5 where the effect of 
MCC grade variability on tablet CQAs (hardness, disintegration, and dissolution) was 
evident. The air stream dried MCC grade showed considerably lower tablet 
dissolution rates in comparison to the air stream dried MCC. The differences 
observed were attributed to the minor differences in tablet solid fraction or porosity, 
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which directly affects the rate at which water enters through the tablet matrix and 
hence disintegration (Yassin et al., 2015). 
6.3 Knowledge related to physical drug-excipient interactions 
The interaction between drug and excipient was investigated in Chapters 3 and 4. In 
Chapter 4 drug-excipient interactions at a particle level in a blend containing 
ibuprofen and MCC were investigated using Percolation Threshold modelling and 
Raman imaging. The Raman imaging instrument used a short time for analysis i.e., 
approximately 15 minutes for each tablet with a diameter of 10 mm. The use of this 
instrument provides a fast and detailed analysis of tablets. Raman imaging, used here 
as an analytical technique, provided important formulation information, such as the 
measurement of drug distribution, and indirectly percolation threshold. Moreover, it 
is not necessary to perform any further analysis, the instrument generates all the 
information necessary for those applications during analysis. Other authors have 
investigated the percolation threshold of MCC (Kozicki, 2007; Kuentz and 
Leuenberger, 2000, 1998; Leuenberger, 1999). However, in this thesis, the critical 
exponent of the percolation power law was determined for the first time for the 
binary blend of MCC and ibuprofen. An accurate prediction of the threshold from 
compaction data was obtained using the percolation power law only because the 
coefficient has been determined as the initial step. The effects of the particle-particle 
interactions between ibuprofen and MCC on tablet CQAs disintegration and 
dissolution were investigated in Chapter 5. A step change in dissolution behaviour 
was noted across the percolation threshold determined. 
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In Chapter 3, drug-excipient interactions at a molecular level were investigated. API, 
hydrochlorthiazide, and several coformers were investigated in silico using quantum 
chemistry and thermodynamics simulations, and experimentally with a range of 
spectroscopic techniques, DSC and PXRD. The type of simulation used was proven to 
have good predictive power for cocrystal screening using excess/mixing enthalpy of 
supercooled API-coformer blends (Loschen and Klamt, 2015). The coformers 
screened had been previously investigated experimentally (Rodrigues et al., 2019, 
2018b; Sanphui et al., 2015; Sanphui and Rajput, 2014). The simulations performed 
in this thesis agreed with the experimental results obtained by these authors.  
6.4 Development of descriptive and predictive models and PAT tools 
Descriptive models are models used for process understanding. PAT-based models 
were designed to support analytical procedures and for process monitoring in 
Chapters 2, 3, and 5 (Table 6.2). Other types of models were applied to support 
process design: percolation threshold was used for tablet binary formulation design 
in Chapter 4, DoE was used for co-crystallization design in Chapter 3, COSMO-RS 
theory was used in Chapter 3 to screen for suitable coformers in early-stage co-
crystallization design, and the Heckel model was used to generate knowledge on 
blend processability in Chapter 4. The models were classified as mechanistic, hybrid 
or empirical (Table 6.3). 
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Table 6.2. Process analytical technology instruments and models used in the different 





Determine critical drug loading in tablet 
formulation 
Raman PCA 5 
Determine cocrystal optimal ratio MIR MCR 3 
Determine co-crystal phase purity MIR MCR 3 
Determine slurry co-crystallization end 
time 
Raman PCA 3 
Determine co-crystallization 
mechanism 
Raman PCA 3 





Determine MCC CMA (crystallinity) 





Table 6.3. Classification of the models used in this thesis within the groups 
mechanistic, hybrid, or empirical. 
Mechanistic Hybrid Empirical 
COSMO-RS theory Heckel PLS 
Simulation of theoretical PXRD Percolation threshold theory PCA 
380-method  MCR 
  DOE 
  GAB equation 
The models investigated in this thesis provided significant knowledge about materials 
and processes studied when used individually or in combination. In Chapter 3, for 
example, COSMO-RS theory was used for early-stage process design aiming to select 
appropriate coformers and solvents. Next, MCR was used to determine relative 
phase purity. Subsequently, a DOE model used the relative phase purity from the 
MCR model as response variable to define optimal process parameters (temperature 
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and agitation for each solvent). Finally, PCA was also performed in the same study to 
define a process parameter (slurry co-crystallization end time). 
The impact of choice of PAT probe was also investigated in this thesis. In Chapter 2, 
the results showed that Raman instruments with larger laser diameter provided a 
more representative information of the overall structure of the batch, averaging out 
localised variability. Smaller laser diameters could predict crystallinity from Raman 
spectra if a larger number of spectra are averaged. However, Raman instruments 
with larger laser diameter require less replicates, which greatly reduces time for 
analysis. In contrast, in Chapters 4 and 5 a Raman instrument with higher resolution, 
RA802 Pharmaceutical Analyser, was used to map ibuprofen distribution and 
quantitatively and qualitatively determine drug percolation threshold in a binary 
ibuprofen/MCC tablet. The imaging method involved the acquisition of around 
76,000 spectra over the entire surface of each tablet, with a pixel size of 10 µm/20 
µm. 
The main benefits of PAT-based methods used in this thesis were: 
 All techniques used are non-destructive, and they do not interfere on process 
transformations when they are used in situ. 
 The analysers can be used in situ to generate information on process 
transformation during the entire duration of the process e.g., Raman and PCA 
used in Chapter 3 to determine co-crystallization end point. 
 PAT based methods provided information that may not be captured by 
traditional techniques e.g., in Chapter 5 PVM and FBRM showed 
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disintegration nuances to which traditional tablet disintegration techniques 
were not sensitive. 
On the other hand, PAT models are data driven. This means that the model is built 
from experimental data and a design space is defined. Thus, the model cannot be 
applied for processes that are outside that design space, for example, for a different 
instrument. In this study, in Chapter 2 the constant values for the univariate linear 
model previously published for this technique (Agarwal et al., 2018) were specific to 
the instrument used and had to be redetermined in this study. Thus, a celebration of 
the model to the new design space had to be performed. 
A direct comparison between a univariate and a multivariate model was investigated 
in Chapter 2. The advantage of using the univariate model (380-method) is that it is 
simple enough to perform the linear regressions required to calibrate the model to 
the Raman instrument used and to calculate the crystallinity by the ratio of the peaks. 
However, milling the sample and Raman spectra deconvolution are required which 
makes the workflow tedious. On the other hand, by performing a PLS regression 
model deconvolution is discarded. Thus, milling a sample for calibration or for each 
batch analysed is not necessary. PLS regression models are rather simpler to be 
performed and have a much shorter time to analysis in comparison with the multi-
steps 380-method. Although, PLS regressions entails the usage of a multivariate 
analysis software or development of a code in a programming language such as 
Python or R. 
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6.5 Strengths and Limitations of the thesis 
6.5.1 Strengths  
 The effects of critical material attributes on the critical quality attributes were 
investigated in depth through a case study including intensive material, 
formulation, and product characterisation. Detailed scientific knowledge was 
developed on the relationship between MCC grade, percolation threshold of 
blends and tablet dissolution behaviour, and the effect of MCC variability on 
tablet disintegration and dissolution. 
 PAT tools were compared against traditional analytical techniques for a wide 
range of applications. 
 A wide range of modelling approaches were investigated. These included 
mechanistic, hybrid models and empirical models. 
 Rapid methods to determine a range of behaviours related to pharmaceutical 
dosage form manufacture and performance have been developed 
6.5.2 Limitations 
 Blends of ibuprofen and microcrystalline cellulose were used to investigate 
whether percolation threshold can predict the critical drug loading 
concentration and relative density of pharmaceutical tablets. However, 
commercial tablet formulations are composed of more complex blends with 
several ingredients. Thus, it would be valuable to apply the knowledge 
developed in this study to commercial tablet formulations. 
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 All models were developed for offline and retrospective usage, although online 
monitorization of processes with feedback control would have had a higher 
impact for industrial applications. 
 A wide range of PATs, models and unit operations were investigated prohibiting 
more in-depth investigation of each subject area. 
6.6 Recommendations for future work 
Based on the findings of this thesis the following work is suggested: 
 Further investigate the relationship between MCC CMAs e.g., crystallinity and 
moisture sorption. 
 Investigate how CPPs can be controlled based on the knowledge of the variability 
of MCC CMA. For example, how wet massing in a wet granulation tableting 
process can be controlled based on MCC crystallinity.  
 Investigate the application of percolation threshold model to multicomponent 
oral dosage form formulations.  
 Use particle modelling tools such as Monte Carlo simulation to estimate 
percolation threshold for complex formulations.   
 Investigate the application of Raman as a PAT tool to monitor tablet disintegration 
and dissolution.  
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6.7 Conclusions 
Extensive knowledge about tablet direct compression was produced: traditional 
techniques for determination of raw material and products characterization were 
critically investigated and alternative technologies were proposed when suitable, 
and percolation threshold model was used to predict formulation behaviour during 
tableting in pilot scale, disintegration, and dissolution. 
Different PAT tools were successfully designed: Raman with PLS to determine 
microcrystalline cellulose crystallinity index; MIR with MCR to determine optimal 
ratio of co-crystal formation and co-crystal phase purity; Raman with PCA to 
determine co-crystallization endpoint and in-process changes; Raman and PCA to 
identify differences between tablets produced with different grades of MCC; and 
PVM and FBRM provided information on tablet disintegration that traditional testing 
was not able to capture. 
Mechanistic and hybrid models were developed to support process design: 
percolation threshold theory was used to determine a critical threshold above which 
disintegration and dissolution showed a significant decrease; DOE was used to 
determine the optimal conditions to obtain the high purity co-crystals; and quantum 
chemistry models were used as an in silico coformer screening, which reduced time 
and cost of performing experimental screenings. 
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